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1. Introduction 
1.1 Introduction of the Sirtuin family 
1.1.1 Discovery of sirtuins and determination of their enzymatic activity 
Sirt7 and Sirt1 belong to a conserved family of proteins known as sirtuin and are 
found in all living species. Sirtuins: Sir-two-ns, derives from the name of yeast Sir2 
(silent information regulator 2). It was originally isolated in a screen for silencing 
factors in the yeast (Rine et al., 1979). The yeast Sir2 was then characterized as an 
important regulator of silencing at repeated rDNA (Gottlieb and Esposito, 1989), 
telomeres (Aparicio et al., 1991) and at mating-type loci (Braunstein et al., 1993). 
Subsequently, Sir2 homologues were found in bacteria, worms, flies, plants and 
mammals, suggesting that the sirtuin family genes are ancient and evolutionarily 
conserved. 
The insight into the enzyme activity of sirtuins came from the discovery that the 
gene silencing at mating-type loci and telomeres in yeast, is associated with 
hypo-acetylated histone proteins at the N-terminal lysine residues (Braunstein et al., 
1993). After the initial observation that CobB, an Escherichia coli homolog of Sir2, 
could catalyze the phosphoribosyltransferase reaction in cobalamin biosynthesis (Tsang 
and Escalante-Semerena, 1998), researchers postulated that Sir2 possessed 
NAD
+
-dependent ADP-ribosyltransferase activity, and the ADP-ribosylation of histones 
by Sir2 interferes with histone acetylation, leading to hypo-acetylation in histones. 
However, soon it was shown that Sir2 deacetylated histones and this activity was 
absolutely dependent on NAD
+ 
(Imai et al., 2000; Landry et al., 2000). Later other 
sirtuins, including bacterial CobB, archeabacterial Sir2-AF (Archaeoglobus fulgidus) and 
human Sirt1-3 and 5 were found also to have NAD+ dependent deacetyalse activity in vitro 
(Smith et al., 2000). The schematic representation of sirtuins enzymatic activity as shown in 
figure 1.1 
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1.1.2 Sirtuins and ageing in non-mammalian species 
A number of studies have suggested the role of sirtuins in aging in 
non-mammalian organisms. More than 14 years ago, the exponential accumulation of 
ERCs (extrachromosomal rDNA circles) was discovered as one of the major causes of 
ageing in S. cerevisiae (Sinclair and Guarente, 1997). ERCs are copied along with the 
mother cell’s chromosomes prior to cell division but remain in the mother cell’s nucleus 
afterward. Thus, a mother cell accumulates an ever increasing number of circles that 
eventually prevent further cell division, possibly because copying the ERCs consumes 
so many resources that the mother cell can no longer manage to replicate her own 
Fig 1.1  Sirtuin enzymatic activities 
Sirtuins are NAD
+
-dependent deacetylases and mono-ADP-ribosyl transferases. As 
deacetylases, they remove acetyl groups from proteins in the presence of NAD
+
. The acetyl 
group to is transferred to the ADP-ribose part of NAD
+ 
to form O-acetyl-ADP-ribose 
(2-OAADPr) and Nicotinamide(NAM). As Mono-ADP-ribosyl transferases, they remove the 
mono-ADP-ribose from NAD
+
 and attach it to protein, also releasing NAM as a reaction 
product.  
(Michan and Sinclair, 2007) 
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genome. However, when an extra copy of the Sir2 gene was added into yeast cells, 
ERCs formation was repressed and the cell’s lifespan was extended by 30% (Kaeberlein 
et al., 1999). That finding indicated that Sir2 could act as a longevity gene in yeast, and 
amazingly, it was soon discovered that extra copies of the Sir2 gene also increased the 
lifespan of roundworms up to 50% (Tissenbaum and Guarente, 2001). Subsequently, it 
was found that an extra copy of the Sir2 gene (dSir2) expressed ubiquitously in 
Drosophila melanogaster causes females and males to live longer (Rogina and Helfand, 
2004). But, the in-depth research work by Burnett and colleagues challenged the 
previous publications. The new data showed that Sir2 overexpression had no effects on 
lifespan in worm and fruitfly (Burnett et al., 2011). These conflicting results may have 
been due to confounding factors in experimental design and the differences in genetic 
backgrounds of the organism used in the individual studies. Even without life span 
extension effect, Sir2 overexpression made worms more resistant to toxic protein 
accumulation (Burnett et al., 2011). It could be that sirtuins play their main roles in 
physiological homeostasis and stress responses rather than in direct lifespan regulation.  
 
1.1.3 The mammalian sirtuin family 
The mammalian sirtuin family consists of seven sirtuins, Sirt1-7. All of them 
share a highly conserved NAD
+
-dependent catalytic core domain, which may act 
preferentially as a NAD
+
-dependent deacetylase (DAC) and/or mono-ADP-ribosyl 
transferase (ART). The flanking N- and C-terminal sequences are specific for each 
sirtuin (Frye, 2000), and may be responsible for their variation in binding partners and 
subcellular localization (Haigis and Sinclair, 2010) (Figure 1.2). Three mammalian 
sirtuins Sirt1, Sirt6 and Sirt7 are mainly nuclear proteins, however, Sirt1 has been found 
to shuttle between the nucleus and the cytoplasm in various tissues (Tanno et al., 2007). 
In the nucleus, Sirt1 mainly associates with euchromatin, whereas Sirt6 binds to the 
heterochromatin and Sirt7 localizes into the nucleous (Ford et al., 2006; Michishita et 
al., 2005). Sirt2 predominately resides in the cytoplasm (Frye, 1999; North et al., 2003), 
while Sirt3, Sirt4 and Sirt5 are mostly found in mitochondria (Michishita, Park et al. 
2005).  
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Mammalian sirtuins differ also in their enzymatic activity, Sirt1 exhibits robust 
deacetylase activity (Vaziri et al., 2001) and Sirt5 has weak deacetylation effect 
(Nakagawa and Guarente, 2009). Recently, a novel report showed that Sirt5 is an 
efficient protein lysine desuccinylase and demalonylase in vitro (Du et al., 2011). Sirt2, 
Sirt3 and Sirt6 possess both deacetylase and mono-ADP-ribosyl transferase activities 
(Frye, 1999; Liszt et al., 2005; North et al., 2003; Shi et al., 2005; Yang et al., 2009). 
The only reported activity so far of Sirt4 is mono-ADP-ribosyl transferase (Haigis et al., 
2006). The least investigated member, Sirt7, had generally been considered to have 
weak or undetectable deacetylase activity (Voelter-Mahlknecht et al., 2006). However, 
experiments from our laboratory demonstrated that Sirt7 can deacetylate p53 in vitro, 
which corresponds to hyperacetylation of p53 in the myocardium of Sirt7 deficient mice 
(Vakhrusheva et al., 2008b). Recently, it was showed that Sirt7 specifically deacetylated 
lysine 18 in histone H3 (H3K18Ac), and displayed no activity on other lysine sites in 
histones (Barber et al., 2012). Like their diverse sub-cellular localization, the 
mammalian sirtuins are differently expressed in organs, and have different protein 
targets. Generally, sirtuins play critical roles in essential physiological or pathological 
processes.  
Fig 1.2  Schematic representation of seven mammalian sirtuins 
The catalytic core domain (red) is conserved between all the seven mammalian sirtuins. The N and 
C-terminal flanking sequences vary in length. The seven sirtuins also show different sub-cellular 
localization. DAC, deacetylase; ART, mono-ADP-ribosyl transferase.    
(Michan and Sinclair, 2007) 
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1.1.4 Functional studies of mammalian nuclear sirtuins 
Sirt1  
Sirt1 is the best characterized sirtuin family member in terms of its function and 
activity (Fig 1.3). Similar to yeast SIR2, mammalian Sirt1 was shown to be able to 
deacetylate histones in vitro at lysine residues 9 and 26 of histone H1, 9 and 14 of H3 
and 16 of H4 (Imai et al., 2000; Vaquero et al., 2004). The hypoacetylation of histones 
facilitates heterochromatin formation and gene repression. Furthermore, Sirt1 directly 
binds to the histone methyltransferase Suv39h1 and enhances its methyltransferase 
activity on H3K9 by deacetylating lysine residue 266 in the SET domain of Suv39h1 
(Vaquero et al., 2007). Several studies have indicated that Sirt1 acts as a stress sensor 
and mediates the cellular survival in response to various stresses, such as inflammation, 
hypoxic stress, heat shock and genotoxic stress (reviewed by Nakagawa and Guarente, 
2011). Sirt1 improves stress resistance by deacetylating and modulating the activity of 
critical stress effectors such as NF-κB (Yeung et al., 2004), HIF1α (Lim et al., 2010), 
HIF2α (Dioum et al., 2009), HSF1(Westerheide et al., 2009), Ku70 (Jeong et al., 2007), 
PARP1 (Rajamohan et al., 2009) and so on, which are thought to be the important 
causes of aging and aging related diseases. Furthermore, a dual role of Sirt1 in 
carcinogenesis was revealed. Sirt1 seems to work as both oncogenic factor and tumor 
suppressor (Bosch-Presegue and Vaquero, 2011). The potential tumor suppressor effect 
of Sirt1 is supported by its role in maintaining genome stability through the regulation 
of chromatin structure and improvement of DNA damage repair (Bosch-Presegue and 
Vaquero, 2011). Alternatively, several studies supported the roles of Sirt1 in tumor 
initiation and progression, which included the effects of Sirt1 on inhibition of 
senescence and apoptosis (mostly via deacetylation and inactivation of some tumor 
suppressors such as p53 (Luo et al., 2001), FOXO family (Brunet et al., 2004), E2F1 
(Wang et al., 2006), Rb (Wong and Weber, 2007) and others), promotion of cellular 
growth and also angiogenesis (Liu et al., 2009).   
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Sirt1 has also been shown to regulate various aspects of metabolism such as 
glucose homeostasis (Rodgers et al., 2005), insulin secretion (Moynihan et al., 2005) 
and sensitivity (Bordone et al., 2006) and lipid metabolism (Kemper et al., 2009; Li et 
al., 2007; You et al., 2008) in different tissues. See below. 
 
Sirt6  
    MEFs and embryonic stem cells (ESCs) which carry Sirt6 deletion show genomic 
instability and impairment in base-excision repair (Mostoslavsky et al., 2006). Sirt6 
forms a macromolecular complex with DNA double-strand break repair factor DNA-PK 
(DNA-dependent protein kinase) and stabilizes its catalytic subunit to chromatin in 
response to DNA damage, thereby promoting DNA DSB repair (McCord et al., 2009). 
Sirt6 also promotes DNA end resection through C-terminal binding protein interacting 
protein (CtIP) deacetylation (Kaidi et al., 2010). Furthermore, Sirt6 can associate with 
telomeric chromatin and Sirt6 depletion leads to telomere dysfunction with end-to-end 
chromosomal fusions and premature cellular senescence (Michishita et al., 2008). The 
critical role of Sirt6 in maintaining the genome integrity and promoting DNA repair 
suggests that Sirt6 may act as a tumor suppressor and prevent cancer formation.  
      Moreover, a pivotal role of Sirt6 in the maintenance of glucose homeostasis by 
inhibiting HIF1 (Zhong et al., 2010) and through the suppression of insulin signaling 
Fig 1.3  Substrates and biological functions of Sirt1 
Adapted from (Nakagawa and Guarente, 2011) 
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and AKT activation (Xiao et al., 2010) has been demonstrated. A recent report 
demonstrated a role for Sirt6 in modulating the tumor metabolism: Sirt6 blocks cancer 
cell aerobic glycolysis (Warburg effect) and inhibits ribosome biogenesis by repressing 
the transcriptional activity of c-MYC, thereby preventing tumor progression (Sebastian 
et al., 2012).  
In addition to its role in genomic stability and regulation of metabolism, Sirt6 
was also shown to be involved in inflammatory processes. Sirt6 interacts with the RelA 
subunit of NF-κB and deacetylates histone H3K9 at NF-κB target gene promoters to 
attenuate NF-κB signaling (Kawahara et al., 2009). Thus, the hyperactive NF-κB 
signaling in Sirt6 deficient cells may contribute to premature and normal aging. Sirt6 
also regulates the production of tumor necrosis factor (TNFα) by acting at a 
post-transcriptional step in response to intracellular NAD
+ 
concentrations (Van Gool et 
al., 2009). It reveals the possible function of Sirt6 in the connection between 
metabolism and the inflammatory response.  
 
   Sirt7 
As the least studied mammalian sirtuin, Sirt7 has been shown to associate with 
rDNA and activate RNA polymerase I-dependent transcription in the nucleolus (Ford et 
al., 2006). Sirt7 may regulate cell growth and metabolism in response to nutritional and 
other signals by driving ribosome biogenesis in dividing cells. However, controversial 
findings were made on the possible influence on cell proliferation by Sirt7. An 
anti-proliferative role of Sirt7 was found in Sirt7 overexpressing cells while Sirt7 
knockout cells showed higher proliferation rates; in addition, Sirt7 expression level was 
decreased in several murine tumorigenic cell lines (Vakhrusheva et al., 2008a; 
Vakhrusheva et al., 2008b). Other reports suggested that Sirt7 may act as a principle 
activator of proliferation. Sirt7 is abundant in highly proliferative tissues but not in 
lowly proliferative tissues (Michishita et al., 2005). Sirt7 was found to be up-regulated 
in several tumors or tumor-derived cells such as thyroid carcinoma cells (Frye R, 2002), 
breast cancer cells (Ashraf et al., 2006) and hepatocellular carcinoma cells (Kim et al., 
2012). A recent report demonstrated that Sirt7 can promote the cancel cell proliferation 
Introduction 
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and transformation through the selective transcriptional repression of some tumor 
repression genes by deacetylating H3K18Ac on their promoters (Barber et al., 2012). In 
vivo studies using the Sirt7 knockout mice demonstrated a decreased life-span, a higher 
stress susceptibility and development of inflammatory cardiomyopathy with age in Sirt7 
deficient mice (Vakhrusheva et al., 2008b) .    
  Taken together, mammalian sirtuins target multiple substrates including histones 
and non-histone proteins, thereby affecting a broad range of cellular functions. They are 
apparently connected to an ever widening circle of activities that encompass cellular 
stress resistance, genomic stability, tumorigenesis and energy metabolism. However, the 
exact biological functions of individual sirtuins still remain only partially characterized. 
Knockout mice are important animal models for studying new genes functions. So far, 
specific knockout mice for all sirtuin members have been created (Fig. 1.4). The 
phenotypes of these knockout mice include a reduction of their lifespan, ranging from 
survival of days (Sirt1) to weeks (Sirt6) or months (Sirt7) (Finkel et al., 2009). In 
contrast, no significant abnormalities were observed in Sirt2 KO mice (Bobrowska et al., 
2012). Although Sirt3-/-, Sirt4-/- and Sirt5-/- mice appeared outwardly normal, some 
biochemical phenotypes have been reported (Haigis et al., 2006; Lombard et al., 2007; 
Nakagawa et al., 2009). In addition, the extensive efforts for screening and 
identification of sirtuin-modulating small molecules raised hopes for development of 
sirtuin targeted drugs which could have therapeutic benefits on metabolic and 
age-related diseases. The first Sir2-activating molecule, resveratrol, a polyphenolic 
compound produced by plants was identified in 2003 (Howitz et al., 2003). Since then 
further compounds have been discovered to activate sirtuins in vitro, collectively called 
the sirtuin activating compounds (STACs) (Milne et al., 2007). On the other hand 
nicotinamide (NAM), as a by-product in both sirtuin enzymatic reactions, can bind to 
the sirtuin/intermediate complex to promote the reverse reaction and thus inhibit the 
catalyzed reaction (Sauve, 2010). NAM was demonstrated to act as a noncompetitive 
inhibitor of sirtuins in yeast, flies and mammalian cells (Anderson et al., 2003; Sauve, 
2010), Subsequently, various other sirtuin inhibitors have been discovered, including 
splitomicin, sirtinol, AGK2, tenovin, suramin, cambino, and Ex527 (Alcain and Villalba, 
Introduction 
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2009; Napper et al., 2005).           
 
 
 
 
 
 
 
 
 
 
1.2  Physiological metabolic adaptation and the roles of sirtuins in liver 
1.2.1 Overview of liver function in metabolic adaptation  
The liver is the largest internal organ (the skin being the largest organ overall) 
and the largest gland in the body. Residing at the crossroads between the digestive tract 
and the rest of the body, the liver has a wide range of functions, the most important 
being the breakdown of food and its convertion into energy. Liver plays an essential role 
in the maintenance of the whole body’s metabolic homeostasis by regulating 
carbohydrate, fatty acid, amino acid and cholesterol metabolism in fed and fasting 
conditions (Zakim and Boyer, 2003). 
       In fed conditions, food intake leads to an increase of blood glucose 
concentration (glucose is quickly absorbed from the intestine and transported via blood), 
which is a potent stimulus for the release of insulin from the pancreas. Insulin then 
binds to its receptor (a member of the tyrosine kinase receptor family) and activates the 
insulin signaling cascade. The hepatic action of insulin has three major targets: a) to 
activate glucose storage as glycogen and to shutdown glucose production and output 
(Bollen et al., 1998), b) to promote lipogenesis in the fed state, and c) to block all 
catabolic actions (Fig.1.5). 
 
Fig 1.4  Mouse knockout models as 
tools for exploring sirtuin function 
Adapted from (Finkel et al., 2009), with 
modifications. 
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      In fasting conditions, glucose production in the liver is responsible for 
maintaining the blood glucose concentration within normal range and supplying glucose 
to the central nervous system. During starvation the liver has the ability to provide 
glucose from two sources: glycogenolysis and synthesis of glucose using 
noncarbohydrate precursors such as lactate, glucogenic amino acids and glycerol 
(gluconeogenesis). Glycogenolysis occurs in the post absorptive state, 2 – 6 hours after 
ingestion of a meal (Suh et al., 2007) and is sufficient for short term fasting. However, 
gluconeogenesis, is more important during prolonged periods of fasting (18 – 24 hours) 
(Klover and Mooney, 2004) and it accounts for up to 90% of endogenous glucose 
production after 40 hours of fasting (Boden, 2004; Chandramouli et al., 1997). Both 
glucose production and the suppression of glycogen synthesis are regulated by glucagon, 
which is also secreted by the pancreas (Fig 1.6).  
 
Fig 1.5 Scheme of hepatic signaling in fed state activating anabolic pathways in 
the liver. aPKC, atypical protein kinase C; ChREBP, carbohydrate response element binding protein; CPT1, 
carnitine palmitoyltransferase 1; FAS, fatty acid synthase; FoxO1/FoxA2, forkhead box protein O1/A2; G6Pase, 
glucose-6-phosphatase; GK, glucokinase; IRS, insulin receptor substrate; LXR, liver X receptor; MAPK, 
mitogen-activated protein kinase; MCAD, medium-chain acyl-CoA dehydrogenase; PEPCK, 
phosphoenolpyruvate carboxykinase; PI3-K, phosphoinositide-3 kinase; PK, pyuvate kinase; SREBP-1c, sterol 
regulatory element binding protein 1c.  (Fritsche et al., 2008) 
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In summary, the liver is under tight control of insulin and its catabolic 
counterpart glucagon to maintain carbohydrate and lipid metabolic homeostasis. The 
regulation of the gene transcription and activity of key enzymes in the postabsorptive 
state and during fasting involves the same key players such as the PI-3 kinase-Akt/PKB 
pathway, PGC-1, HNF-4, and transcription factors of the forkhead box protein and 
SREBP family (Fritsche et al., 2008). They are regulated less at their transcription 
levels but mostly by post-translation modifications under the response to hormones, 
thereby quickly promoting the body’s adaptation to energy alteration and maintaining 
homeostasis (Fritsche et al., 2008). 
 
1.2.2 Ribosome biogenesis and its role in liver 
 Ribosome biogenesis is the process that leads to assembly of ribosomal RNA 
(rRNA) and ribosomal proteins into the mature 40S and 60S ribosomal subunit. In 
Fig 1.6  Scheme of hepatic signalling events during fasting resulting in an 
increased glucose output from the liver. cAMP, cyclic adenosine monophosphate; CBP, CREB 
binding protein; CREB, cAMP response element binding protein; FoxO1, forkhead box protein O1; G6Pase, 
glucose-6-phosphatase; HNF-4, hepatocyte nuclear factor 4; PEPCK, phosphoenolpyruvate carboxykinase; 
PGC-1, peroxisome-proliferator-activated receptor-γco-activator 1; PK, pyuvate kinase; PKA, protein 
kinase A; Torc2, transducer of regulated CREB activity 2. (Fritsche et al., 2008) 
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eukaryotes, it takes place both in the cell cytoplasm and in the nucleolus of eukaryotic 
cells. Like most proteins, ribosomal proteins are synthesized in the cytoplasm and 
imported into the nucleus. 3 rRNAs (18S, 5.8S, 28S) are transcribed by RNA 
polymerase Ⅰ while 5.8s rRNA is transcribed by RNA polymerase Ⅲ in the nucleolus 
(Lafontaine, 2010; McStay and Grummt, 2008). In mammalian cells, rDNA 
transcription is a cell-cycle regulated process: transcription is absent during mitosis and 
gradually increases during G1, peaking in the S and G2 cell-cycle phases (Russell and 
Zomerdijk, 2005). The phosphorylation status of rDNA transcription factors including 
SL1 (Heix et al., 1998; Klein and Grummt, 1999; Sirri et al., 1999), UBF (Klein and 
Grummt, 1999) and TTF1 (Sirri et al., 1999) is mediated by cyclin-dependent kinases 
and participates in the regulation of rDNA transcription. After transcription, the rRNAs 
are put together with the ribosomal subunits to generate mature ribosomes in the 
nucleolus (Boisvert et al., 2007). A ribosome is a cellular component that synthesizes 
protein chains. While the liver is an important organ for protein synthesis, ribosome 
biogenesis has a great significance in hepatocyte cellular growth and function.  
Ribosome biogenesis is an energy consuming process, so it is critical for the 
cell to regulate ribosome production tightly depend upon the availability of nutrients 
and energy sources in the extracellular environment (Rudra and Warner, 2004). 
Switching off the rRNA synthesis is an effective way of saving energy in an attempt to 
maintain cellular homeostasis during acute stress (Murayama et al., 2008; Salminen and 
Kaarniranta, 2009). This is illustrated by regulation of rDNA transcription and ribosome 
biogenesis in the liver, where starvation leads to decrease in the ribosome production 
while refeeding stimulates ribosome biogenesis (Conde and Franze-Fernandez, 1980; 
Hutson and Mortimore, 1982). Ribosome biogenesis in response to nutrient signaling 
(in particular amino acid) is regulated by the mammalian target of rapamycin (mTOR). 
After stimulation by nutrient or growth factors, mTOR phosphorylates and activates 
eukaryotic initiation factor 4E (e-IF4E) and S6 kinase (S6K) to enhance translation 
(Hay and Sonenberg, 2004). In addition, mTOR also promotes rRNA transcription 
through phosphorylation of TIF-IA, a subunit of SL19 (Mayer et al., 2004) and UBF 
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(Hannan et al., 2003). Insulin plays a key role in liver function especially in the 
regulation of protein synthesis. Cell culture systems have provided evidence that insulin 
enhances ribosome biogenesis, i.e. by stimulating the transcription of rRNA genes 
(rDNA) in primary chick embryo fibroblast (DePhilip et al., 1979), undifferentiated 
mouse myoblasts (Hammond and Bowman, 1988), and primary rat hepatocytes 
(Antonetti et al., 1993). The mechanism through which insulin causes these alterations 
was not associated with a change in the cellular content of RNA polymerase I but with 
the increased nuclear content of upstream binding factor (UBF) and RNA polymerase 
I-associated factor 53 (PAF53) (Hannan et al., 1998). Both of them are thought to be 
involved in recruitment of RNA Pol I to the rDNA promoter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Furthermore, the structure of chromatin is also very important in regulation of 
Pol Ⅰ mediated rRNA transcription. The rDNA locus can be either active or silent 
depending on the epigenetic regulation of the chromatin structure. Epigenetic 
mechanisms such as DNA methylation and histone modification determine whether the 
chromatin structure of certain rDNA locus is open or closed for Pol Ι transactivation 
Figure 1.7 A model for the epigenetic on/off switch regulating nucleolar 
dominance. Changes in rRNA gene cytosine methylation, histone deacetylation and histone methylation 
occur in a concerted fashion. The “off” switch involves cytosine methylation, histone deacetylation, H3K9 
dimethylation and condensation of the rRNA genes into heterochromatin. In contrast, the “on” switch involves 
the loss of cytosine methylation, histone H3 and H4 hyperacetylation, H3K4 trimethylation and 
decondensation of rRNA genes into euchromatin. Adapted from (Preuss and Pikaard, 2007)  
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(Grummt, 2007; Grummt and Pikaard, 2003; McStay and Grummt, 2008; Preuss and 
Pikaard, 2007) (Fig 1.7). The chromatin remodeling complexes such as NoRC 
(nucleolar remodeling complex) (Grummt and Pikaard, 2003; McStay and Grummt, 
2008) and eNoSC (energy-dependent nucleolar silencing complex) (Murayama et al., 
2008) interact with histone deacetylases including Sirt1 and methyltransferases, which 
are potent epigenetic repressors in mammalian rDNA locus and mediate the epigenetic 
silencing of rRNA gene expression via methylation and deacetylation of histones.  
 
1.2.3 Nuclear sirtuins and liver metabolism 
      All members of mammalian sirtuin family have been found to be expressed in 
the liver with Sirt3, Sirt5 and Sirt7 showing a high mRNA expression (Dali-Youcef et 
al., 2007). Although Sirt1 mRNA expression is low, it is an important regulator of liver 
metabolism. Various reports have shown that Sirt1 regulates gluconeogenesis and 
glycolysis in the liver during starvation stress. For instance, Sirt1 leads to decreased 
gluconeogenesis during short-term fasting phase (less than 18 hrs) through its 
attenuation of TORC2, a key mediator of early phase gluconeogenesis (Liu et al., 2008). 
Prolonged fasting (24 hrs) promotes Sirt1 to deacetylate and activate PGC-1, an 
essential co-activator for a number of transcription factors, resulting in increased fatty 
acid oxidation and improved gluconeogenesis (Dominy et al., 2010; Purushotham et al., 
2009; Rodgers et al., 2005). Sirt1 also increases the activity of transcriptional factor 
Foxo1 via deacetylation, resulting in enhanced gluconeogenesis (Rodgers and 
Puigserver, 2007). In addition, Sirt1 suppresses the inhibitory effect of STAT3 (signal 
transducer and activator of transcription 3) on gluconeogenesis by deacetylating STAT3 
and decreasing its phosphorylation (Nie et al., 2009). So far, several lost of function 
studies of Sirt1 in knockout mice documented the essential role of Sirt1 also in 
maintaining hepatic lipid metabolic homeostasis. Specific deletion of the exon 4 which 
encodes the conserved catalytic domain of Sirt1 in mouse liver, resulted in impaired 
PPAR signaling and fatty acid β-oxidation, thereby increasing the susceptibility of 
mice to high-fat diet induced hepatic steatosis, inflammation and endoplasmic reticulum 
(ER) stress (Purushotham et al., 2009). Another deletion of hepatic Sirt1 exons 5 and 6 
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leads to the development of liver steatosis even under normal chow diet due to the 
increased expression of ChREBP (Wang et al., 2010). Conversely, overexpression of 
Sirt1 or treatment with specific Sirt1 activators attenuates hepatic steatosis and 
ameliorates systemic insulin resistance especially after high-fat feeding (Banks et al., 
2008; Feige et al., 2008; Li et al., 2011; Pfluger et al., 2008). Sirt1 also regulates hepatic 
cholesterol and bile acid homeostasis through direct modulation of the liver X receptor 
(LXR), farnesoid X receptor (FXR), and the sterol regulatory element binding protein 
(SREBP) family of transcription factors. It was previously shown that Sirt1 can directly 
deacetylate LXRs, resulting in increased LXR turnover and target gene expression. 
Systemic loss of Sir1 in mice results in decreased expression of LXR target genes 
involved in HDL biogenesis (Li et al., 2007). Recently, Kemper et al. showed that 
downregulation of hepatic SIRT1 increases the nuclear bile acid receptor FXR 
acetylation and inhibits its transaction activity, causing liver steatosis and decreased bile 
output (Kemper et al., 2009). Further studies showed that Sirt1 may also regulate 
hepatic lipid metabolism through deacetylation of SREBPs (Walker et al., 2010), which 
promotes the expression of lipogenic and cholesterolgenic genes and facilitates lipid 
storage (Osborne and Espenshade, 2009). In summary, these findings imply that hepatic 
Sirt1 plays a critical role in hepatic metabolic regulation and the improved activity of 
Sirt1 in the liver may be beneficial in treating obesity-associated diseases. 
          Sirt6, another nuclear sirtuin, also plays an important role in hepatic 
metabolism. Sirt6 null mice suffer from a severe metabolic imbalance, acute onset of 
hypoglycemia and premature death at one month of age (Mostoslavsky et al., 2006; 
Zhong et al., 2010). The hypoglycemia phenotype in Sirt6 knockout mice may be 
caused by an enhanced glucose uptake, associated with the more abundant GLUT1 and 
GLUT4 expression in Sirt6 deficient mice and increased insulin signaling and activation 
of AKT (Xiao et al., 2010). It was reported that Sirt6 functions as a histone H3K9 
deacetylase to inhibit the expression of the transcription factor Hif1 and its multiple 
glycolytic target genes (Zhong et al., 2010). Thus, Sirt6-deficient cells or mice exhibit 
high Hif1 activity and increased glucose uptake with upregulation of glycolysis and 
diminished mitochondrial respiration, providing another explanation for the 
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hypoglycemia phenotype of Sirt6 KO mice. Moreover, the liver-specific knock out of 
Sirt6 mice results in liver steatosis due to increased glycolysis and triglyceride synthesis, 
and reduced fatty acid oxidation (Kim et al., 2010).  
     So far, the function of nucleolar Sirt7 in control of the metabolic homeostasis in 
the liver was not analyzed.  
 
1.3 Molecular basis of adipocyte differentiation (adipogenesis) 
1.3.1 Adipose tissue and its function 
Adipose tissue or fat tissue is a loose connective tissue which is composed 
mainly of adipocytes and fibroblasts. Generally, two types of adipose tissue can be 
recognized in mammals: white adipose tissue (WAT) and brown adipose tissue (BAT). 
WAT is dispersed throughout the body with major intraabdominal depots around the 
omentum, intestines, and perirenal areas, as well as in subcutaneous depots in the 
buttocks, thighs, and abdomen (Gesta et al., 2007). 90% of cytoplasm in these 
adipocytes consists of lipids, mainly triacylglycerol, thus, WAT constitutes a primary 
site of energy storage. White adipose tissue functions to store energy in form of 
triacylglycerol. During starvation, this storage can be mobilized for energy utilization. 
The white adipose tissue can also act as insulator to maintain the body temperature in 
warm-blooded animals and protect the surrounded organ from injury. Moreover, adipose 
tissue has in recent years been recognized as a major endocrine organ (Kershaw and 
Flier, 2004), as it produces certain cytokines called adipokines such as adiponectin, 
leptin, resistin, TNFα (Rondinone, 2006) and also hormones as for example the sex 
hormone estrogen (Nelson and Bulun, 2001). Brown adipose tissue is especially 
abundant in newborns and in hibernating mammals (Gesta et al., 2007).
 
In contrast to 
white adipocytes, brown adipocytes contain numerous smaller lipid droplets and a much 
higher number of mitochondria, which contain iron and responsible for the brown 
coloring (Enerback, 2009). Its primary function is to generate body heat by energy 
expenditure in animals or newborns (Cannon and Nedergaard, 2004). 
1.3.2 Development of obesity and adipogenesis 
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Obesity is a medical condition in which excess body fat has accumulated to 
the extent that it has adverse effect on health, leading to reduced life expectancy and/or 
various diseases such as type 2 diabetes mellitus, coronary heart disease, certain forms 
of cancer, asthma and osteoarthritis (Kopelman, 2000). There is a marked increase in 
the incidence of obesity in modern societies, especially in the western countries 
(Haslam and James, 2005; Woodhouse, 2008). 
Obesity develops when energy intake exceeds energy expenditure 
(Spiegelman and Flier, 2001). Growth in adipose tissue and long-term changes in fat 
storage is the result of both hypertrophy (increase in size) and hyperplasia (increase in 
number) of adipocytes (Hausman et al., 2001). Hypertrophy is thought to be the initial 
event that occurs during development of obesity. The excess energy is stored in white 
adipocytes as triacylglycerol, the accumulation of lipids leads to the expanded size of 
adipocytes. However, adipocytes cannot grow and accumulate lipids indefinitely. When 
adipocytes exhaust their storage capacity, there is a subsequent increase in cell number 
(Otto and Lane, 2005). Hyperplasia is related to the generation of new adipocytes from 
precursor cells, called preadipocytes, which are fibroblast-like cells (Hausman et al., 
2001). This process, also referred as ‘adipogenesis’, is the key regulatory process 
involved in the normal adipose tissue development and the development of obesity.  
 
1.3.3 Adipocytes development 
Adipose tissue develops from pluripotent mesenchymal stem cells (MSCs), 
which are capable of differentiating into adipocytes, osteoblasts, chondrocytes, 
myoblasts, and connective tissue (Gesta et al., 2007). Signaling factors responsible for 
the commitment to the adipocyte lineage are still not well characterized. The signals 
may be secreted by a mature adipocyte to recruit new cells to the adipocyte lineage 
(Otto and Lane, 2005; Rosen and MacDougald, 2006). BMP4 has been shown to play a 
role in commitment to preadipocytes in vitro. BMP4-treated 10T1/2 cells (multipotent 
stem cell line similar to mesenchymal stem cells) acquire the characteristics of 
preadipocytes capable for differentiating into adipocytes (Tang et al., 2004). Recently, 
several studies demonstrated that other multiple factors may influence the MSCs 
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commitment to preadipocytes, including transforming growth factor β (TGFβ), insulin 
like growth factor 1 (IGF1), fibroblast growth factor 1 (FGF1), FGF2, activin, Wnt 
signaling, etc (reviewed by (Lowe et al., 2011). Once committed, MSCs give rise to 
undifferentiated precursors (osteoblast, adipoblast/preadipocyte, and myoblast), which 
upon activation of key transcription factors enter a differentiation program to acquire 
their specific functions. The transition from preadipocyte to adipocyte is orchestrated by 
a transcriptional cascade involving the nuclear receptor PPARγ and members of the 
C/EBPs family. Adipogenesis comprises four stages: preadipocytes proliferation, 
contact growth arrest, mitotic clonal expansion (early differentiation), and terminal 
differentiation (Gesta et al., 2007).  
 
1.3.4 Transcription factors in adipogenesis 
      The most important transcription factors involved in the regulation of 
differentiation are the peroxisome proliferator-activated receptors (PPARs) family and 
the CCAAT/enhancer-binding proteins (C/EBPs) family, both of them belong to the 
nuclear receptor family similar to retinoic acid receptors and vitamin D3 receptors (Otto 
and Lane 2005). There are 3 members of the PPAR family: , β and γ (Moreno et al., 
2010), among which, PPARγ plays a critical role in adipocytes differentiation and is 
both necessary and sufficient for adipogenesis. No factor has been identified that can 
rescue adipogenesis in the absence of PPARγ so far (Rosen and MacDougald, 2006). 
Two major protein isoforms of PPARγ (PPARγ1 and PPARγ2) are generated from a 
differential promoter usage and an alternative first exon of the PPARγ gene, the latter 
contains an additional 30 amino acids at its N-terminus (Tontonoz and Spiegelman, 
2008). In contrast to the ubiquitous expression of PPARγ1 in many tissues, PPARγ2 
expression is restricted to adipose tissue under normal condition and can be induced in 
the liver of mice exposed to a high fat diet (Vidal-Puig et al., 1996). Adipogenesis of 
PPARγ2-deficient primary preadipocytes or MEFs is severely impaired 
(Medina-Gomez et al., 2005; Zhang et al., 2004). In 3T3-L1 cells, in which both 
PPARγ1 and PPARγ2 were inhibited, ectopic expression of PPARγ2 rescued the 
adipogenesis whereas ectopic expression of PPARγ1 did not (Ren et al., 2002). 
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Although both PPARγ1 and PPARγ2 can enhance adipocytes differentiation in PPARγ 
deficient embryonic fibroblasts, PPARγ2 is more efficient at promoting adipogenesis 
(Mueller et al., 2002; Ren et al., 2002).  
Like most nuclear receptors, PPARγ forms a heterodimer with RXR prior to 
binding to DNA, then binds to the PPAR response element in the promoter region of the 
target genes and controlling their expression (Aranda and Pascual, 2001). Although the 
specific endogenous PPARγ ligands remain unclear, several dietary fat and lipid 
metabolites including polyunsaturated fatty acids, certain prostanoids and oxidized fatty 
acids have been postulated to activate PPARγ receptor (Tontonoz and Spiegelman, 
2008). Furthermore, synthetic ligands, such as antidiabetic drugs thiazolidinedione (for 
example, rosiglitazone and piglitazone) were identified as potent activators/agonist of 
PPARγ (Tontonoz and Spiegelman, 2008).     
 PPARγ is the key regulator of adipogenesis and sits at the core of the 
adipogenic cascade in a feedback loop with C/EBPα. A variety of positive signaling 
regulators have been identified that act upstream of PPARγ, including C/EBPβ and -δ, 
STAT5, KLF4 and 5, early B cell factor-1 (EBF1), early growth response-2 (EGR2, 
also known as KROX20), brain and muscle Arnt-like protein 1 (BMAL1, also known as 
ARNTL1). In addition to the activators, inhibitory effects have been described for 
forkhead box protein O1 (FOXO1), globin transcription factors 2 and 3 (GATA2 and 
GATA3), C/EBP homologous protein 10 (CHOP10), KLF3, HIF1, C-terminal-binding 
proteins 1 and 2 (CTBP1 and CTBP2) and others (reviewed by Lowe et al., 2011). 
Activation of PPARγ promotes terminal differentiation through the induction of a 
variety of differentiation-dependent target genes important for triglyceride uptake and 
storage, including fatty-acid-binding protein (FABP4, also known as adipocyte protein 
2, aP2), sn-1-acylglycerol-3-phosphate acyltransferase 2 (AGPAT2), lipoprotein lipase 
(LPL), perilipin and the secreted factors adiponectin and leptin (Lowe et al., 2011).  
C/EBP family consists of 6 isoforms: α, β, γ, δ,  (CHOP-10), and ε. All 
members except the ε are involved in adipogenesis (Otto and Lane, 2005). C/EBPβ and 
δ are involved in the early regulation of the adipogenesis. They are rapidly induced and 
achieve the maximal protein levels within 4 hours after the induction of differentiation 
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(Tang and Lane, 1999). The early expressed C/EBPβ and δ then induce the expression 
of C/EBP and PPARγ (Farmer, 2006). C/EBP is induced late in adipogenesis and it 
is essential for differentiation. It activates several adipogenic genes including PPARγ, 
C/EBP itself and other adipocyte marker genes (Otto and Lane, 2005). Despite the fact 
that both C/EBP and PPARγ are very important in adipogenesis, PPARγ appears to 
play a dominant role, since ectopic expression of PPARγ can rescue the differentiation 
of MEFs lacking C/EBPα to adipocytes (Wu et al., 1999), but forced expression of 
C/EBPα cannot rescue the impaired differentiation in MEFs lacking PPARγ (Rosen et 
al., 2002). Other C/EBP isoforms, CHOP10 and C/EBPγ, seem to be anti-adipogenic 
factors, presumably through the inactivation of C/EBPβ (Darlington et al., 1998). 
        In addition, the basic helix-loop-helix (bHLH) transcription factor 
ADD1/SREBP1c is also an important regulator linking lipogenesis and adipogenesis. 
ADD1/SREBP1c can activate a broad battery of genes involved in fatty acid and 
triglyceride metabolism in both fat and liver and can also accelerate adipogenesis (Kim 
and Spiegelman, 1996). The mechanism of how ADD1/SREBP1c promotes adipogensis 
could act via direct activation of PPARγ (Fajas et al., 1999) or through generation of 
endogenous PPARγ ligands (Kim et al., 1998). 
 
1.3.5 The role of sirtuin proteins in adipose tissue and adipogenesis 
Recent studies have shown that sirtuins regulate many metabolic adaptations 
linked with obesity (the relations of sirtuins and metabolic adaptation have been 
introduced in 1.1 and 1.2.6). So far, some investigations have suggested that sirtuins 
control metabolic balance through the modulation of adipogenesis, as well as 
maturation and remodeling of adipose tissue. Sirt1 was shown to attenuate adipogenesis 
and increase lipolysis through the repression of PPAR-γ transcription by docking with 
its cofactors NCoR (nuclear receptor co-repressor) and SMRT (silencing mediator of 
retinoid and thyroid hormonereceptors) to its promoter (Picard et al., 2004). 
Overexpression of ectopic Sirt1 blocks adipogenesis in 3T3-L1 cells, a cell culture 
model of adipocyte differentiation, while inhibition of endogenous Sirt1 by knockdown 
promotes it (Picard et al., 2004). Consistently, the specific genetic ablation of Sirt1 in 
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white adipose tissues leads to obesity and insulin resistance similar to the high-fat diet 
induced obesity in wildtype mice (Chalkiadaki and Guarente, 2012). In contrast, 
transgenic mice moderately overexpressing Sirt1 or mice treated with Sirt1 specific 
activators gain less body weight and have less WAT mass, and are protected against 
high-fat-diet induced obesity and metabolic damage (Baur et al., 2006; Bordone et al., 
2007; Feige et al., 2008; Kim et al., 2011b; Lagouge et al., 2006). Moreover, Sirt1 
represses the inflammatory gene expression in WAT, which leads to block of 
macrophage influx and inhibition of inflammation in adipose tissue (Gillum et al., 2011). 
Sirt1 also improves the insulin sensitivity in adipose tissue by deacetylating NF-κB 
(Yoshizaki et al., 2009). A recent report showed that Sirt1 can directly deacetylate 
PPARγ to recruit the brown adipose tissue program coactivator Prdm16 to PPARγ, 
leading to selective induction of BAT genes and repression of visceral WAT genes 
(Qiang et al., 2012). 
       Another sirtuin family member Sirt2, the most abundant sirtuin in adipocytes 
was also shown to regulate adipocyte differentiation (Jing, Gesta et al. 2007). Sirt2 
overexpression inhibits adipogensis while Sirt2 reduction promotes adipogenesis in 
3T3-L1 preadipocytes. The mechanism underlying Sirt2 effects includes the 
deacetylation of FOXO1, which in turn represses its phosphorylation and increases 
FOXO1 nuclear localization to promote FOXO1’s binding to PPARγ promoter and 
subsequent repression of PPARγ transcriptional activity (Jing et al., 2007; Wang and 
Tong, 2009). 
Sirt3, a mitochondrial sirtuin, has been shown to regulate mitochondrial 
function and thermogenesis in brown adipocytes. Enforced expression of SIRT3 in the 
HIB1B brown adipocytes enhances expression of the uncoupling protein UCP1, and 
several other mitochondria-related genes. Both ADP-ribosyltransferase and deacetylase 
activities of Sirt3 are required for this action. It was postulated that Sirt3 stimulates 
CREB phosphorylation, which then directly activates PGC-1 promoter, resulting in the 
increased UCP1 expression (Shi et al., 2005).  
The nucleolar sirtuin Sirt7 interacts with RNA polymerase I and the transcription 
factor UBF to positively regulate rDNA transcription (Ford et al., 2006; Grob et al., 
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2009). Therefore, Sirt7 seems to be a regulator linking cell growth and metabolism to 
nutrition response through its impact on the ribosome biogenesis. Such functions are 
especially important in the metabolically active tissues such as adipose tissue and liver. 
However, no investigations of Sirt7 role in these tissues in vivo were reported so far. 
The Sirt7 knockout mice generated in our laboratory exhibited various phenotypes such 
as smaller size, kyphosis, loss of visceral and subcutaneous fat and protection against 
high fat induced obesity (Vakhrusheva et al., 2008b; Yoshizawa et al., unpublished data). 
These preliminary data suggest that Sirt7 might play important roles in the adipogenic 
differentiation and in the maintenance of the adipose tissue.  
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2. Materials and Methods 
2.1 Materials 
2.1.1 Antibodies 
Table 2.1 List of primary antibodies 
Name  Type 
Company or other 
resource 
Application 
Sir 2 (Sirt1) rabbit, polyclonal 
Upstate 
(Cat.07-131) WB (1:1000), ChIP 
Sirt1 
rabbit, polyclonal 
Cell Signaling 
Techn.(Cat.2028) WB (1:1000), IF 
Sirt7 mouse, monoclonal 
A. Vaquero, 
Barcelona, Spain WB (1:1000) 
RalA mouse, monoclonal BD (Cat.610221) WB (1:5000) 
GAPDH  rabbit, polyclonal 
Cell Signaling 
Techn.(Cat.2118) WB (1:2000) 
β-actin mouse, monoclonal 
Sigma 
(Cat.A-5441) WB (1:5000) 
β-tubulin mouse, monoclonal Sigma (Cat.T-4026) WB (1:5000) 
aP2 Chicken, IgY 
Millipore 
(Cat.ab3515) WB (1:1000) 
FLAG M2 mouse, monoclonal 
Sigma 
(Cat.F-1804) WB (1:5000), IP 
p53 rabbit, polyclonal 
Cell Signaling 
Techn.(Cat.9282) WB (1:1000) 
p53 (acetyl 
K373 + K382) mouse, monoclonal 
abcam 
(Cat.ab4276) WB (1:1000) 
Pan-actin 
rabbit, polyclonal 
Cell Signaling 
Techn.(Cat.4968) WB (1:5000) 
Histone 
AcH3K9 rabbit, polyclonal 
abcam 
(Cat.ab10812) WB (1:1000), ChIP 
Histone 
H3K9me3 rabbit, polyclonal 
abcam 
(Cat.ab8898) ChIP 
Histone H3 rabbit, polyclonal 
abcam 
(Cat.ab1791) 
WB (1:10000), 
ChIP 
(CGY)FP Tag 
mouse, monoclonal 
Evrogen 
(Cat.ab122)  WB (1:5000), IP 
PPARγ 
rabbit, polyclonal 
Santa Cruz 
(Cat.sc-7196) WB (1:1000), IF 
PPARγ2 
goat, polyclonal 
Santa Cruz 
(Cat.sc-22022) WB (1:200) 
RNA pol I rabbit, polyclonal Santa Cruz ChIP 
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(Cat.sc-28714) 
UBF 
rabbit, polyclonal 
Santa Cruz 
(Cat.sc-9131) ChIP 
 
Table 2.2 List of secondary antibodies 
Name  Type 
Company or other 
resource 
Application 
anti-rabbit 
IgG 
goat, HRP-conjugated Pierce (Cat.1858415) 
WB (1:5000) 
anti-mouse 
IgG 
goat, HRP-conjugated Pierce (Cat.1858413) 
WB (1:5000) 
anti-Chicken 
IgY 
goat, HRP-conjugated abcam(Cat.ab6877-1) 
WB (1:1000) 
anti-goat IgG donkey, HRP-conjugated 
rockland 
(Cat.600667625) WB (1:1000) 
anti-rabbit 
IgG 
goat, Alex594-conjugated 
Invitrogen 
(Cat.A11012) WB (1:1000) 
anti-rabbit 
IgG 
goat, Alex488-conjugated 
Invitrogen 
(Cat.A11070) WB (1:1000) 
 
2.1.2 Primers  
All primers were synthesized and ordered from Invitrogen or Sigma-Aldrich 
Table 2.3 List of primers for quantitative real-time-PCR (QRT-PCR) 
Name Sequence 
Annealing  
temp.in °C  
mouse rDNA 
(promoter) 
Forward: 5’-GTTGTCAGGGTCGACCAGTTGT-3’ 
Reverse: 5’-GTGTCCTTTAGTGTTAATAGGG-3’   
56 
mouse PPARγ2 
(promoter) 
Forward: 5’-CTGTACAGTTCACGCCCCTC-3’ 
Reverse: 5’-TCACACTGGTGTTTTGTCTATG-3’   
62 
human pre-rRNA 
(5'ETS) 
Forward: 5’-GAACGGTGGTGTGTCGTTC-3’ 
Reverse: 5’-GCGTCTCGTCTCGTCTCACT-3’   
56 
human β-actin 
Forward: 5’ATCGTCCACCGCAAATGCTTCTA-3’ 
Reverse: 5’-AGCCATGCCAATCTCATCTTGTT-3’    
60 
mouse pre-rRNA 
(5'ETS) 
Forward: 5’-TTTTTGGGGAGGTGGAGAGTC-3’ 
Reverse: 5’-CAGAACAAGAGAACACAACGAG-3’   
56 
mouse β-actin 
Forward: 5’-CAACGAGCGGTTCCGATG-3’ 
Reverse: 5’-GCCACAGGATTCCATACCCA-3’    
60 
mouse Sirt1  
Forward: 5’-AAAAGATAATAGTTCTGACTGGAGCTG-3’ 
Reverse: 5’-GGCGAGCATAGATACCGTCT-3’    
60 
mouse Sirt7  
Forward: 5’-CCCCGGACCGCCATCTCAG-3’ 
Reverse: 5’-ATCTCCAGGCCCAGTTCATTCAT-3’   
56 
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mouse PPARγ2  
Forward: 5’-TGCGGAAGCCCTTTGGTGAC-3’ 
Reverse: 5’-CTTGGCGAACAGCTGAGAGGAC-3’    
60 
mouse C/EBPα 
Forward: 5’-GGATTCCTGCTTCCTCTCG-3’ 
Reverse: 5’-CGGGATCTCAGCTTCCTGTA-3’    
58 
mouse aP2 
Forward: 5’-GAAAACGAGATGGTGACAAGC-3’ 
Reverse: 5’-GCCCTTTCATAAACTCTTGTGG-3’    
58 
 
Table 2.4 List of primers for semi-quantitative RT-PCR 
Name Sequence 
Annealing  
temp.in °C  
mSirt1 Ex1-Ex56 
Forward: 5’-GACGACGAGGGCGAGGAGGAGGAC-3’ 
Reverse: 5’-TTGCAAAGGAACCATGACACTGAA-3’    
62 
mSirt7 Ex6-Ex9 
Forward: 5’-CCCCGGACCGCCATCTCAG-3’ 
Reverse: 5’-ATCTCCAGGCCCAGTTCATTCAT-3’   
62 
mouse GAPDH 
Forward: 5’-GACGACGAGGGCGAGGAGGAGGAC-3’ 
Reverse: 5’-TTGCAAAGGAACCATGACACTGAA-3’    
56 
 
Table 2.5 List of primers for genotyping 
Name Sequence 
Annealing  
temp.in °C  
mouse SnaB loxP 
P1F 
Forward: 5’-GGCAGTATGTGGCAGATT-3’   56 
mouse SnaB loxP 
P2R 
Reverse: 5’-CCTGAAACAGACAAGACCT-3’   56 
mouse Sfi loxP P3F Forward: 5’-CAGGCTGGTTTCCAATGTCT-3’ 56 
mouse Sfi loxP P4R Reverse: 5’-AAAGGCTGCGGCTCAGACAA-3’ 56 
Neo loxP P5 F Forward: 5’-CCTCCCCCGTGCCTTCCT-3’ 56 
Neo loxP Del P6 R Reverse: 5’-GAACATAACAGCCAGGCAT-3’ 56 
Cre 
Forward: 5’-GACCAGGTTCGTTCACTCATGG-3’ 
Reverse: 5’-AGGCTAAGTGCCTTCTCTACAC-3’    
55 
Flp 
Forward: 5’-CTGGAGGATAACTTGTTTATTGC-3’ 
Reverse: 5’-CTAATGTTGTGGGAAATTGGAGC-3’    
54 
 
Table 2.6 List of primers for Northern blot probes 
Name Sequence 
Annealing  
temp.in °C  
mSirt7 NB   
Forward: 5’-CCCCGGACCGCCATCTCAG-3’ 
Reverse: 5’-ATCTCCAGGCCCAGTTCATTCAT-3’   
58 
mSirt1 NB 
Forward: 5’-GTTCTGACTGGAGCTGGGGTTTCT-3’ 
Reverse: 5’-TGGGCGTGGAGGTTTTTCAGTAAT-3’   
62 
mAceCS1 NB Forward: 5’-TCCCAGCGCTGCCCCATTGTAGAC-3’ 55  
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Reverse: 5’-AGGGGCAGGATGGATGGGCAGAAA-3’   
mPEPCK NB 
Forward: 5’-ATCATCTTTGGTGGCCGTAG-3’ 
Reverse: 5’-CCTCCTTCTCCCAGAACTCC-3’   
56 
mFAS NB 
Forward: 5’-CTGCGGCTGCGTGGCTATGATTAT-3’ 
Reverse: 5’-TCCAGCTGCAGGTTCCCGTTGAG-3’   
56 
 
Table 2.7 List of primers for Southern blot probes 
Name Sequence 
Annealing  
temp.in °C  
mSirt1 SB internal 
probe 
Forward: 
5’-CCGCTCGAGTGGTATGTTTTATAATGGAC-3’ 
Reverse: 5’-GGCCGAATTCAAAATCTTGAGACAAT-3’   
56 
mSirt1 SB 3'probe  
Forward: 5’-CGAGTGCTGGGATTAAAGGTGTAT-3’ 
Reverse: 5’-TCAGCCCCTCATCCTCACAA-3’   
56 
 
Table 2.8 List of primers for the construction of targeting vectors 
Name Sequence Application 
mSirt1 1RP5’ 
Forward: 5’-TCCCCCGGGGTTTAAACAAAGATGGGC 
CAGACATGGT -3’ 
Reverse: 5’-CCGAAGCTTGCACTCAGTGTATACAGCA 
-3’   
mSirt1 CKO  
target 
construct 
mSirt1 1RP3’ 
Forward: 5’- GCCGAGATCTGGCATACATACTATCA -3’ 
Reverse: 5’- GGAATTCTGCCATATGGTCTCATATAG -3’   
mSirt1 CKO  
target 
construct 
mSirt1 1MT5’ 
Forward: 5’- CGGGATCCGTCACTAGAAACTTTGCAA -3’ 
Reverse: 5’-GTTCCGCGGACCCTTACAGTTCTGAGA-3’   
mSirt1 CKO  
target 
construct 
mSirt1 1MT3’ 
Forward: 5’-CCGCTCGAGTGGTATGTTTTATAATGGAC 
-3’ 
Reverse: 5’- GGCCGAATTCAAAATCTTGAGACAAT -3’   
mSirt1 CKO  
target 
construct 
 
mSirt1 CKO 
loxP F/R 
Forward: 5’-GAGGCTACGTAATAACTTCGTATAATGT 
ATGCTATACGAAGTTATTACGTAGATCC-3’ 
Reverse: 5’-GGATCTACGTAATAACTTCGTATAGC 
ATACATTATACGAAGTTATTACGTAGCCTC-3’   
loxp sequence 
for insertion 
into the SnaB 
I or SfiI site 
 mSirt7-flag   
Forward: 5’-ATGGCAGCCGGTGGCGGTCTGAGCC-3’ 
Reverse: 5´-CTATCACTTGTCGTCATCGTCTTTGTAGT 
CTGCCACTTTCTTCCTTTTTGCACG-3´ 
pBabe-mSirt7
Flag construct 
 
 
Table 2.9 List of primers for mutagenesis 
These primers were designed by the "Quick Change primer design" program of 
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Stratagene and synthesized by Sigma-Aldrich. 
Name Sequence 
mSirt7 H188Y  
Forward: 5'-ACCGCCATCTCAGAGCTCTATGGGAATATGTATATTGA-3' 
Reverse: 5'-TCAATATACATATTCCCATAGAGCTCTGAGATGGCGGT-3'   
mSirt1 K230R 
Forward: 5'-GAACCACCAAAGCGGAAAAAAAGAAGAGATATCAAT 
ACAATTGAAG-3' 
Reverse: 5'-CTTCAATTGTATTGATATCTCTTCTTTTTTTCCGC 
TTTGGTGGTTC-3'   
mSirt1 K369R 
Forward: 5'-AACAGCATCTTGCCTGATTTGTAAATACAGAGTTGA 
TTGTGAAGC-3' 
Reverse: 5'-GCTTCACAATCAACTCTGTATTTACAAATCAGGCA 
AGATGCTGTT-3'   
mSirt1 K505R 
Forward: 5'-GTAAAGCTTTCAGAAATTACTGAAAGAC 
CTCCACGCCCA-3' 
Reverse: 5'-TGGGCGTGGAGGTCTTTCAGTAATTTCTGAAAGCTTTAC-3'   
mSirt1 K600R 
Forward: 5'-TGGTTCCAGTACTGCAGACAGAAATGAAAGAA 
CTTCAGTTG-3' 
Reverse: 5'-CAACTGAAGTTCTTTCATTTCTGTCTGCAGTAC 
TGGAACCA-3'   
 
Table 2.10 List of primers for sequencing 
Name Sequence 
T7 5'-TAATACGACTCACTATAGGG-3'   
Sp6 5'-ATTTAGGTGACACTATAG-3' 
CMV Forward 5'-CGCAAATGGGCGGTAGGCGTG-3' 
pBABE 5' 5'-CTTTATCCAGCCCTCAC-3' 
BGH Reverse 5'-TAGAAGGCACAGTCGAGG-3'  
YFP Forward 5'-CAGAGCTGGTTTAGTGAACC-3' 
SnaB loxP For 5'-GGCAGTATGTGGCAGATT-3’   
Sfi loxP For 5'-CAGGCTGGTTTCCAATGTCT-3’ 
 
2.1.3 DNA probes for Northern blot and Southern blot 
 Table 2.11 List of probes for Northern blot 
Name PCR primers Note 
mSirt7   
 mSirt7 NB For 
 mSirt7 NB Rev   
the 456 bp PCR fragment was cloned into the pGEM-T Easy 
vector and excised with EcoR I, the resulting 470 bp fragment 
was used for hybridization at 60 °C 
mSirt1  
 mSirt1 NB For 
 mSirt1 NB Rev   
the 678 bp PCR fragment was cloned into the pGEM-T Easy 
vector and excised with EcoR I, the resulting 690 bp fragment 
was used for hybridization at 60 °C 
mAceCS1  mAceCS1 NB F the 807 bp PCR fragment was cloned into the pGEM-T Easy 
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 mAceCS1 NB R vector and excised with EcoR I, the resulting 820 bp fragment 
was used for hybridization at 60 °C 
mPEPCK 
 mPEPCK NB F 
 mPEPCK NB R  
the 474 bp PCR fragment was cloned into the pGEM-T Easy 
vector and excised with EcoR I, the resulting 488 bp fragment 
was used for hybridization at 60 °C 
mFAS 
 mFAS NB For 
 mFAS NB Rev  
the 592 bp PCR fragment was cloned into the pGEM-T Easy 
vector and excised with EcoR I, the resulting 606 bp fragment 
was used for hybridization at 60 °C 
 
Table 2.12 List of probes for Southern blot genotyping 
Name 
PCR 
primers 
Note 
mSirt1 CKO 
internal 
probe   
 mSirt1 SB 
internal For 
 mSirt1 SB 
internal Rev 
the 540 bp PCR fragment was cloned into the pGEM-T Easy 
vector and excised with EcoR I, the resulting 554 bp fragment 
was used for hybridization at 65 °C 
mSirt1 CKO 
3'probe 
 mSirt1 SB 3’ 
probe For 
 mSirt1 SB 3’ 
probe Rev 
the 426 bp PCR fragment was cloned into the pGEM-T Easy 
vector and excised with EcoR I, the resulting 440 bp fragment 
was used for hybridization at 65 °C 
 
2.1.4 Plasmid vectors 
 Table 2.13 List of vectors 
Name Description and source 
pKOII-DTA kindly provided by Nabeel Bardeesy, Boston 
pL451 kindly provided by Dr. Stefan Günther (MPI Bad Nauheim) 
pGEM-T-Easy Promega, Mannheim  
pTag CFP-C BioCat (Evrogen), Heidelberg 
pTag YFP-N BioCat (Evrogen), Heidelberg 
pTag-CFP-mSirt
1 
mSirt1 ORF was cloned into the pTag CFP-C vector for ectopic 
overexpression, kindly provided by Christian Smolka (MPI Bad Nauheim) 
pTag–mSirt7–Y
FP 
mSirt7 ORF was cloned into the pTag YFP-N vector for ectopic 
overexpression, kindly provided by Christian Smolka (MPI Bad Nauheim) 
pCemmCTAP Euroscarf (Cat. ABO 76910, Frankfurt) 
pCMVTag2a-hS
irt7-Flag 
hSirt7 ORF was cloned into the pCMVTag2a vector for ectopic 
overexpression, kindly provided by Dr.Yonggang Zhou (MPI Bad Nauheim) 
pCMV-sport6-m
Sirt1-Flag 
mSirt1 ORF fused with C-terminal Flag tag was cloned into the pCMV-Sport6 
vector for ectopic overexpression, kindly provided by Prof. Leo, Bruxelles 
pCMV-sport6-m
Sirt1HY-Flag 
mSirt1 H355Y mutant ORF fused with C-terminal Flag tag was cloned into 
the pCMV-Sport6 vector for ectopic overexpression, kindly provided by Prof. 
Leo, Bruxelles 
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pBabe kindly provided by Prof. Grummt, Heidelberg 
pQsupR-Scramb
le 
retroviral vector for expression of the scramble shRNA, kindly provided by 
Prof. Grummt, Heidelberg 
pQsupR-mSirt1s
hRNA 
retroviral vector for expression of the mSirt1 shRNA to knock down mouse 
Sirt1, kindly provided by Prof. Grummt, Heidelberg 
pBabe-Flag-HA-
mPPARγ2 
retroviral vector for ectopic overexpression of mouse PPARγ2 fused with N- 
terminal Flag and HA tag, Addgene, Cambridge MA 
pLKO.1-puro  
lentiviral vector with either scramble shRNA or target gene shRNA for 
transient transfection or for the production of lentiviral particles for stable 
expression of the specific shRNA , purchased from Sigma-Aldrich  
pCMVdR8.74ps
PAX2 
packaging vector for the production of lentiviral particles, kindly provided by 
Dr. Johnny Kim (MPI Bad Nauheim)  
pMD2.G 
envelope vector for the production of lentiviral particles, kindly provided by 
Dr. Johnny Kim (MPI Bad Nauheim) 
 
2.1.5 Bacterial strains 
 Table 2.14 List of bacterial strains 
Name Description 
XL1-Blue 
Stratagene; recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZ_M15 Tn10 (Tetr)6] 
DH5α 
F- φ80lacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 (rK
-
, 
mk
+
) phoA supE44 λ- thi-1 gyrA96 relA1 
BL21 (DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) 
 
2.1.6 Cell lines 
Table 2.15 List of cell lines 
Name Description 
HEK 293 
ATCC CRL-1573
TM
 
human embryonic kidney, kidney epithelial cell line 
HEK 293T 
ATCC CRL-11268
TM
 
HEK 293 cells constitutively expressing the simian virus 40 (SV40) large 
T antigen 
Phoenix-AMPHO  
ATCC CRL-3213
TM
 
variant of the 293T cell line that has been stably transfected to express 
the Moloney Murine Leukemia Virus (M-MLV) viral packaging proteins 
Hela ATCC 
CRM-CCL-2
TM
 
human cervical adenocarcinoma cell line 
 
3T3-L1 
ATCC CL-173
TM
 
mouse embryonic fibroblasts, a sub strain of 3T3 cells (Swiss albino) 
developed through clonal isolation, preadipocytes 
 
 
2.1.7 Media for cell culture 
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All media and reagents for cell culture were purchased from Invitrogen and PAA except 
as noted otherwise in the text. 
Table 2.16 List of media for cell culture 
Medium composition 
Proliferation 
medium 
Dulbecco’s modified Eagle’s medium (DMEM, low glucose) supplemented 
with 10% heat-inactivated fetal calf serum (FCS, Gibco), 100 U/ml of 
penicillin-streptomycin and 20mM of glutamine. 
Freezing medium Proliferation medium supplemented with 10% DMSO, 20%FCS.  
Hepatocytes 
medium 
M199 medium supplemented with 10% FCS, 20mM HEPES, 5nM 
dexamethasone and 1nM insulin.  
Adipogenesis 
MDI medium 
Proliferation medium supplemented with 0.5μM isobutylmethylxanthine 
(IBMX), 1μM dexamethasone and 10μg/ml insulin 
Adipogenesis 
insulin medium 
Proliferation medium supplemented with 5μg/ml insulin 
 
2.1.8 Mouse strains 
Table 2.17 List of mouse strains 
Strain Name Description 
C57BL/6J Harlan-Winkelmann, Paderborn 
CMV-Cre Tg 
In this transgenic strain, deletion of loxP-flanked genes occurs in all tissues, 
including germ cells. The cre gene in this strain is under the transcriptional 
control of a human cytomegalovirus minimal promoter and is likely to be 
expressed before implantation during early embryogenesis. Kind gift from 
Klaus Rajewsky, University of Frankfurt. 
TG Alb-Cre 
The hepatocyte specific Cre-recombinase mediates the excision of floxed 
DNA regions in hepatocytes during the embryogenesis and early postnatal 
development. Kindly provided by Dr. Thilo Borchardt, MPI Bad Nauheim. 
TG Flp deleter 
The constitutively expressed Flp recombinase mediates the 
recombination between Flp-recognition motifs during the early 
embryogenesis. The Flp transgene in this strain is driven by a human β-actin 
enhancer element. Kindly provided by S.M. Dymecki, Boston, USA 
Sirt7 bKO 
In this mouse strain, the deletion of the putative deacetylation domain of Sirt7 
encoded by the exons 4 to 9 constitutively occurs in all tissues including germ 
cells. Kindly provided by Olesya Vakhrusheva, MPI Bad Nauheim 
 
2.1.9 Special materials and chemicals 
  
BSA, Fraction V 
Bromophenol blue 
Cell culture dishes 
Chelex 100 resin 
Merck (Cat.112018) 
Merck (Cat.1081220005) 
Nunc; Greiner 
BioRad (Cat. 143-2832) 
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Collagenase type I Sigma (Cat. C9891) 
Collagenase type II Invitrogen(Cat. 17101-015)  
DAPI Invitrogen (Cat.D1306) 
Dexamethasone 
Ethidium bromide 
Ex527 
Falcon
®
 cell strainer (40µM, 70µM) 
Filter paper 
Sigma (Cat.D4902) 
AppliChem (Cat.A1152,0100) 
Cayman (Cat. 10009798) 
BD Biosciences 
Schleicher & Schuell, Dassel 
HEPES buffer 1M Invitrogen (Cat.15630-056) 
Insulin (10 mg/mL insulin in 25 mM HEPES) Sigma (Cat.I0516) 
Isobutylmethylxanthinen (IBMX) Sigma (Cat.I7018) 
MES running buffer 
MOPS running buffer 
Invitrogen (Cat.NP0002) 
Invitrogen (Cat.NP0001) 
Mowiol Merck (Cat.475904) 
Nicotinamide (NAM) 
NuPAGE
®
 Novex
®
 PAGE gel  
Sigma (Cat.N0636) 
Invitrogen 
Oil red O Sigma (Cat.O0625) 
Paraformaldehyde (PFA) Merck (Cat.1040051000) 
Polybrene 
Protein Standards (Novex® Sharp) 
Proteinase inhibitor cocktail tablets   
Protran
TM
 nitrocellulose membrane (BA85) 
Sigma (Cat.107689) 
Invitrogen (Cat.LC5800) 
Roche (Cat.04693116001) 
Whatman (Cat.1048374) 
Puromycine 
Red Alert
TM 
(Ponceau S) (10x) 
Sigma (Cat. P8833) 
Novagen (Cat. 710783)  
Rosiglitazone 
Sterile Filter NML (0.2 and 0.45 µm) 
Super Signal West
TM
 Femto 
SYBR
® 
Green I Fluorescein qPCR Mix (2x) 
Enzo Life Science(Cat.ALX350-125) 
Sartorius 
Thermo Fisher Scientific (Cat.34095) 
Thermo Fisher Scientific (Cat.k0241) 
3,3’,5-Triiodo-L-thyronine (T3) 
TRIzol
® 
Reagent 
Sigma (Cat. T2877) 
Invitrogen (Cat.15596026) 
TSA Sigma (Cat. T8552) 
 
2.1.10 Standard buffers and solutions  
                   
2x HBS 50 mM HEPES, 280 mM NaCl, 1.5 mM 
Na2HPO4, adjust pH to 7.05-7.1 
  
100 mM Sodium phosphate 5.77 ml 1M Na2HPO4, 4.23 ml 1M 
NaH2PO4, add DEPC treated water to 100 
ml and adjust pH to 7.0 
  
Glyoxal mixture 
 
 
4.5 μl 100 mM Sodium phosphate, pH7.0 
22.5 μl DMSO, 6.6 μl 6M deionized 
glyoxal, 1 μl 10 mg/ml Ethidium bromide 
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10x MOPS buffer     
 
 
 
 
Immunoprecipitation  
lysis buffer 
 
 
 
Extraction buffer 
 
 
 
Protease and phosphatase inhibitor mix 
 
 
 
2x Laemmli loading buffer 
 
 
 
10x PBS (pH7.2) 
 
 
RNA loading buffer 
 
 
 
20x SSC 
 
 
 
Tail lysis buffer 
 
 
 
Church & Gilbert buffer 
 
 
400 mM MOPS, 100 mM NaAc, 10 mM 
EDTA, final pH 7.0, the solution was 
made with DEPC treated water and 
autoclaved 
 
20 mM Tris-HCl, pH7.4, 200 mM NaCl, 
2 mM EDTA, 2 mM EGTA, 1% Triton 
X-100 (v/v), protease and phosphatase 
inhibitor mix 
 
100 mM Tris-HCl, pH8.0, 10% SDS 
(w/v), 10 mM EDTA, protease and 
phosphatase inhibitor mix 
 
0.5 μg/ml Benzamidine, 2 μg/ml 
Aprotinin, 2 μg/ml Leupetin, 2 mM 
PMSF, 1 mM Na3VO4, 20 mM NaF  
 
125 mM Tris-HCl, pH 6.8, 4% SDS(w/v), 
20% Glycerol (v/v), 100 mM DTT, 
0.004% Bromophenol blue 
 
137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4 
 
50% Glycerol (v/v), 10 mM Sodium 
phosphate, pH7.0, 0.25% Bromophenol 
blue (w/v), 0.25% Xylene cyanol (w/v) 
 
3 M NaCl, 0.3 M Na-Citrate, adjust pH to 
7.0, the solution was made with DEPC 
treated water and autoclaved 
 
10 mM Tris, pH 8.0, 100 mM NaCl, 10 
mM EDTA, pH 8.0, 0.5% SDS, 200 
μg/ml proteinase K  
 
0.5 M NaH2PO4, pH 6.76, 1 mM EDTA, 
7% SDS (w/v)  
 
Washing buffer for Northern  
blot and Southern blot 
40 mM NaH2PO4, pH 6.76 
1% SDS (w/v) 
 
Materials and Methods 
33 
 
10x TBS 
 
 
TBST 
500 mM Tris-HCl, 1.5 M NaCl 
adjust pH to 7.4 
 
1 x TBS 
0.1% Tween-20 
  
1x TAE buffer  
 
 
TE buffer 
 
40 mM Tris-HCl pH 8.3, 1 mM EDTA, 
20 mM Acetic acid 
 
10 mM Tris-HCl pH 8.0, 1 mM EDTA 
Transfer buffer for Western blot 25 mM Tris base, 192 mM Glycine, 20% 
Methanol 
 
Perfusion medium I 
 
 
6.3g NaCl, 0.32g KCl, 0.15gKH2PO4 
0.27g MgSO4 x7H2O , 1.81g NaHCO3 
3.58g HEPES, 1.5g Glucose , 0.038g 
EGTA, add to 1000 ml with water and 
adjust pH to 7.4 
  
Perfusion medium II DMEM/Ham’s F12 (1:1), 10 mM HEPES 
pH7.4, 500 µg/ml Collagenase type II 
  
Washing buffer  DMEM/Ham’s F12 (1:1), 10 mM HEPES 
pH7.4, 20% FCS 
  
  
Hypotonic buffer A 10 mM HEPES, pH7.9, 10 mM KCl, 1.5 
mM MgCl2, protease and phosphatase 
inhibitor mix 
 
Nuclei lysis buffer  
 
 
 
ChIP dilution buffer 
 
 
50 mM Tris-HCl, pH8.0, 10 mM EDTA, 
1% SDS (w/v), 1x protease inhibitor 
cocktail   
 
20 mM Tris-HCl, pH8.0, 150 mM NaCl, 
2 mM EDTA, 1% Triton X-100, 1x 
protease inhibitor cocktail   
 
Low salt washing buffer  
 
 
 
High salt washing buffer  
20 mM Tris-HCl, pH8.0,150 mM NaCl, 2 
mM EDTA, 0.1% SDS (w/v), 1% Triton 
X-100 
 
20 mM Tris-HCl, pH8.0, 500 mM NaCl, 
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LiCl washing buffer 
2 mM EDTA, 0.1% SDS (w/v), 1% 
Triton X-100 
 
10 mM Tris-HCl, pH8.0, 250 mM LiCl, 2 
mM EDTA, 1% Na-deoxycholate, 1% 
NP-40 
  
  
2.1.11 Enzyme                         
DNase I 
Klenow-Fragment 
Roche (Cat.04716728001) 
Promega (Cat. M220A) 
Pfu DNA Polymerase Promega (Cat. M774A) 
PfuTurbo DNA-Polymerase AD Stratagene (Cat. 600255)  
Proteinase K Roth (Cat. 7528.1) 
RNase A 
Restriction endonuclease  
Sigma (Cat. R4875) 
New England Biolabs;  
Jena Biosciences 
Shrimp Alkaline Phosphatase  
T4 DNA Ligase 
Promega (Cat.M820A) 
Promega (Cat.M1801) 
Taq DNA Polymerase 5 Prime (Cat.2200000) 
 
2.1.12 Kits    
Table 2.18 List of used kits 
Name Company 
DC
TM
 Protein Kit BioRad (Cat.500-0111) 
Nucleobond AX 500 Maxi Kit Macherey-Nagel (Cat. 740414.10) 
QIAEX II Gel Extraction Kit Qiagen (Cat. 20021) 
SuperScript
TM
 II Reverse Transcriptase Invitrogen (Cat. 18064-014) 
                    
2.1.13 Equipment                        
Table 2.19 List of special equipment 
Equipment Type Company 
Microscopes 
Axiophot 2 
Z1 fluorescence microscope    
Carl Zeiss Jena 
PCR machines  
Thermocycler  
Master cycler gradient PCR 
iCycler iQ Multicolor Real Time PCR 
Machine  
StepOnePlus™ Real-Time PCR System 
 
SensoQuest 
Eppendorf 
BioRad 
 
Applied 
Biosystems 
Spectrophotometer  
NanoDrop 2000/2000c Thermo Fisher 
Scientific 
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Ultrasonic 
Homogenizer 
Bioruptor  
Sonopuls HD 2070/2200 
Diagenode 
Bandelin 
VersaDoc Image 
System 
VersaDoc
TM 
3000  BioRad 
 
2.1.14 Software                        
Table 2.20 List of used software 
Software  Company 
AxioVision® 4.8 Carl Zeiss Imaging Solutions, Jena 
DNASTAR Lasergene® DNASTAR Inc. (USA) 
ImageJ National Institutes of Health (USA) 
Photoshop 8.0 Adobe Systems Incorporated (USA) 
Quantity One BioRad, München 
StepOne Software v2.2.2 Applied Biosystems 
 
2.2 Methods 
Standard molecular biology procedures were performed according to the following 
books except noted otherwise in the text: 
 
Current Protocols in Molecular Biology 
F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. 
Struhl; Wiley Interscience, 1989 
Molecular Cloning: A Laboratory Manual, 2nd Edition 
J. Sambrock, E.F. Frisch, T. Maniatis; Cold Spring Harbor Laboratory Press, 1989  
 
2.2.1 Sterilization of materials and solutions  
Glassware was sterilized with dry heat at 180 °C. Sensitive glassware, plastic ware, 
solutions and media were autoclaved at 121 °C and a pressure of 2.2 bars for 30 min. 
Non-autoclavable solutions or media were sterilized by filtering through a 0.2 µm or a 
0.45 µm cellulose acetate filter.  
 
2.2.2 Cloning and constructs 
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All used expression constructs are listed in Table 2.13. For cloning, the desired 
fragments were generated by PCR using specific primers covering the whole open 
reading frame. With the primers, specific restrictions sites were introduced, that allow 
the directed cloning into the target vector. The used primers are listed in Table 2.8.  
 
2.2.3 Cell culture and transfection 
All cells were cultured in an incubator at 37°C and 5% CO2 according to their 
requirements in media listed in table 2.14. For harvesting and passaging, cells were 
washed with 1x PBS and detached using 0.05% trypsin/0.2% EDTA. The enzyme 
reaction was stopped with 2 volumes of serum containing medium and a desired number 
of cells was seeded in fresh medium to the culture dishes. For freezing, the trypsinized 
cell pellets were resuspended in freezing medium and aliquoted into cryovials (about 2 
x 10
6
 cells per cryovial).    
 
2.2.3.1 Isolation of primary cells 
Preparation of primary mouse hepatocytes 
Mouse primary hepatocytes were isolated from WT control and Sirt7 KO mice by a 
two-step collagenase perfusion technique, modified from Seglen protocol (Seglen, 
1976). These preparations were done by Ms. Marion Wiesnet. The liver was perfused 
twice with perfusion buffer I and perfusion buffer II respectively, and resected to obtain 
the single cells. The single cells were filtered through 100μm nylon mesh and washed 
with washing buffer. Then the hepatocytes (about 6 x 10
6
 cells per 3.5cm dish) were 
seeded on collagen type I coated dishes in hepatocytes medium.  
Preparation of primary mouse embryonic fibroblasts (MEFs)  
Mouse embryonic fibroblasts (MEF’s) were prepared by Monika Euler. For embryo 
preparation, heterozygous mice of the Sirt7 KO mouse line were mated and the embryos 
were removed at embryonic day E14.5 and placed on ice. The inner organs of the 
embryos were removed and discarded, whereas the membranes of the embryos were 
used for DNA extraction and genotyping by PCR. The remaining tissues of each 
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embryo were minced and incubated for 10 min in 5 ml 0.25% trypsin solution at 37°C. 
The digestion was stopped by adding 5 ml of DMEM supplemented with 10% FCS. 
Afterwards, cells were pipetted up and down to obtain single cells and pelleted by 
centrifugation at 300xg for 5 min. The cells were than resuspended in 24 ml of DMEM 
with 10% FCS and seeded to 3x 10cm dishes. One cell stock was prepared from each 
plate after 2 days of incubation.  
Preparation of primary white preadipocytes 
Primary white preadipocytes were isolated from Sirt7-/- and Sirt7-/- Sirt1+/- mice and 
their control littermates (Sirt7+/-) (the age was less than 8 weeks). Subcutaneous and 
visceral adipose tissue from these mice was excised, minced and incubated at 37°C with 
1ml collagenase isolation buffer (100 mM HEPES pH7.5, 4.8 mM KCl, 120 mM NaCl, 
1.4 mM CaCl2 x 2H2O, 5mM Glucose, 2.5% BSA, 1% Per/Strep, 2 mg/ml Collagenase 
type I) for 1 hr. Then, the same amount of medium was added to the collagenized tissue, 
resuspended by pipetting and transferred to a 15 ml falcon and spun down at 300xg for 
5min. The cell pellets were then resuspended in 10 ml medium, filtered through a 40 µm 
mesh strainer and transferred to a 15 ml falcon tube. After centrifugation at 300xg, the 
cell pellets were resuspended in 5 ml erythrocyte lysis buffer (154 mM NH4Cl, 10 mM 
KHCO3, 0.1 mM EDTA, sterile filtered), incubated for 10 min, and centrifuged again at 
300xg for 5min. Upon resuspension of the pellets in an appropriate volume of fresh 
medium, the cells were seeded on collagen-coated plates.  
 
2.2.3.2 Transient plasmid DNA transfection in HEK cells 
Transfection of HEK cells was performed according to the calcium phosphate 
transfection method. Approximately 24 hours before transfection, cells were seeded in 9 
ml of DMEM in 10 cm dishes at a density of 2.5 x 10
6
 cells per plate. 5-10 µg of 
plasmid DNA was diluted in 450 μl ddH2O and 50 μl of 2.5 M CaCl2 was added drop 
wise. The mixture was then added to 500 μl of 2x HBS buffer drop by drop. The 
calcium phosphate-DNA complex was then distributed to the cells drop wise. The next 
day, the medium was replaced by fresh medium and the cells were harvested usually 48 
h after transfection.    
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2.2.3.3 Retrovirus production and infection 
Phoenix cells were transfected with either pBabe, pBabe–mSirt7, pBabe-PPARγ2-Flag, 
pQsupR-Scramble, pQsupR-mSirt1shRNA or pCemm, pCemm-hSirt7-Flag plasmids 
using the calcium phosphate transfection method. After 48 hrs of transfection, the 
medium containing the retroviruses was collected and filtered through a 0.45 µm filter. 
After addition of 4 μg/ml polybrene, the virus solution was transferred to the target cells 
(immortalized MEF’s or 3T3L1 cells). Infected cells were selected with 2.5 mg/ml 
puromycin (the selection procedure was skipped for the pCemm retroviral vectors) for 7 
days to generate stable cell lines. 
 
2.2.3.4 Lentiviral shRNA transduction 
HEK293T cells were cotransfected with 3 lentiviral plasmids (pLKO.1-shRNA vectors   
either scramble or Sirt7 knockdown; packaging vector pCMVdR8.74psPAX2; envelope 
vector pMD2.G) using the calcium phosphate transfection method. 18 hours after 
transfection, the medium was replaced by fresh high (30%) FCS medium. After 
additional 24 h of incubation, the medium containing the viruses was collected, filtered 
through a 0.45 µM filter and 4 μg/ml polybrene was added. The virus medium was then 
transferred to the 3T3L1 target cells. Infected cells were selected with 2.5 mg/ml 
puromycin for 7 days to generate the stable cell lines. 
 
2.2.3.5 Adipogenesis assay and Oil red O staining 
To induce adipogenesis in 3T3L1 and MEFs, cells were grown to 100% confluence. 2 
days after cells reached confluence (day 0), adipogenesis was induced with MDI 
medium supplemented with or without 0.5μM rosiglitazone (rosiglitazone was only 
added to medium for MEF’s differentiation, similarly hereinafter). Two days later, 
medium was exchanged with insulin medium containing 0.5μM rosiglitazone or not. 
The insulin medium was exchanged every second day over a time period of 7-8 days.   
To induce adipogenesis in primary white preadipocytes, cells were seeded into chamber 
slides with a density of 2×10
4 
cells per cm
2
 for 4 days before induction. At day 0, cells 
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were treated with MDI medium supplemented with 0.2 nM T3 and 0.5 μM rosiglitazone. 
Two days later, medium was changed to insulin medium containing 0.2 nM T3 and 0.5 
μM rosiglitazone. The medium was replaced every second day over a time period of 8 
days.  
Fat accumulation was visualized by staining of lipids with Oil red O. Therefore, cells 
were washed twice with 1x PBS and 4% PFA was added to each well for 20 min to fix 
the cells. Then, each well was washed twice with 1x PBS and rinsed twice with 60% 
isopropanol, 30s each time. Freshly prepared 3 mg/ml Oil red O solution in 60% 
isopropanol was added into each well and incubated at 56°C for 15 min. Then, the cells 
were rinsed twice with 60% isopropanol for 30s. Next, the cells were rinsed twice with 
1x PBS and covered with 1x PBS or mounted with mowiol and a glass slide. The lipids 
were visualized by red colour.    
  
2.2.4 RNA analysis 
2.2.4.1 RNA extraction 
Total RNA from cells and mouse tissues was isolated using TRIzol reagent from 
Invitrogen according to the manufactory’s protocol. The concentration of RNA was 
determined with a Nano Drop 2000c spectrophotometer.  
 
2.2.4.2 Northern blot 
The Northern blot analysis was performed according to Brown et al., (Current Protocol 
in Molecular Biology, 2004) with some modifications. 30 μg of total RNA was mixed 
with 35 μl glyoxal mixture in a total volume of 48 μl and denatured at 65°C for 1 hr and 
cooled down on ice for 5 min. Then 12 μl RNA-loading buffer was added to the 
samples and the mixture was loaded on a 1% agarose gel prepared with 10 mM sodium 
phosphate buffer. The RNA was separated at a constant voltage of 5V/cm of gel in 1x 
MOPS running buffer for about 4 hrs. The RNA was blotted to Nylon Duralon-UV 
membranes (Stratagene) by capillary transfer method in 15x SSC buffer overnight. 
Then, the membranes were washed twice in 2x SSC buffer for 5 min. Afterwards, the 
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transferred RNA was cross-linked to the membrane with an UV crosslinker (Stratagene) 
(the energy was about 1.5 J/cm
2
). The ribosomal 28S and 18S RNAs could be seen 
under UV-light and were used as a loading control.   
For hybridization, the membrane was pre-hybridized in 15 ml Church & Gilbert buffer 
containing 200 μg/ml denatured herring sperm DNA at 65°C for 2-3 hrs. The cDNA 
probes were generated by RT-PCR, purified by QIAEX II Gel Extraction Kit (Qiagen) 
and either subcloned into the T-vector or directly used for hybridization. The sequence 
of each probe was confirmed by sequencing. The 
32
P-lableled radioactive cDNA probe 
was generated following the random primer labelling protocol (Feinberg and Vogelstein, 
1983). 50-100 ng of cDNA probe in a total volume of 32 μl was denatured at 95°C for 
10 min and cooled down on ice for 5 min, mixed with 10 μl of 5x labelling buffer 
(Promega), 2 μl BSA (10 mg/ml), 5 μl [α32P] dCTP (Amersham), 1 μl of Klenow enzym 
(2 U/μl) (Promega) and incubated for 2-3 h at 37°C. The probes were then purified by 
NAP-5
TM
 Sephadex G25 columns. The radioactive labelled probes as well as the herring 
sperm DNA were denatured 5 min at 95°C and cooled down on ice. After 
pre-hybridization, new Church & Gilbert buffer containing 100 μg/ml denatured herring 
sperm DNA and the probe at a dilution of 3000000 counts/ml was added to the 
membrane. The hybridization was performed overnight at 60°C in a rotary shaker. The 
next day, the membrane was washed 3 times for 15 min at 60°C with washing buffer 
and afterwards exposed to an X-ray film at -80°C.       
     
2.2.4.3 Reverse transcription 
First-strand cDNA synthesis was done by reverse transcription (RT) of 1 μg of each 
RNA sample using the Invitrogen SuperScriptII Reverse Transcriptase System with 
random primers according to the manufactory’s manual. The cDNAs were stored at 
-20 °C or directly used as a template for the PCR (polymerase chain reaction). 
 
2.2.4.4 Polymerase chain reaction (PCR) 
The PCR was applied to exponentially amplify DNA fragments in vitro, by using the 
heat-stable Taq DNA polymerase originally isolated from the bacterium Thermus 
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aquaticus (Saiki et al., 1988). The Taq DNA polymerase from 5 Prime was used for the 
RT-PCR and for genotyping, whereas the Pfu DNA Polymerase and the PfuTurbo DNA 
Polymerase AD were used for cloning. All used primer pairs and their respective 
annealing temperatures are listed in the tables of part 2.1.2. The 25 μl standard PCR 
reaction was prepared as follows: 1 μl template, 2.5 μl 10x PCR buffer (with or without 
Mg
2+), 1 μl of 50 mM MgCl2 (when the 10× PCR buffer did not contain Mg
2+), 1 μl 
forward primer (10 μM) and 1 μl reverse primer (10 μM), 0.5 μl dNTP mix (10 mM) 
and 2U Taq DNA polymerase. The initial denaturation step (94°C, 5 min) was followed 
by 25-40 cycles, each with 94°C denaturation 30s, 52-65°C annealing 30s and 1min/kb 
elongation at 72°C.  The last cycle was followed by a final extension step at 72°C for 5 
min.      
 
2.2.4.5 Quantitative real time PCR (QPCR) 
QPCR was performed to quantitatively determine the mRNA expression by using 
fluorescent dyes that incorporate into double stranded DNA. A typical QPCR setup 
contained 12.5 µl 2x SYBR Green Mix (Thermo Fischer), 1 µl of each primer (2.5 pmol) 
and 10 µl of cDNA (1:100 diluted) in a total volume of 25 µl. The PCR conditions were 
chosen according to the manufactory’s protocol and the annealing temperatures of the 
primers. The PCR runs were carried out in an iCycler iQ Multicolor Real Time PCR 
machine (BioRad). For each gene, 5 standards (using the mixture of WT & Sirt7 KO 
liver or MEFs cDNA in 1:2, 1:20, 1:200, 1:2000, and 1:20000 dilutions) were carried 
out in triplicate to produce a standard curve. The relative amount of the target gene and 
endogenous housekeeping control β-actin was determined from the standard curve. The 
relative expression level of each target gene was equated to the ratio: SQtarget/SQβ-actin 
where SQ means the starting quantity. 
For the quantitation of the Sirt7 expression, QPCR runs were performed with TaqMan 
assays (Applied Biosystems) on a StepOnePlus Real-Time PCR machine (Applied 
Biosystems) using the comparative Ct method with GAPDH as an internal control. The 
Sirt7 specific FAM TaqMan probe (Mm00461899_g1) and the GAPDH specific VIC 
TaqMan probe (4352339E) were purchased from Applied Biosystems. 
Materials and Methods 
42 
 
 
2.2.5 DNA and chromatin analysis 
2.2.5.1 Genomic DNA extraction 
Small pieces of mice tails (0.5-1 cm), embryonic membranes or ES cells were digested 
in 500 μl of the tail lysis buffer with 0.4 mg/ml proteinase K by vigorously shaking at 
55°C overnight. The supernatant was transferred to a fresh 1.5 ml tube containing 500 
μl isopropanol and mixed well. The tubes were then centrifuged at 12000xg for 10 min 
at room temperature to precipitate the genomic DNA. The DNA pellets were washed 
with 75% ethanol, air dried and then dissolved in 150-200 μl 1x TE. The genomic 
DNAs were stored at 4°C until use. 
 
2.2.5.2 Southern blot 
After sufficient digestion by specific restriction enzymes, the genomic DNAs were 
separated on a 1% agarose gel with ethidium bromide in 1x TAE at 10V/cm for 4-5 hrs. 
The gel was photographed and the DNA was transferred to a Hybond-N membrane 
(Amersham) in alkaline buffer (0.4 M NaOH) by capillary blot for overnight. The 
transferred DNA was cross-linked to the membrane with an UV crosslinker and an 
energy of 1.5 J/cm
2
. Then, the membranes were washed briefly in 2x SSC and dried on 
paper. For hybridization, the membrane was first incubated in Church & Gilbert buffer 
containing 200 μg/ml denatured herring sperm DNA at 65°C for 2-3 hrs. During the 
pre-hybridization, the internal or 3’ probes were 32P-labelled using the same protocol as 
for the Northern blot. The hybridization was performed in fresh Church & Gilbert buffer 
containing 100 μg/ml herring sperm DNA and 3 000 000 counts/ml at 65°C overnight in 
a rotary shaker. Following hybridization, the membrane was washed 3 times for 15 min 
at 60°C with washing buffer and then exposed to an X-ray film at -80°C. 
2.2.5.3 Chromatin immunoprecipitation  
After washing with 1x PBS twice, cells were cross-linked with 1% formaldehyde at 
room temperature for 10 min under gentle shaking directly in the culture dishes. The 
reaction was then quenched by adding 125 mM glycine for 5 min. Cells were washed 3 
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times with ice-cold 1x PBS, scraped into 1 ml 1x PBS and pelleted at 1000xg for 3 min 
at 4°C. The cell pellets were resuspended in hypotonic buffer A and incubated on ice for 
10 min to lyse the cells and extract the crude nuclei. The nuclei were collected by brief 
centrifugation (1000xg, 5 min and 4°C). The nuclear pellets were then resuspended in 5 
times the volume of nuclei pellet and incubated on ice for 10 min. The chromatin was 
then sheared into fragments with a length of 0.2-0.5 Kb by sonication, using a 
diagenode Bioruptor (20 min, 30 seconds on, 30 seconds off, high level, 4°C). To check 
the sonication efficiency, 10μl of sample were subjected to chromatin extraction using 
90 μl of 10% Chelex slurry. After the addition of Chelex, the crosslinking was reversed 
by boiling the samples. Proteins were digested with 10 μg of proteinase K at 55°C for 
30 min, and the proteinase K was inactivated by boiling the sample at 100°C for 10 min. 
The samples were briefly centrifuged at 12000xg for 1 min and 60 μl of the supernatant 
were transferred to a fresh tube. The concentration was measured using the Nano Drop 
2000c Spectrophotometer. 3 μg of extracted chromatin were run on a 1.5% agarose gel 
to verify the sonication efficiency. 50-100 μg of sheared chromatin was diluted 10 times 
in ChIP dilution buffer. 10% of the chromatin was saved as the “input” sample, while 
the rest of the diluted chromatin was incubated with the respective primary antibody 
overnight at 4°C on a rotating wheel. The immuno-complexes were precipitated with 
protein A/G Sepharose beads (diagenode, Cat.ch-503-028) for 3 hours at 4°C. The 
beads were washed sequentially, once with low salt washing buffer, once with high salt 
washing buffer, once with LiCl washing buffer and twice with TE buffer. After the final 
wash, the residual buffer was aspirated with an insulin needle. 100 μl of 10% Chelex 
slurry were added to the beads and the chromatin was extracted as described above. 
Samples were centrifuged at 12000xg for 1 min and 60 μl of the supernatant were 
transferred to a fresh tube. Additional, 40 μl of distilled H2O were added to the Chelex 
resin, centrifuged at 12000xg for 1 min, and 40 μl of the supernatant were combined 
with the previously collected supernatant. The DNA was analysed by QPCR using an 
iCycler Real Time PCR machine (BioRad) and the quantification was performed by 
standard curve method.  
Materials and Methods 
44 
 
2.2.6 Protein analysis 
2.2.6.1 Total protein extraction  
For isolation of whole-cell extracts, cells grown on 12 well plates or 6 cm dishes were 
washed twice with ice-cold 1x PBS and lysed on ice with an appropriate amount of 
extraction buffer. The cells were then scraped off, transferred to an eppendorf cup and 
homogenized by sonication on ice. For mouse samples, small pieces of tissue were 
lysed and homogenized in extraction buffer by sonication on ice. The lysates were then 
clarified by centrifugation (20000 x g, 5 min, 4°C) and supernatants were stored at 
-80°C or used for Western blot immediately. 
 
2.2.6.2 Quantification of protein concentration 
Protein concentrations were determined using the colorimetric BioRad DC Protein 
Assay according to manufacturer’s instructions. The whole assay is based on the Lowry 
method (Lowry et al., 1951) and results, dependent on the protein concentration, in the 
formation of a blue colour change. The absorbance was read-out at 750 nm and a 
standard curve was generated based on the absorbance values of different amounts of 
BSA. The concentrations of the protein samples were determined by comparison with 
the standard curve. 
 
2.2.6.3 SDS-PAGE and Western blot 
20-50 μg of total protein lysate were denatured by boiling at 99°C for 5 min in 2x 
Laemmli loading buffer before loading on 4-12% NuPAGE Novex Bis-Tris gels 
(Invitrogen). Electrophoresis was performed in 1x MES SDS Running Buffer 
(Invitrogen) at a constant voltage of 75 volts for 30 min following 150 volts for 1.5 hrs. 
Separated proteins were transferred to a nitrocellulose membrane (Bio-Rad) using the 
XCell II Blot module (Invitrogen) and transfer buffer. The transfer was performed for 
2-3 hrs at constant voltage of 30V. The transfer efficiency was verified by a water 
soluble staining with Ponceau S and membranes were stored dry until use. For antibody 
staining, membranes were shortly washed with ddH2O and blocked with 5% skim milk 
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in 1x TBST for 1hr at room temperature with mild agitation. Then the membranes were 
washed 5 times with 1x TBST for 5 min at room temperature and incubated with 
primary antibody diluted in 1x TBST/3% milk or 1x TBST/3% BSA  for overnight 
with gentle shaking at 4°C. The following day, the membranes were washed 6 times for 
5 min at room temperature with 1x TBST. Afterwards, the membranes were incubated 
for 1 hr at RT in 1x TBST/3% milk with a species specific horseradish 
peroxidase-conjugated secondary antibody that is directed against the primary antibody. 
After several washing steps for at least 2 hrs at RT with 1x TBST, the detection of the 
antigen-antibody reaction was monitored using “increased chemiluminescence” 
(SuperSignal West Femto, Pierce) in a VersaDoc 3000 gel imaging system.  
 
2.2.6.4 Immunoprecipitation assay 
For immunoprecipitation assays, cells were washed twice with ice-cold 1x PBS, 
harvested by scraping into 1x PBS and centrifuged at 4˚C for 5 min at 600 x g. The 
pellet was lysed in immunoprecipitation lysis buffer (for detection of protein acetylation, 
the lysis buffer was supplemented with 10 μM TSA and 20 mM NAM) and incubated 
on ice for 10 min. Then, the sample was sonicated for 5 min at 4˚C and MgCl2 (final 
concentration of 10 mM) and 10 units of DNaseI (Roche, Cat.04716728001) were 
added, immediately. After 30 min of incubation at room temperature under constant 
rotation, the samples were centrifuged for 10 min at 20000 x g at 4˚C and the 
supernatant was transferred to a clean tube. Then, 500 μg-1 mg of protein lysate was 
incubated with the desired primary antibody for overnight at 4˚C under constant rotation. 
The following day, immunocomplexes were purified by the addition of 25 μl protein G 
Sepharose beads (Roth, Cat.05015952001) for 2-3 hrs at 4˚C with agitation. Beads were 
washed 7-8 times with lysis buffer and the residual buffer was aspirated with a 
hypodermic needle after the last washing step. Finally, the beads were boiled in 2x 
Laemmli loading buffer, separated by SDS-PAGE and analysed by Western blot. 
 
2.2.6.5 Immunofluorescence 
Cells grown on 4 well, 8 well or 16 well chamber slides (Lab-Tek chamber slides, Nunc) 
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were fixed in 4% PFA for 20 min at room temperature, washed 3 times with 1x PBS, 
permeabilized with 0.1% TritonX-100 in 1x TBS for 10 min and blocked for 1 h with 
3% BSA in 1x TBSTritonX at room temperature. The primary antibody was diluted in 
1% BSA in 1x TBSTritonX and applied to the cells for overnight at 4˚C. The next day, 
the cells were washed 3 times for 5 min with 1x TBSTritonX and subsequently 
incubated with a fluorophore-conjugated secondary antibody and DAPI 
(4',6'-Diamidino-2-phenylindol) diluted in 1% BSA in 1x TBSTritonX for 1 h at room 
temperature in the dark. Prior to mounting with mowiol, cells were washed 5 times with 
1x TBSTritonX and 2 times with 1x TBST. Pictures were made using fluorescent light 
microscopy. 
 
2.2.7 Mice experiments 
2.2.7.1 Mice housing and care 
All animal experiments and transgenic manipulations were performed in accordance to 
the applicable technological guidelines and animal welfare regulations with the 
approval of the regional council Giessen. All mice were kept under a 12 h light/dark 
cycle at 25˚C in cages of the laboratory animal facility of the MPI. The mice were fed 
dry food and water ad libitum.  
 
2.2.7.2 Killing of the laboratory mice 
The mice were killed by cervical dislocation (CD) according to the particular laboratory 
mice euthanasia protocol and approved by the Institutional Animal Care and Use 
Committee.   
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3. Results 
3.1 Sirt7 is required for the stimulation of hepatic rDNA transcription in 
response to insulin 
3.1.1 Disturbed hepatic response to fasting/refeeding in Sirt7 KO mice 
Sirt7 is a least investigated sirtuin and little information is still available about 
the functions of Sirt7 in mammals so far. Sirt7 deficient mice were generated and 
analyzed in our laboratory. Sirt7 -/- mice had a reduced mean and maximal lifespan and 
developed a progressive, age-dependent inflammatory cardiomyopathy (Vakhrusheva et 
al., 2008b). Another striking phenotypic feature of Sirt7 -/- mice was their smaller size 
and leanness, which became apparent at around five months of age. Since the food 
consumption of Sirt7 -/- mice was even slightly increased, the leanness of the animals 
could not be attributed to a restricted calorie intake but to a metabolic dysfunction. 
Because PGC-1 deficient mice show similar phenotypes to the Sirt7 -/- mice (Arany et 
al., 2005), we analyzed the expression level of PGC-1 and other important metabolic 
genes. Interestingly, a significant reduction of the expression of both, PGC-1 and 
PGC-1β was detected in the liver of Sirt7 -/- mice along with a decreased expression of 
key enzymes of fatty acid synthesis such as ACC and ACLY (Vakhrusheva and Smolka, 
unpublished data, Fig 3.1).  
PGC-1 is a key regulator of glucose production in the liver of fasted mice 
through activation of the gluconeogenic pathway (Rodgers et al., 2008). To determine 
whether Sirt7 deficiency interferes with the gluconeogenic and lipogenic response in 
liver under conditions of feeding and fasting, the WT mice and Sirt7 KO mice were 
divided into three groups and fed a normal diet, fasted for 24hrs and refed for 24hrs 
after fasting, then the gene expression of key enzymes involved in gluconeogenesis and 
lipogenesis metabolism was analyzed through Northern blot. 
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As expected, fasting increased levels of mRNAs encoding the gluconeogenic enzyme 
PEPCK and down regulated the key enzymes of fatty acid synthesis FAS and AceCS1 
in wild type mice, and expression of these genes was restored to normal levels upon 
refeeding (Fig 3.2A). The patterns of these key enzymes changes under fasting and 
refeeding in the liver of mice lacking Sirt7 were similar as their control wild type mice. 
However, the degree of these genes response to fasting and refeeding in the liver of 
Sirt7 KO mice was exaggerated: Expression of lipogenic genes AceCS1 and FAS was 
more severely reduced under fasting and showed less recovery upon refeeding than WT. 
Likewise, gluconeogenic enzyme PEPCK was increased much more under fasting and 
decreased less under refeeding (Fig 3.2A).    
      Sirt7 is reported as an activator of pre-rRNA transcription and is enriched in 
metabolically active tissues including the liver (Ford et al., 2006). Since the ribosome 
biogenesis is very important for liver growth and function (Chaudhuri and Lieberman, 
1968), the pre-rRNA transcription levels in the liver of Sirt7KO and WT animals were 
examined by quantitative real-time PCR. Fig 3.2B shows that the relative levels of 
pre-rRNA in the liver were slightly induced upon fasting and reduced to normal levels 
after refeeding in WT mice. Although there was no significant change between WT and 
Figure 3.1 Dysregulation of key enzymes involved in hepatic fat metabolism and 
of PGC1α expression. Quantitative RT-PCR analysis of the expression of acetylcarboxylase (ACC1) and 
ATP-citrate lyase (ACLY) (enzymes involved in fat metabolism)(A) and PGC-1α and PGC-1β(B) in the WT and 
Sirt7 deficient liver. The relative mRNA levels represent means from three different animals per group and 
were calculated as a difference of expression between wild-type and knockout. Significance was determined 
by Student’s t test. * indicates the significance between WT and Sirt7KO: * P< 0.05; ** P < 0.01. Data from 
Christian Smolka. 
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KO in the normal diet condition, fasting caused a much stronger increase in pre-rRNA 
transcription in the Sirt7 deficient mice liver than in the WT controls (WT PF/ND=0.01 
vs. S7KO PF/ND=8.94E-05). After refeeding, the pre-rRNA transcription levels remained 
high and did not revert to the normal levels in Sirt7 KO mice (WT PRF/F<0.001 vs. 
S7KO PRF/F=0.07). These results indicated that although the adaptive response to 
fasting/refeeding in the liver of Sirt7 deficient mice still exists, its regulation and 
fine-tuning are severely disturbed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.2 Higher Sirt1 expression in the liver of Sirt7 deficient mice during fasting 
      Since recent papers had indicated that hepatic Sirt1 is an important factor in the 
regulation of glucose and lipid metabolism in response to fasting (Rodgers et al., 2005; 
Figure 3.2 Disturbed expression of genes encoding key enzymes involved in 
gluoconeogensis and lipid metabolism and of the pre-rRNA transcription in Sirt7 
deficient mice liver in response to fasting/refeeding. Wild-type (WT) (n=15) and Sirt7 KO 
mice (n=15) were divided into 3 groups: normal diet (ND), fasting for 24hrs (F) and refeeding for 24hrs after 
fasting (RF). The total liver RNA was isolated and pooled for each group. (A) Northern blot analysis of 
expression of phosphoenolopyruvate kinase (PEPCK), acetyl-CoA synthetase 1 (AceCS1) and fat synthase 
(Kralisch et al.). Ethidium bromide (Eth Br) staining of ribosomal RNA was shown as a loading control. (B) 
Quantitative RT-PCR analysis of pre-rRNA transcription levels. The relative pre-rRNA levels were normalized to 
β-actin. Values are average±SD. Significance was determined by Student’s t test. * indicates the significance 
between WT and Sirt7KO: ** P < 0.01. (C) Northern blot analysis of expression of Sirt1 in the liver. Ethidium 
bromide (Eth Br) staining of ribosomal RNA as loading control. 
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Rodgers and Puigserver, 2007), I was further interested in whether the hepatic Sirt1 
expression level was changed in Sirt7 deficient mice. Although there was no change at 
the mRNA level of Sirt1 in the livers lacking Sirt7 under the normal diet condition, 
fasting enhanced the transcription of Sirt1 significantly higher in the Sirt7 KO mice (Fig 
3.2C). 
 
3.1.3 Transcription levels of pre-rRNA do not change in WT and Sirt7KO hepatocytes 
cultured in different glucose concentration 
Primary cultures of hepatocytes are widely used to investigate liver function. It 
was shown that the rDNA transcription level was down-regulated following deprivation 
of glucose in Hela cells (Murayama et al., 2008). Therefore, I wanted to check whether 
similar glucose-dependent regulation of rDNA transcription takes place in WT and Sirt7 
KO hepatocytes. WT and Sirt7 deficient primary hepatocytes were cultured in different 
glucose concentration for 24hrs, and then the pre-rRNA transcription level was 
measured by real-time PCR. Fig 3.3A showed that there were no significant changes at 
low and normal glucose concentration in WT or KO hepatocytes. However, the rDNA 
transcription levels were significantly higher in the Sirt7 deficient hepatocytes when 
cultured in the high glucose medium (0.01<p<0.05). To prove whether the hepatocytes 
responded normally to change in glucose concentration, the expression of PEPCK, a 
critical enzyme regulated by glucose, was analyzed by qPCR. Indeed, PEPCK 
expression was high in no or low glucose and was down regulated in high glucose 
medium (data not shown). Real time quantitative PCR analysis also confirmed the 
enhancement of pre-rRNA transcription in HeLa cells cultured in the high glucose 
medium as previously described (Murayama et al., 2008) (Fig 3.3B).  
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3.1.4 Insulin stimulates pre-rRNA transcription in WT hepatocytes, but not in the Sirt7 
KO hepatocytes 
Insulin is a critical hormone for regulation of glucose and lipid homeostasis in 
the body. It also plays a key role in the regulation of protein synthesis in a number of 
tissue and cell culture systems. It has been reported that insulin enhances ribosome 
biogenesis by stimulating the transcription of the pre-rRNA to some extent (Hannan et 
al., 1998). Studies in primary cultures of rat hepatocytes indicated that insulin caused an 
elevation in the rRNA content by stimulating the transcription of rDNA and by slowing 
the degradation rate of ribosome (Antonetti et al., 1993). Primary hepatocytes isolated 
from both WT and Sirt7 KO mice (age about 3 months) were cultured in medium with 
or without insulin. Interestingly, the pre-rRNA transcription level was increased 
following the insulin treatment in WT hepatocytes, whereas loss of Sirt7 blocked the 
stimulation of hepatic pre-rRNA transcription by insulin (Fig 3.4A). In contrast, PEPCK 
expression was significantly down-regulated by insulin in both WT and KO hepatocytes 
(data not shown). In experiments with hepatocytes derived from old mice (more than 18 
months), insulin treatment also increased pre-rRNA transcription level in WT 
Figure 3.3 Different glucose concentration does not affect transcription of 
pre-rRNA in hepatocytes but in HeLa cells. (A) Primary hepatocytes from Wild-type (WT) (n=6) 
and Sirt7 KO mice (n=6) were cultured in medium containing 0, 1.5, 5, 10, 25mM glucose, and pre-rRNA 
transcription levels were analyzed by quantitative RT-PCR. The relative pre-rRNA levels were normalized to 
β-actin. Values are average±SD. Significance was determined by Student’s t test. * indicates the significance 
between WT and Sirt7KO: * P< 0.05; ** P < 0.01. (B) Analysis of pre-rRNA transcription levels in HeLa cells 
cultured in medium containing 0mM, 1.5mM or 5mM glucose for 24hrs. Values are average±SD for triplicate 
measurements. Significance was determined by Student’s t test. * indicates the significance between no 
glucose and different glucose concentration: * 0.01<P< 0.05. 
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hepatocytes (Fig 3.4B), although the changes were significant only when treated by 
20nM insulin while in young hepatocytes significant activation of rDNA transcription 
was observed already after treatment with low insulin concentration (10nM) (Fig 3.4A). 
Interestingly, insulin failed completely to enhance the transcription of pre-rRNA in the 
hepatocytes from old Sirt7 KO mice (Fig 3.4B). These results suggest that Sirt7 is 
required for insulin stimulated hepatic ribosomal DNA transcripton.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.5 Hypoacetylation of histones and lower Pol Ⅰ and UBF binding to rDNA 
promoter after insulin stimulation in Sirt7 deficient hepatocytes 
RNA polymerase Ⅰ and UBF are both important components of transcription 
initiation complex on the rRNA gene promoter. Insulin was found to increase the 
nuclear content of UBF in 3T6 and H4-ⅡE-C3 rat hepatoma cells (Antonetti et al., 
1993). However, no significant changes were detected in the protein levels of UBF or 
Pol Ⅰ with or without insulin treatment in both WT and KO mice hepatocytes on the 
western blot (data not shown). ChIP analysis revealed that the binding of Pol Ⅰ and 
UBF to the rDNA promoter was both increased after insulin stimulation in WT but 
slightly decreased in Sirt7 deficient hepatocytes, which is consistent with the alteration 
Figure 3.4 Insulin stimulates pre-rRNA transcription in WT but not in Sirt7 
deficient hepatocytes. (A) Primary hepatocytes from young (about 3 months) Wild-type (WT) (n=3) 
and Sirt7 KO mice (n=3) were cultured in medium containing 0 or 10nM insulin. Glucose concentration was 
kept as 5mM in all assays. The pre-rRNA transcription levels were analyzed after 24hrs by quantitative 
RT-PCR. The relative pre-rRNA levels were normalized to β-actin. Values are average±SD. Significance was 
determined by Student’s t test. * indicates the significance after insulin treatment: ** P < 0.01. (B) Analysis of 
pre-rRNA transcription levels in primary hepatocytes from old (more than 18 months) wild-type (WT) (n=3) 
and Sirt7 KO mice (n=3), which were cultured in medium containing 0nm, 1nm, 10nm or 20nM insulin for 
24hrs. Values are average±SD. Significance was determined by Student’s t test. * indicates the significance 
after insulin treatment: * P< 0.05; ** P < 0.01.  
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of pre-rRNA transcription observed after insulin treatment. Moreover, the occupancy of 
Pol Ⅰ and UBF was diminished in Sirt7 lacking cells as compared to the WT cells (Fig 
3.5A and 3.5B). In addition, insulin induced acetylation at Lys9 of histone H3 on rDNA 
promoter in WT hepatocytes, thus transforming rDNA genes into euchromatin to turn 
on transcription. In contrast, in the Sirt7KO hepatocytes, H3K9 was deacetylated which 
explains the repression of pre-rRNA transcription (Fig 3.5C). These results imply that 
Sirt7 is required for the stimulation of rDNA transcription by insulin in the liver via the 
recruitment of RNA Pol Ⅰ and UBF to the rDNA promoter and the increased 
acetylation of histones.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 The increased recruitment of Pol I and UBF to rDNA promoter and 
higher of acetylation of H3K9 at the rDNA can be seen in WT but not Sirt7 KO 
hepatocytes after insulin treatment. (A-B) ChIP assay of RNA polymerase I(Pol I) (A) and upstream 
binding factor (UBF) (B) recruitment to the rDNA promoter in WT(n=3) and Sirt7 deficient (n=3) hepatocytes 
from old mice, cultured with 20nM or without (0nM) insulin for 24hrs. (C) ChIP assay of AcH3K9 enrichment 
on the rDNA promoter in WT and KO hepatocytes in the medium with (20nM) or without (0nM) insulin for 
24hrs. The 3 different hepatocytes from the same genotype were mixed together for ChIP experiments. All 
values are average±SD for triplicate. Significance was determined by Student’s t test. * indicates the 
significance after insulin treatment and between WT and Sirt7KO: * P< 0.05; ** P < 0.01.      
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3.2 Sirt7 is necessary for an efficient adipocyte differentiation and WAT 
homeostasis through repression of Sirt1, a negative regulator of 
PPARγ 
3.2.1 Sirt7 is necessary for efficient adipocytes differentiation in culture 
      Adult Sirt7 KO mice reveal strikingly diminished fat stores and have reduced 
body size and mass beginning at 5 months of age (Vakhrusheva et al., unpublished data, 
Fig 3.6 A, B). These changes were not caused by hypophagy since Sirt7 KO mice 
consumed similar amounts of food as the WT mice (data not shown). Furthermore, 
histological analysis of sections through the skin of mutant and normal mice showed 
that the subcutaneous fat layer was greatly reduced in Sirt7 KO mice, together with the 
significantly reduced cell size of adipocytes in the mutant mice (Vakhrusheva et al. 
unpublished data, Fig 3.6 C, D). In line with these observations, gene expression 
analysis of white adipose tissue taken from 8-month-old mice demonstrated a marked 
decrease in adipogenic markers PPARγ and aP2 in the remaining Sirt7 deficient adipose 
tissue (Fig 3.6 E). 
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      A decreased amount of adipose tissue may be caused by various factors. As we 
excluded hypophagy as a cause of the fat stores reduction, I wanted to investigate 
whether the potency to adipogensis might be impaired in Sirt7 KO mice. Primary MEFs 
(mouse embryonic fibroblasts) derived from either wild type or Sirt7 KO mice were 
isolated and cultivated in the presence of synthetic PPARγ agonist rosiglitazone. A 
significant decrease in the abundance of Oil Red O positive lipid droplets was observed 
in the Sirt7 deficient MEFs compared with wild type cells differentiated for 5 days and 
8 days (Fig 3.7A). Consequently, quantitative real-time PCR performed on the MEFs 
Figure 3.6 Sirt7 knockout mice accumulate less subcutaneous and visceral fat 
with age. (A) General appearance of 10 months old Sirt7 KO mice as compared to wildtype littermates. (B) 
Skinned wildtype and Sirt7 KO mice reveal diminished fat stores pointed out by arrows. (C) HE stained cross 
section through the skin of Sirt7 knockout and control mice. (D) Estimates of adipocytes sizes in WT and KO 
mice. (A-D) from Olesya Vakhrusheva. (E) Quantitative RT-PCR analysis of adipogenic genes PPARγ and aP2 in 
white adipose tissue of WT (n=3) and Sirt7 KO (n=3) mice (18months old). Gene expression was normalized to 
β-actin. The relative mRNA levels represent average from three different animals per group and were 
calculated as a difference of expression to wild-type, WT control as 1. All values are average±SD. Significance 
was determined by Student’s t test. * indicates the significance between WT and Sirt7KO: * P< 0.05; ** P < 
0.01.  
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during different time points of differentiation revealed a dramatic reduction of 
adipogenic gene markers expression, including PPARγ, CEBP, and aP2 in Sirt7 KO 
MEFs as compared to WT cells (Fig 3.7B-D). In agreement with the mRNA results, 
protein expression of adipocytes marker aP2 was also severely reduced in Sirt7 
deficient MEFs cultivated for 5 and 8 days in differentiation medium (Fig 3.7E).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       The white preadipocytes cell line 3T3-L1 has been extensively used to study 
adipocytes differentiation in vitro. To further investigate the potential role of Sirt7 in 
adipogenesis, I therefore performed knock-down experiments using lentiviral RNAi 
constructs in 3T3L1 cell lines and generated five stable cell lines containing different 
shRNA sequences against Sirt7. The target sequences of Sirt7 were ShRNA No.1#, 
Figure 3.7 Sirt7 is required for adipogenesis in primary MEFs. (A) In vitro adipocytes 
differentiation of primary MEFs isolated from WT and Sirt7 KO mice. Morphological differentiation after 5 
days (left) or 8 days (right) was visualized with oil red O staining. (B-D) The mRNA expression of adipogenic 
markers PPARγ, C/EBPα and aP2 at different time points after differentiation, respectively, was analyzed by 
quantitative RT-PCR and normalized to β-actin. All values are average ± SD for triplicate measurements. 
Significance was determined by Student’s t test. * indicates the significance between WT and Sirt7KO: * P< 
0.05; ** P < 0.01. (E) Protein expression levels of Sirt1, Sirt7 and aP2 in WT and KO MEFs during adipogenesis 
were detected by Western blot. β-actin is the loading control .  
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5’-CCTCC CTCTT TCTAC TCCTTA-3’; ShRNA No.2#, 5’-CCTGG AGATT CCTGT 
CTACAA-3’; ShRNA No.3#, 5’-CGGGA TACCA TTGTG CACTTT-3’; ShRNA 
No.4#, 5’-TGCAT CCCTA ACAGA GAGTAT-3’ and ShRNA No.5#, 5’-GTAGG 
AAGTC ACTAT GCAGAA-3’. The results showed that Sirt7 was strongly decreased at 
both the mRNA and the protein level in these stable cell lines, the most efficient one 
was the cell line No.5 (Fig 3.8A-B). Importantly, the results determined by Oil red O 
staining assay indicated that Sirt7 knockdown by RNA interference (RNAi) suppressed 
adipocyte differentiation, the most efficient impaired adipogenesis was in cell line No.5 
(Fig 3.8C). These results confirmed the essential role of Sirt7 in adipogenesis 
demonstrated in the Sirt7 -/- MEFs. However, a slightly increased adipogenesis was 
observed in the No.3 knockdown cells. Analysis of No.3 shRNA sequence revealed that 
it can not only knock down Sirt7 but also other genes including EGF, kif14 and adam25. 
The No.5 knock down stable cell line was chosen for further investigation. After 7 days 
of differentiation in medium without rosiglitazone, oil red O staining showed that there 
were significantly fewer terminally differentiated adipocytes in cells in which Sirt7 had 
been silenced than in control scramble cells (Fig 3.8D). Furthermore, the mRNA 
expression of PPARγ and aP2 were decreased in Sirt7 knock down cells as 
demonstrated by quantitative real-time PCR. In agreement with the mRNA levels, the 
western blot results indicated down-regulation of adipocytes specific protein aP2 in the 
Sirt7 knock down cells (Fig 3.8 E-F). Taken together, these results suggest that Sirt7 is 
required for the efficient adipogenesis of fibroblasts and 3T3-L1 preadipocytes in 
culture.    
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Figure 3.8 Sirt7 is required for differentiation of 3T3-L1 preadipocytes. 
(A) The Sirt7 mRNA level in stable Sirt7-knockdown 3T3-L1 cells without adipogenesis. S7KD1#, 2#, 3#, 4# and 
5# were five stable celllines generated by five different retroviral shRNA constructs. Scramble indicates 
control shRNA construct. Endogenous Sirt7 mRNA was determined by quantitative RT-PCR and normalized to 
GAPDH. Results are presented as fold expression compared to scramble. All values are average ± SD for 
triplicate measurements. Significance was determined by Student’s t test. * indicates the significance 
compared to scramble cells: ** P < 0.01. (B) Sirt7 protein level in stable Sirt7-knockdown 3T3-L1 cells without 
differentiation was detected by Western blot. GAPDH was blotted as loading control. (C) The inhibited 
adipocyte differentiation in Sirt7-knockdown 3T3-L1 cells (2#, 4# and 5#). The cells were induced with 
standard differentiation medium without rosiglitazone. On day 8, the cells were stained with Oil-red-O. (D) 
The stable 3T3-L1 cells infected with S7KD5# or scramble were induced to adipogenesis for 7 days. Oil red O 
staining showed the blocked differentiation in Sirt7 knockdown cells. (E) The mRNA levels of Sirt7, PPARγ and 
aP2 in S7KD 5# or scramble stable cells after 7 days differentiation were detected by QRT-PCR and normalized 
to β-actin. Results are presented as fold expression compared to scramble. All values are average ± SD for 
triplicate measurements. Significance was determined by Student’s t test. * indicates the significance 
compared to scramble cells: ** P < 0.01. (F) Protein expression levels of Sirt7 and aP2 in knock down cells 
after adipogenesis were detected by Western blot. β-actin is the loading control .  
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3.2.2 Sirt7 is required for PPARγ expression during adipogenesis 
     Immortalized MEFs obviate the need to isolate new cells repeatedly and allow 
more sustained manipulation (such as multiple viral transductions) compared with 
primary MEFs. Moreover the immortalized MEFs do not easily undergo replicative 
senescence after repeated divisions. Thus, immortalized WT and Sirt7 KO MEFs were 
generated and cultured in adipocyte differentiation inducing medium containing 
rosiglitazone. Subsequently, gene expression of PPARγ and the adipocyte 
differentiation marker aP2 was analyzed by qRT-PCR during different time points of 
differentiation. Again, a significantly decreased expression of PPARγ, C/EBP and aP2 
was detected in Sirt7 mutant cells (Fig 3.9A-C). The immunofluorescence staining 
confirmed the drastic decrease of PPARγ expression also at the protein level in Sirt7 
KO immortalized MEFs, which was correlated with the dramatic decrease in lipid 
accumulation as assessed by Oil red O staining (Fig 3.9D). A similar result was 
observed in Sirt7 knock down 3T3-L1 cells via immunostaing (Fig 3.9E). To investigate 
how Sirt7 influences PPAR expression, I further analyzed the epigenetic markers on the 
promoter. Chromatin immunoprecipitation assays were performed in differentiating 
immortalized MEFs to reveal the epigenetic status of the PPARγ promoter during 
adipogenesis in WT and Sirt7 KO MEFs. As expected, a lower acetylation of lysine 9 of 
histone 3 (AcH3K9), indicating gene inactivation was detected at the PPARγ promoter 
in Sirt7 KO MEFs after 5 days of differentiation. Interestingly, Sirt7 deletion also led to 
significant increase of H3K9 trimethylation (H3K9me3), another epigenetic mark for 
repressed genes at the PPARγ promoter (Fig 3.9F). Similarly, Sirt7 knock down also 
caused lower acetylation of H3K9 and H4K16 on PPARγ promoter in the differentiating 
3T3-L1 cells (Fig 3.9G). These data indicate that Sirt7 is required for the robust 
transcription of PPARγ during adipogenesis by maintaining high H3K9 acetylation and 
low H3K9 trimethylation. 
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3.2.3 PPARγ overexpression but not Sirt7 overexpression can completely rescue the 
impaired adipogenesis in Sirt7 KO immortalized MEFs 
      Ectopic PPARγ is sufficient to stimulate immortalized wild-type MEFs to 
differentiate into adipocytes even in the absence of synthetic PPARγ ligand (Ge et al., 
Figure 3.9 Sirt7 is required for PPARγ expression in MEFs. (A-C) mRNA expression levels 
of adipogenic markers PPARγ, C/EBPα and aP2 in WT and Sirt7 KO immortalized MEFs during different 
differentiation time were determined by quantitative RT-PCR and normalized to β-actin. All values are 
average ± SD for triplicate. Significance was determined by Student’s t test. * indicates the significance 
between WT and Sirt7KO: * P< 0.05; ** P < 0.01. (D-E) Micrographs of Oil red O staining (red) of the WT and 
KO immortalized MEFs (D) or scramble and S7KD stable 3T3-L1 cells (E) after 8 days of adipogenesis. The 
endogenous PPARγ (green) was stained with anti-PPARγ antibody by immunofluorescence assay. Nuclei were 
stained with DAPI (blue). (F-G) ChIP assay of histone acetylation (AcH3K9) and methylation (H3K9me3) on 
PPARγ2 promoter in WT&KO MEFs (F) or scramble&S7KD 3T3-L1 preadipocytes (G). The immunoprecipitatied 
DNA was analyzed by quantitative PCR and normalized to the histone H3. All values are average ± SD for 
triplicate measurements. Significance was determined by Student’s t test. * indicates the significance 
between WT and Sirt7KO: ** P < 0.01.     
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2002) and PPARγ can rescue the differentiation of MEFs lacking C/EBP to mature 
adipocytes (Rosen et al., 2002). I further asked whether overexpression of PPARγ could 
rescue the impaired adipogenesis in the Sirt7 knock out MEFs. To investigate whether 
the severe adipogenesis defects in Sirt7-deficient cells were solely due to the defective 
expression of endogenous PPARγ, the immortalized MEFs derived from WT or Sirt7 
KO mice were infected with either retroviral expression vector for PPARγ-flag or 
empty vector to create stable cell lines. In these cells, ectopic PPARγ overexpression 
significantly stimulated the differentiation in wildtype cells as expected, and its 
overexpression could completely rescue the impaired adipogenesis in Sirt7 deficient 
MEFs (Fig 3.10A and B), even reaching the differentiation level of WT cells 
overexpressing PPARγ. However, ectopic overexpression of Sirt7 was not able to fully 
restore the adipogenic potential in these cells despite the fact that Sirt7 overexpression 
inhibited Sirt1 protein levels in Sirt7 KO cells to a similar extent as did the PPARγ 
overexpression (Fig 3.10B). Interestingly, when Sirt7 knock down 3T3L1 cells were 
infected with retrovirus overexpressing human Sirt7, the expression levels of PPARγ 
were increased both at mRNA level and protein levels (Fig 3.10C and D). However, no 
significant changes in the expression level of adipocyte marker gene aP2 (Fig 3.10C) 
and in lipid droplets accumulation (data not shown) were detected.    
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3.2.4 Sirt1 expression is increased in Sirt7 deficient MEFs during adipogenesis 
especially at protein level 
      Sirt1 was reported to inhibit adipogenesis and promote fat mobilization by 
repressing the activity of PPARγ (Picard et al., 2004). Thus, it was of interest to 
determine whether Sirt1 expression or activity was affected in Sirt7 knockout cells. 
Although no significant changes in the expression level of Sirt1 transcripts were 
detected in wild-type and knockout adipose tissues (Fig 3.11A) and MEFs (Fig 3.11B), 
Figure 3.10 Ectopic PPARγ but not Sirt7 overexpression rescues the 
adipogenesis defect in Sirt7 deficient cells. (A-B) Sirt7 deficient immortalized MEFs were 
infected with retroviral pBabe vector expressing ectopic Sirt7 or PPARγ2-Flag, and induced to adipocytes 
differentiation. WT MEFs were also infected to overexpress ectopic Sirt7 or PPARγ2 as controls. Cells were 
stained with oil red O after 8 days of differentiation (A). Western blot analysis of ectopic Sirt7 and PPARγ2 
(with anti-Flag antibody) and the endogenous protein expression of Sirt1 and aP2 in the Sirt7 KO cells infected 
with ectopic Sirt7 or PPARγ2 after 8 days of differentiation (B). (C-D) Scramble and S7KD 3T3-L1 preadipocytes 
were infected with retroviral CTAP vector expressing ectopic human Sirt7 or empty control. (C) After 8 days of 
adipogenesis, the mRNA expression levels of adipogenic markers PPARγ and aP2 were determined by 
quantitative RT-PCR and normalized to β-actin. Results are presented as fold expression compared to 
scramble. All values are average ± SD for triplicate measurements. Significance was determined by Student’s t 
test. * indicates the significance between control and hSirt7 OE: ** P < 0.01. (D) Protein expression of ectopic 
Sirt7 and endogenous Sirt1, Sirt7 and PPARγ was detected by Western blot, RalA was blotted as loading 
control.      
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the Sirt1 protein expression was indeed elevated in Sirt7 KO MEFs, especially in the 
early stage of differentiation (less than 5 days) (Fig 3.6E and 3.11C). Similar increase of 
Sirt1 protein expression was observed in the Sirt7 knock down 3T3L1 cells (Fig 3.10D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Higher accumulation of Sirt1 protein in Sirt7 deficient cells. (A-B) No 
significant changes were detected in Sirt1 mRNA levels in Sirt7 deficient mice WAT (A) or primary MEFs during 
differentiation (B) by QRT-PCR and normalized to β-actin. In (A) mRNA was isolated from 3 WT and 3 Sirt7 KO 
mice, results are presented as fold expression compared to WT mice. (C) Detection of Sirt1 protein by 
immunofluorescence in WT and Sirt7 KO immortalized MEFs pre-induced to differentiation (day 0). (D) 
Western blot of cytoplasmic (Cyto) or nuclear proteins (Nuc) fractionated from WT and Sirt7KO MEFs at 
different days of differentiation. aP2 expression indicated adipogenic differentiation; cytosolic fraction 
β-tublin and nuclear marker histone H3 were blotted as loading control and cell fraction purity control.  
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Interestingly, the subcellular localization of Sirt1 seems also to be affected in Sirt7 
deficient cells during adipogenegsis: While in wild type cells Sirt1 predominantly 
resides in the cytoplasm of undifferentiated cells (day0), in the knockout cells Sirt1 is 
not only present in higher amounts in the cytoplasm but also is already detectable in the 
nucleus (Fig 3.11D). After induction to differentiation, Sirt1 gradually accumulates in 
the nucleus during adipogenesis in wild type cells and is present in the nucleus and in 
cytoplasm in all phases of differentiation (Fig 3.11D). In contrast, in Sirt7 knockout 
cells, Sirt1 is present in the nucleus at early stage of differentiation (day0 and day2) and 
is no more detectable in the nucleus after prolonged adipogenesis induction (day5 and 
day8), whereas, Sirt1 is present at higher level in the cytoplasm of Sirt7 KO cells at all 
investigated time points (Fig 3.11D).    
 
3.2.5 Sirt7 inhibits Sirt1 protein level and blocks the recruitment of Sirt1 to the 
PPARγ promoter during adipogenesis  
      Sirt1 has been demonstrated to represses PPARγ by docking with its cofactors 
NCoR (nuclear receptor co-repressor) and SMRT (silencing mediator of retinoid and 
thyroid hormone receptors) to PPARγ promoter and inhibiting its transcription (Picard 
et al., 2004). Sirt1 binding to PPARγ promoter was then analyzed in WT&Sirt7 KO 
MEFs during adipogenesis. ChIP assays showed that Sirt1 binding was increased in 
Sirt7 KO MEFs after 5 days of differentiation (Fig 3.12A) in consistence with the lower 
acetylation of H3K9 on PPARγ promoter (Fig 3.8E). The significant increase of Sirt1 
occupancy at the PPARγ promoter was observed in the differentiating Sirt7 knock down 
3T3-L1 preadipocytes as well (Fig 3.12B). Together, these data suggested that the 
increased nuclear accumulation of Sirt1 and its increased recruitment at PPARγ 
promoter might directly contribute to higher deacetylation and hypermethylation of 
histone 3 on the PPARγ promoter leading to repression of PPARγ transcription in Sirt7 
KO cells and thus being, at least in part, responsible for the reduced adipogenesis in 
Sirt7 deficient cells.   
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3.2.6 Adipogenesis defects in Sirt7 deficient MEFs can be partly restored by Sirt1 
knock down or Sirt1 inhibition by NAM 
It was indicated previously that Sirt1 inhibition by RNA interference enhances 
the adipogenesis potency in 3T3L1 cell lines (Picard et al., 2004). Thus, we wanted to 
know, whether Sirt1 knock down would improve the adipocytes differentiation of Sirt7 
KO MEFs. Sirt1 expression was silenced through retroviral infection with pQsup-Sirt1 
RNAi in the immortalized Sirt7 KO MEFs. The knock down efficiency was evaluated 
by qRT-PCR and Western Blot (Fig. 3.13A and B). After 7 days of differentiation 
PPARγ and aP2 mRNA expression was significantly increased upon Sirt1 knockdown 
(Fig. 3.13A). In addition, Sirt1 knockdown cells had slightly increased PPARγ protein 
and lipid droplets accumulation as compared to control cells (Fig. 3.13C). Similar effect 
was achieved when Sirt7 KO cells were incubated with Sirt1 inhibitor nicotinamide 
during the differentiation process (Fig 3.13E). In consistence with the increased number 
of oil red o positive cells, NAM treatment significantly enhanced the mRNA expression 
of PPARγ and aP2 in Sirt7 KO MEFs. Thus, inhibition of Sirt1 partially rescues the 
Figure 3.12 Increased occupancy of Sirt1 at the PPARγ promoter in Sirt7 deficient 
cells during adipogenesis. (A-B) ChIP assays of Sirt1 binding at the PPARγ2 promoter in pre- (day0) 
and post-induced differentiation (day5) WT and Sirt7 KO immortalized MEFs (A) and Scramble and Sirt7KD 
3T3-L1 cells (B). The immunoprecipitatied DNA was analyzed by quantitative PCR and normalized to the input 
DNA. All values are average ± SD for triplicate measurements. Significance was determined by Student’s t test. 
* indicates the significance between WT and Sirt7KO or Scramble and Sirt7 KD: * 0.01< P< 0.05.     
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impairment of adipocyte differentiation in Sirt7 deficient MEFs (Fig 3.13D).  
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
3.2.7 Removal of one Sirt1 allele rescued the highly compromised adipogenic 
potential of Sirt7-/- primary white preadipocytes and the abnormality of WAT in 
adult Sirt7 deficient mice     
      To investigate whether Sirt7 is required for differentiation in primary 
preadipocytes, primary white preadipocytes were isolated from WT and Sirt7 KO mice 
and induced to differentiation for 8 days, followed by adipogenesis assay using Oil red 
Figure 3.13 Sirt1 knock down or inhibition of Sirt1 activity can partly rescue the 
impaired adipogenesis in Sirt7 KO immortalized MEFs. (A-C) Sirt7 deficient MEFs were 
infected with retroviral pSuper scramble shRNA or pSuper-Sirt1 shRNA constructs, then the cells were induced 
to differentiation for 8 days. (A) mRNA levels of Sirt1 and adipogenic proteins PPARγ and aP2 were 
determined by quantitative RT-PCR and normalized to β-actin. Results are presented as fold expression 
compared to Scramble controls. All values are average ± SD for triplicate measurements. Significance was 
determined by Student’s t test. * indicates the significance between Scramble and Sirt1 RNAi: * P< 0.05; ** P 
< 0.01. (B) Western blot analysis of Sirt1 protein level, β-actin was the loading control. (C) Cells after 8 days  
of differentiation were stained with Oil red O and with anti-PPARγ antibody. Nuclei were stained in blue 
(DAPI). (D-E) Sirt7 deficient MEFs were cultured with or without 10mM nicotinamide (NAM) and induced to 
differentiation for 8 days. (D) mRNA levels of PPARγ and aP2 were determined by quantitative RT-PCR and 
normalized to β-actin. Results are presented as fold expression compared to WT controls. All values are 
average ± SD for triplicate measurements. Significance was determined by Student’s t test. * indicates the 
significance between Normal medium and 10mM NAM: * P< 0.05; ** P < 0.01. (E) Oil red O stained cells after 
8 days of adipogenesis in normal medium or in medium containing 10mM NAM. 
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O staining. Sirt7 deletion led to a nearly complete block of adipogenesis in white 
preadipocytes (Fig 3.14A). Interestingly, the primary white preadipocytes from 
Sirt7-/-//Sirt1+/- mice showed increased mature adipocytes accumulation after 8 days of 
differentiation in contrast to the preadipocytes from Sirt7-/-//Sirt1+/+ mice (Fig 3.14A). 
Furthermore, in contrast to the phenotype of the significant decrease of WAT weight 
and the lower mRNA expression of PPARγ in adult Sirt7 KO mice (10-12 months) (Fig 
3.14B and C), Sirt7-/-//Sirt1+/- mice of the same age showed no significant changes as 
compared to the WT mice or Sirt1+/-mice (Fig 3.14B and C). It should be noted that 
one Sirt7KO mouse (no. 5584) showed even a higher white adipose tissue weight than 
the average weight of WAT in control mice; however, the PPARγ expression level was 
still significantly decreased. These findings indicate that Sirt7 is required for 
adipogenesis in primary preadipocytes and maintains the white adipose mass balance in 
organismal metabolic homeostasis through the inhibition of the anti-adipogenetic factor 
Sirt1.     
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Figure 3.14 Removal of a single Sirt1 allele improves the adipogenesis of primary 
Sirt7 deficient preadipocytes and increases the WAT mass and PPARγ 
expression of Sirt7 KO mice. (A) Oil red O staining of primary white preadipocytes isolated from 
Sirt7+/-, Sirt7-/- and Sirt7-/-//Sirt1+/- mice cultured in adipocytes differentiation medium for 8 days. Nuclei 
are stained with DAPI (blue). Note the impaired differentiation of Sirt7-/- cells, which is restored after removal 
of one Sirt1 allele. (B-C) The relative weights of WAT (B) and relative mRNA levels of PPARγ, Sirt7 and Sirt1 (C) 
in WT, Sirt7 KO, Sirt7 KO//Sirt1+/- and Sirt1+/- mice. The mRNA levels were determined by quantitative 
RT-PCR quantitative RT-PCR (Taqman probe method) and normalized to GAPDH. Results represent average 
from several mice per group and were calculated as a fold difference to wild-type, WT control as 1. All values 
are average ± SD. Significance was determined by Student’s t test. * P< 0.05; ** P < 0.01.  
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3.3  Sirt7 can inhibit Sirt1 activity by interfering with its    
auto-deacetylation   
3.3.1 Sirt7 does not deacetylate Sirt1 but increases the acetylation of Sirt1 and inhibits 
its activity 
      Taken together, our data imply that Sirt7 normally ensures efficient adipocytes 
differentiation by inhibition of Sirt1 activity and/or by destabilization of Sirt1 protein. 
Moreover, Sirt7 deficient hepatocytes have the disturbed response to fasting/refeeding 
and fail to stimulate the rDNA transcription by insulin. These changes might be also 
caused by a high protein amount and/or high activity of Sirt1. We exclude an influence 
of Sirt7 on Sirt1 transcription since there were no significant changes in Sirt1 transcripts 
levels in Sirt7 KO WAT or MEFs (Fig 3.11A and B). In contrast, the protein levels were 
significantly higher in Sirt7 KO MEFs or Sirt7 knock down cells (Fig 3.7E, Fig 3.10D, 
Fig 3.11C and D). We further asked whether Sirt1 protein might interact with and be 
regulated by Sirt7 via post-translation-modification. In fact, in cells overexpressing 
Sirt1-CFP fusion protein, endogenous Sirt7 peptides could be identified by 
mass-spectrometry among proteins precipitated with anti-(CGY)FP antibody and vice 
versa endogenous Sirt1 peptides were found in cell precipitates from the Sirt7-YFP 
ovexpressing cells. The interaction between Sirt1 and Sirt7 was further confirmed in 
immunoprecipitation experiments (Fig 3.15A Smolka, unpublished data). The 
Sirt1/Sirt7 interaction was dependent on the intact Sirt7 deacetylation core domain 
because point mutation of two critical residues (N169 and H188) in its catalytic domain 
or expression of amino acids 1-210 of 5’-N-terminus without an intact catalytic domain 
both abolished binding of Sirt1 to Sirt7 (Fig 3.15A Smolka, unpublished). The inability 
of Sirt7 inactivating mutations to bind Sirt1 suggested that Sirt1 might be a substrate for 
Sirt7 dependent deacetylation. However, co-expression of Sirt7 with Sirt1 resulted in 
increased Sirt1 acetylation level whereas the Sirt1 acetylation was very low when it was 
expressed alone (Fig 3.15B). Moreover, when wildtype Sirt7, but not its catalytic 
inactive H188Y mutant was co-expressed with Flag-tagged Sirt1, a higher Sirt1 
acetylation was observed (Fig 3.15C). Therefore, we hypothesized that Sirt7 does not 
Results 
70 
 
directly deacetylate Sirt1, but promotes certain acetyltransferase(s) to acetylate Sirt1 or 
inhibits other deacetylation enzyme(s). Since Sirt1 is a deacetylase we speculated that 
Sirt1 might deacetylate itself and that Sirt7 prevents its auto-deacetylation activity. 
Importantly, mapping of the acetylation sites of Sirt1 by liquid chromatography-tandem 
mass spectrometry analysis (LC-MS/MS) identified 4 acetyl-modified lysine residues in 
Sirt1 in the presence of Sirt7 (Fig 3.15D), while no acetylated residues were detected in 
the absence of Sirt7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To determine whether the increased acetylation of Sirt1 could alter its activity, we tested 
the Sirt1 deacetylation activity by estimating the acetylation status of its cellular target 
p53. The results showed that the acetylation inhibits Sirt1 activity, as demonstrated by 
Figure 3.15 Sirt7 physically interacts with Sirt1 and increases the acetylation of 
Sirt1. (A) Wildtype Sirt7, but not Sirt7 bearing point mutation in the deacetylase domain nor the Sirt7 
N-terminally truncated protein can interact with Sirt1 (data from Christian Smolka). (B) Increased acetylation 
of Sirt1 after co-expression with Sirt7. (C) The increased Sirt1 acetylation was only detected in cells expressing 
Sirt1 together with WT Sirt7 but not with a Sirt7 H188Y inactive mutant. (D) Overview of the localization of 
acetylated lysines in the mouse Sirt1, which were found in the presence of Sirt7 by mass-spectrometry 
analysis. (E) Acetylation of p53 in HEK293T cells expressing Sirt1 and Sirt7 alone or in combination was 
detected by Western blot. RalA was used as loading control.     
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an increased acetylation levels of p53 in cells expressing Sirt1 together with Sirt7 and in 
contrast to low acetylation of p53 in cells overexpressing Sirt1 without Sirt7 (Fig 3.15E). 
High p53 acetylation was also observed in cells only overexpressing Sirt7 suggesting 
that Sirt7 increases acetylation of p53 through inhibition of endogenous Sirt1 activity 
and/or by other ways (Fig 3.15E).  
 
3.3.2 Sirt1 has an auto-deacetylase activity in vivo and in vitro   
      To investigate whether Sirt1 is an auto-deacetylase, Sirt1-specific inhibitor 
Ex527 was used to block the activity of Sirt1 in vivo and acetylation of Sirt1 was 
measured using Sirt1 immunoprecipitation and anti-acetyl-lysine antibody in a western 
blot analysis. Fig 3.16A and B demonstrate that, indeed, Ex527 treatment leads to 
higher level of Sirt1 acetylation in cell culture. In vitro deacetylation assays using 
acetylated Sirt1 derived peptides and recombinant Sirt1 protein were also performed to 
detect the auto-deacetylation of Sirt1. These experiments were kindly supervised and 
analysed by Dr. Marcus Krüger and his group. Notably, Sirt1 showed highly efficient 
deacetylation activity on peptide containing acetylated lysine 230 (K230), the efficiency 
of the K230 auto-deacetylation was quantified by mass-spectrometry employing stable 
isotope labelled peptides (Fig 3.16C). These data indicate that Sirt1 can deacetylate 
itself both in vivo and in vitro.          
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3.3.3 The acetyltransferase MOF acetylates and decreases the activity of Sirt1 
      It was reported that Sirt1 can interact with some acetyltransferases including 
p300/CBP (Bouras et al., 2005), PCAF (Pediconi et al., 2009), TIP60 (Wang and Chen, 
2010), MOF (Lu et al., 2011) and modulates their catalytic activity through 
deacetylation. Therefore, further investigations were performed to examine whether 
these acetyltransferases can acetylate Sirt1. HEK cells were transfected with Sirt1 in the 
presence or absence of p300 (CBP), MOF, PCAF respectively, and the acetylation 
levels of immunoprecipitated Sirt1 were detected by anti-acetyl-lysine immunoblotting. 
The level of Sirt1 acetylation was only increased in the presence of MOF and was 
similar to the increase of Sirt1 acetylation after addition of WT Sirt7 (Fig 3.17A, B). 
Next, the effect of Sirt1 acetylation by MOF on its enzymatic activity to deacetylate 
Figure 3.16  Sirt1 is self-deacetylated in vivo and in vitro. (A-B) Increased acetylation of 
Sirt1 was observed after specific inhibition of Sirt1 deacetylase activity by Ex527 in cell culture. Two different 
Sirt1 expressing constructs, Sirt1-CFP (A) and Sirt1-Flag (B) were used for transfections. Cell lysates were 
immunoprecipitated with CFP and Flag antibodies, respectively, followed by Western Blot analysis using 
Anti-CFP, anti-Flag and anti-Acetyl lysine (AcK) antibodies. Relative intensities of acetylated Sirt1 proteins were 
quantified and are shown in histograms. All values are average ± SD for triplicate measurements. Significance 
was determined by Student’s t test. * P< 0.05; ** P < 0.01. (C) Quantitative mass spectrometry analysis of 
deacetylation of Sirt1-derived peptides containing acetylated K230 residues by recombinant Sirt1. The 
acetylated K230 Sirt1 peptides were synthesized and labelled with the natural isotope for lysine (labelled with 
L (0)) and with the 
13
C6
15
N2 lysine isotope (labelled with H (8)) respectively using the SILAC technique (Guarani 
et al.).  
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H3K9 was examined in cell culture experiments. Deacetylation of H3K9 by Sirt1 was 
significantly reduced when cotransfected with MOF acetyltransferase (Fig 3.17C). Thus, 
the MYST acetyltransferases family member, MOF, can acetylate and repress the 
deacetylase activity of Sirt1. Surprisingly, MOF acetyltransferase increased acetylation 
of WT Sirt1 much stronger than of Sirt1 enzymatic inactive mutant, Sirt1H355Y (Fig 
3.17D).  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Acetyltransferase MOF acetylates Sirt1 and attenuates its 
deacetylase activity. (A) HEK 293T cells were transfected with Sirt1-Flag and acetyltransferases CBP-HA 
or MOF-EGFP as indicated. Acetylation of Sirt1 was examined by immunobloting using anti-acetyl-lysine 
antibody (AcK) after immunoprecipitaion. (B) Sirt1-CFP was transfected into HEK 293T cells in the presence of 
hSirt7-Flag or MOF-EGFP. Sirt1-CFP was immunoprecipitated with anti-GFP antibody and the acetylation 
detected by immunobloting with anti AcK antibody. (C) HEK 293T cells were transfected with Sirt1-Flag alone 
or together with MOF-EGFP. The activity of Sirt1 was examined by the levels of acetylated H3K9 (AcH3K9) on 
the Western Blot using anti-acH3K9 antibody. The levels of histone H3 were used as loading control. (D) HEK 
293T cells were transfected with WT Sirt1-Flag or inactive mutant Sirt1H355Y-Flag expression vectors 
together with WT Sirt7-CFP, inactive Sirt7H188Y-YFP and MOF-EGFP plasmids as indicated. The cell lysates 
were immunoprecipitated with anti-G(CY)FP antibody. The acetylation signals of precipitated products were 
analyzed by Western blot with anti-AcK antibody.              
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However, it was reported previously, that Sirt1 can deacetylate MOF and increase its 
activity and recruitment on the chromatin (Lu et al., 2011). The lower acetylation level 
of Sirt1H355Y mutant in the presence of MOF may thus reflect the lack of positive 
feedback regulation of MOF activity by Sirt1. The exact molecular mechanism of the 
regulatory loop existing among Sirt1, MOF, and Sirt7 has yet to be elucidated. 
 
3.3.4 A combination of acetylation and deacetylation at specific lysine residues is 
responsible for Sirt1 activation 
     To further test the impact of the acetylation at specific lysine site(s) of Sirt1 on its 
enzymatic activity, a series of Sirt1 point-mutants in which the lysine residues at 
positions 230, 369, 505 and 600 were separately replaced with arginine to prevent 
acetylation were generated and assessed for their deacetylation activity on endogenous 
p53. Interestingly, only the K230R mutant showed increased catalytic activity on p53 as 
the acetylated p53 signal was significantly decreased when compared with the WT Sirt1 
while none of the other mutants decreased p53 acetylation (Fig 3.18A). Together with 
the finding that Sirt1 efficiently auto-deacetylated lysine 230 in vitro, these results 
strongly suggest that K230 residue is a critical site of Sirt1 auto-deacetylation and the 
autodeacetylation of this site enhances the enzymatic activity of Sirt1. However, 
mutation of all four lysines converted to arginines (4KR) failed to decrease p53 
acetylation (Fig 3.18B). This result indicates that Sirt1 activity is enhanced not only by 
deacetylation of K230, but the acetylation at one or more remaining lysines is also 
required for the catalytic activity of Sirt1. To test this hypothesis, several 3KR mutants, 
in which 3 of the four identified lysine residues were mutated to arginine while the 
fourth remaining lysine could still be acetylated, were constructed and analysed for their 
enzymatic activity on endogenous p53. The results showed that the increased 
deacetylation activity was only seen with the 3KR2 mutant (in which K369 remained 
unchanged) but not with the other 3 KR mutants (Fig 3.18C). Furthermore, ectopic 
over-expression of WT Sirt7 or MOF not only repressed the deacetylase activity of WT 
Sirt1 on endogenous p53, but they also inhibited the activity of Sirt1 3KR2 (without 
K369) mutant (Fig 3.18B and C), suggesting that the specific acetylation at K369 site, 
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which enhance the activity of Sirt1, is not possibly modified by the acetyltransferase 
MOF. Taken together, these findings demonstrate that the modification of Sirt1 at 
specific lysine residues, which can affect the function of Sirt1 is more complex: In 
addition to the deacetylation of K230, an acetylation at K369 may be responsible for the 
activation of Sirt1. 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18 Autodeacetylation of Sirt1 occurs mainly at K230. The combination of 
acetylation at K369 and deacetylation at other lysines may be responsible for the 
promotion of Sirt1 deacetylase activity. (A) WT Sirt1-CFP and a series of Sirt1-CFP single KR 
mutation expression plasmids were transfected into HEK 293T cells as indicated. The acetylated p53 levels 
were detected by Western blot with anti-acetyl-p53 (K373, K382) antibody. RalA was used as loading control. 
Red arrow indicated the lowest acetylated p53 (the highest Sirt1 activity). (B-C) HEK 293T cells were 
transfected with WT Sirt1-CFP or 4KR mutants (B) or a series of 3KR mutants (C) together with Sirt7-YFP or 
MOF-EGFP. The acetylation level of p53 was detected by acp53 antibody in WB. β-actin was the loading 
control. Red arrows indicated the lowest acetyl-p53 in each picture.         
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3.4 Generation and initial characterization of Sirt1 conditional KO mice 
and Sirt1/Sirt7 double knock-out mice  
      Since we have found that Sirt7 inhibits Sirt1 expression and its activity, the 
disturbed hepatic response to fasting/refeeding and the diminished induction of 
transcription of hepatic rDNA by insulin as well as the impaired adipogenesis of white 
adipose tissue in Sirt7 deficient mice might be due to a higher expression and/or excess 
activation of Sirt1. To further study the in vivo roles of Sirt1 together with Sirt7 in the 
cross regulatory circuits important in the metabolic homeostasis, conditional Sirt1 
knockouts and double knockout heterozygotes Sirt1+/- Sirt7-/- or Sirt1-/- Sirt7+/- in the 
whole body or in the special organ were generated. 
 
3.4.1 Constructing of targeting vectors for conditional Sirt1 knockouts  
Two targeting strategies were employed to create conditional Sirt1knockouts 
(Sirt1 CKO). The first one was designed to conditionally delete Sirt1 exon4, which 
encodes 51 amino acids of the conserved Sirt1 catalytic domain. This targeting vector 
Sirt1 CKOS(short) was utilized to introduce one loxP site upstream of the exon4 in 
mouse Sirt1 locus, and a FRT neomycin-resistance (neo) cassette followed by the 
second loxP site downstream of exon4 (Fig 3.19A). Because the aberrant Sirt1△ex4 
protein might retain partial function or have dominant-negative activity, a second 
targeting construct Sirt1 CKOL(long) was designed to conditionally delete the exon2, 
exon3 and exon4 of Sirt1, which completely abolishes Sirt1 protein expression. The neo 
cassette and the 2nd loxP site was the same as in the first strategy, but the 1st loxP site 
was inserted into the genomic sequence between exon1 and exon2 (Fig 3.19B). The 
protocols to generate the conditional target vectors followed the published methods (Liu 
et al., 2003) with some modifications. The strategy and workflow of the 
recombineering-based method for generating the Sirt1 conditional knockout targeting 
vectors was illustrated in Fig 3.20    
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Figure 3.19 Generation of two Sirt1 conditional knockout constructs. (A) A schematic 
diagram of the Sirt1 germline locus, pKOII-Sirt1 SnaB targeting vector, target locus with floxp and neomycin 
cassette and Sirt1 locus after Exon4 deletion. Sirt1 exons, the relative locations of the internal probe, 3’probe 
for Southern blot and primers for genotyping and relevant restriction enzymes sites are indicated. (B) A 
schematic diagram of the Sirt1 germline locus, pKOII-Sirt1 Sfi targeting vector, target locus with floxp and 
neomycin cassette and Sirt1 locus after Exon2, Exon3 and Exon4 deletion. Sirt1 exons, the relative locations of 
the internal probe, 3’probe for Southern blot and primers for genotyping and relevant restriction enzymes 
sites are indicated.       
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      The targeting vectors were made using homologous recombination to introduce 
the mouse Sirt1 genomic DNA sequence including 5’UTR, Ex1, Ex2, Ex3, Ex4, Ex5 
and the corresponding introns from BAC DNA into pKOII (Fig 3.20). At first, two 
homologous arms 1 RP-5’ and 1 RP-3’ were amplified by PCR from BAC DNA as a 
template. 1 RP-5’ arm is located in 5’UTR of Sirt1 genomic DNA and contains SmaI 
and PmeI sites at its 5’end and HindIII site at the 3’end, while 1 RP-3’ arm is located in 
the intron between exon4 and exon5 of the genomic DNA and contains BglII and EcoRI 
sites at its 5’ and 3’ ends. The two fragments were inserted into SmaI HindIII sites and 
BglII EcoRI sites of the pKOII plasmid, respectively. Subsequently, the neomycin 
cassette was deleted by SacII and XhoI digestion, the linearized vector fragment 
containing the two homologous arms was gel extracted and transformed into 
recombination-competent cells carrying the BAC DNA. After the 1st retrieving, the 
targeting vector pKOII containing the 18kb DNA sequence spanning exon1 to exon4 of 
mouse Sirt1 has been produced. The next step in creating the cko-targeting vector was 
introduction of a loxP site and a FRT floxed neomycin resistance cassette from pL451 
plasmid into the subcloned DNA. To introduce the floxed Neo gene at the correct 
location in the target DNA vector, it was first flanked with two approximately 500bp 
long arms that are homologous to the targeting BAC DNA: 1MT-5’ and 1MT-3’. These 
homologous arms were generated by PCR amplification of the BAC DNA including 
XhoI and EcoRI or BamHI and SacII restriction sites and inserted into the XhoI EcoRI 
and BamHI SacII restriction sites of pL451 plasmid, respectively (Fig. 3.20). Then, 
DNA fragment containing FRT neo and loxP sites was excised by XhoI and SacII 
digestion, purified and electroporated along with the subcloned target DNA vector into 
EL350 cells for recombination. After the 2nd retrieving, the target vector contained a 
FRT floxed neo and one loxP site (Fig 3.20). The final step in the construction of the 
cko-targeting vector was the introduction of a second loxP site into the subcloned DNA, 
downstream of exon3 (Sirt1CKOS) or downstream of exon1 (Sirt1CKOL). A single 
loxP site with short extension sequence, favorable for genotyping by PCR, was inserted 
into the unique SfiI or SnaBI site of each cko-targeting vector. For confirmation of 
homologous recombination, 3’ probe and the internal probe, 540bp and 771bp in length 
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respectively, were prepared by PCR using BAC DNA template (Fig 3.19).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2 Production of targeted ES cell clones and chimera formation 
The two constructed CKO targeting vectors were subsequently linearized at the 
unique PmeI site and electroporated into mouse embryonic stem (ES) cells derived from 
a hybrid line (SV129/C57BL6). For Sirt1 CKOS, from two electroporations, about 95 
colonies with good morphology were isolated after 250μg/ml G418 selection. Targeted 
clones were identified by PCR using a 5’ primer (neoP7), specific to the neo cassette, 
and 3’ primer (neoP8) corresponding to the genomic sequence outside the vector (see 
Figure 3.20 Strategy and work flow chart used in generating the Sirt1 conditional 
knockout targeting vector by recombination.  
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Figure 3.18). To ensure that a single loxP site upstream of exon4 did exist, PCR using 
primers SnaBloxP P1 and SnaBloxP P2 was performed to selectively amplify this loxP 
sequence (Fig 3.21A). 80% of colonies were positive and they were subsequently 
verified by Southern blot analysis with both 3’ and internal probes as shown in Fig. 
3.21B. A novel longer band of 2.6 Kb after PstI digestion and of 11.4kb after EcoRV 
digestion corresponding to the targeted allele appeared as expected after hybridization 
with each probe, confirming homologous recombination of both arms (Fig 3.21B). After 
Southern blot verification, a total of 8 clones were positive. For Sirt1 CKOL, 170 
positive colonies were isolated and analyzed by PCR using primers P7 and P8 to 
confirm the neo cassette, and the SfiloxP P3 and SfiloxP P4 primers to confirm the loxP 
site (Fig3.21C). Then 122 candidate positive clones were verified by Southern 
hybridization with both internal and 3’ end probes (Fig 3.21D). At last, a total of 11 
positive clones were confirmed for homologous recombination after Southern blot. 
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3.4.3 Generation and genotypic verification of Sirt1 conditional KO mice 
Two targeted ES cell clones carrying the Sirt1CKOS targeting vector were 
chosen for injection experiments. Using micromanipulator and dissecting microscope, 
10-15 ES cells of each clone carrying the intergrated targeting vector were injected into 
C57BL/6 blastocysts. The injected blastocysts were implanted into the uteri of 
pseudopregnant NMRI foster mothers, each mouse was implanted with 8-10 blastocysts. 
A total of 15 chimeric mice with different degree of ES cell contribution in coat color 
were obtained and verified by Southern blot. The Sirt1 CKOS mice were backcrossed to 
WT C57Bl6 mice for at least 6 times. They were then bred with mice expressing Flp 
recombinase to delete the neo cassette and generate floxed Sirt1 exon4 (Sirt1SNeo) 
mice. Then these mice (Sirt1 Ex4 floxp/floxp, Flp negative) were crossed to CMV Cre 
Figure 3.21 Genotyping of two Sirt1 conditional knockout ES cells or mice tails 
by PCR and Southern blot. (A) PCR genotyping of Sirt1 CKOS (short) ES cells. The first loxP site 
located between exon3 and exon4 was detected by P1 and P2 primers; the second loxP site located 3’ to the 
Neo cassette was detected by P5 and P6; the allele generated by Cre recombinase deletion was detected by 
P1 and P6 primers. (B) Southern blot of PstI and EcoRV digested DNA isolated from Sirt1S +/+, Sirt1S +/floxP 
and Sirt1S +/- (Cre deletion) mice tails and hybridized with the internal probe and 3’probe, respectively. (C) 
PCR genotyping of Sirt1 CKOL (Nin et al.) ES cells. The first loxP site located between exon1 and exon2 was 
detected by P3 and P4; the allele generated by Cre recombinase deletion was detected by by Cre recombinase 
was detected by P3 and P6. (D) Southern blot of PstI and EcoRV digested DNA isolated from Sirt1L +/+, Sirt1L 
+/floxP and Sirt1L +/- (Cre deletion) mice tails and hybridized with the internal probe and 3’probe, 
respectively. All the relative locations of the internal probe and 3’probe for Southern blot and primers for PCR 
were indicated in Fig 3.19  
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transgenic mice (expressing the Cre recombinase driven by CMV promoter) or to liver 
specific Cre mice (expressing the Cre recombinase driven by albumin promoter) to 
generate the constitutive Sirt1 knockout mice (Sirt1 CMVKOS) and liver-specific Sirt1 
knockout mice (Sirt1sLiKO), respectively. RT-PCR analysis demonstrated the presence 
of a short length Sirt1 mRNA (without exon4) in the liver of Sirt1sLiKO mice (Fig 
3.22A). The successful removal of exon4 was also confirmed at the protein level: In the 
liver of albumin Cre expressing Sirt1sLiKO mice only a truncated, smaller Sirt1 protein 
band could be detected on the WB while normal size Sirt1 protein band was present in 
the other tissues (Fig 3.22B). The heterozygote Sirt1S CMVKO (Sirt1+/- CMVCre 
negative) mice were bred with Sirt7-/-mice to generate Sirt1/Sirt7 double knockout 
mice, and the homozygous Sirt1SLiKO (Sirt1s floxP/floxP Liver-Cre+/-) mice were 
crossed to Sirt7-/- mice to generate Sirt7/Liver Sirt1S double knockout mice for the 
further investigation. 
      For generation of mice with a longer Sirt1 deletion, one Sirt1CKOL positive ES 
clone was injected into the blastocysts. 10 chimeras were obtained and verified by 
Southern blot. Similar to strains generated with the short Sirt1 deletion, the Sirt1LNeo 
mice carrying the floxed Sirt1 exon2-4 (Sirt1 Ex2-Ex4 floxp/floxp, Flp negative) were 
bred with CMV Cre and albumin-Cre transgenic mice to generate Sirt1LCMVKO and 
Sirt1lLiKO mice, respectively. RT-PCR and Western blot analyses confirmed that Sirt1 
expression was eliminated at mRNA level and protein levels exclusively in the liver of 
Sirt1 lLiKO mice, with no detectable decrease in the other tissues (Fig 3.22C and D). 
Furthermore, the homozygous Sirt1LLiKO (Sirt1l floxP/floxP Liver-Cre+/-) mice were 
bred with Sirt7-/- mice to generate Sirt7/Liver Sirt1L double knockout mice for the 
further investigation. 
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3.4.4 Confirmation of embryonic lethality of Sirt1 deficiency by Sirt1 CMVKO mice 
      Previous reports showed that Sirt1 constitutive KO mice died at perinatal stages 
or later at the age up to several months into adulthood, depending on the genetic 
background (Cheng et al., 2003; McBurney et al., 2003; Wang et al., 2008). After 
analyzing of 142 Sirt1CMVKOS offsprings, it was found that only 8 mice of Sirt1S -/- 
survived after birth (Table 3.1). Among which, 2 of the surviving Sirt1S -/- mice had 
Figure 3.22 Sirt1 is specifically knocked out in the livers of Sirt1sLiKO and 
Sirt1lLiKO mice. (A-B) Expression of Sirt1 mRNA and proteins in different tissues of Sirt1sLiKO mice 
detected by RT-PCR (A) and Western blot (B), GAPDH or pan-actin was used as internal control in RT-PCR or 
loading control in Western blot, respectively. (C-D) Expression of Sirt1 mRNA and proteins in different tissues 
of Sirt1lLiKO mice detected by RT-PCR (C) and Western blot (D), GAPDH or β-tublin was used as internal 
control in RT-PCR or loading control in Western blot, respectively. H, heart; Li, liver; Lu, lung; B, brain; K, 
kidney; Te, testis; U, uterus.       
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reduced life span and died in less than 1 month. In contrast to their WT or heterozygous 
littermates, the Sirt1S -/- mice were smaller in size after birth and their postnatal growth 
was inhibited. In addition, some of the Sirt1S -/- mice showed morphological eye 
defects as already described for constitutive Sirt1 KO mice (Cheng et al., 2003; 
McBurney et al., 2003). For the second Sirt1 knockout mouse carrying the longer 
deletion, Sirt1CMVKOL, no surviving homozygous deficient mice were found after 
birth (Table 3.1). 
 
 
 
 
To investigate whether embryonic lethality of Sirt1 deficiency was the cause of 
low number of surviving Sirt1 -/- mice, embryos were isolated from Sirt1CMVKOS 
mice at E13.5. Indeed, among of 17 embryos analyzed, homozygous deficient embryos 
were present at approximately Mendelian ratio (4 of 17). Sirt1S -/- embryos were 
smaller than littermate controls, and often exhibited morphological malformations, 
lordosis and eye abnormalities (Fig 3.23A). The most often observed eye defect was the 
abnormal closure of the optic fissure (arrow in the Fig 3.23B). These observations are 
consistent with the findings of Cheng’s study (Cheng et al., 2003).     
 
 
 
 
 
  Genotypes of offsprings 
Sirt1 
CMVKOS 
Total of pups WT +/+ Sirt1s +/- Sirt1s -/- 
142 44 90 8 
Sirt1  
CMVKOL 
Total of pups WT +/+ Sirt1l +/- Sirt1l -/- 
39 19 20 0 
Table 3.1 Genotypes of offsprings from crosses between heterozygous parents of 
Sirt1 CMVKOS and Sirt1 CMVKOL    
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   Summing up, I demonstrated a successful generation of two Sirt1 targeting 
mouse strains, which allow conditional inactivation of the Sirt1 gene. These lines 
provide a valuable tool for further investigation of Sirt1 specific function. Considering 
the novel finding of regulation of Sirt1 through Sirt7, generation of double knockouts 
will help to further evaluate the sirtuin functions.    
Figure 3.23 Developmental abnormalities in Sirt1 deficient embryos. (A) WT, Sirt1S 
+/- and Sirt1S -/- E13.5 embryos, arrows indicate developmental abnormalities in Sirt1 deficient embryos. (B) 
The enlargements of heads and eyes from the E13.5 WT and Sirt1 deficient embryos, arrows point at the 
abnormal optic fissure in Sirt1S -/- embryos.  
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4. Discussion 
Mammalian sirtuins constitute a family of cellular regulators that are involved 
in preservation of organ functions during stress response and aging. A variety of 
specific mouse models to knock out the members of sirtuin family have been created 
recently. The disruption of energy metabolism, genome stability and stress response in 
these sirtuin-deficient mice demonstrated that mammalian sirtuins are major 
contributors to maintain the balance between metabolism and aging. However, a few 
studies have shown the roles of the nucleolar Sirt7 in the metabolic homeostasis and 
aging so far. We generated the Sirt7 deficient mice. Mice lacking Sirt7 were born at the 
expected Mendelian ratio and did not show any significant phenotypical abnormalities 
during the first months of life, but Sirt7 -/- mice had a reduced lifespan, most animals 
died between 10 and 13 months of age. Moreover, the knockout mice were smaller and 
leaner compared to WT mice, which became apparent at around five months of age. 
Sirt7 -/- mice were very sensitive to cold and starvation stress. They were not able to 
keep a constant body temperature and normal blood glucose concentration under 
combined cold and starvation stress (Vakhrusheva et al., unpublished data). The 
impaired cold resistance has been described in several mouse mutants with defects in 
energy and/or fat metabolism (Exil et al., 2006; Goetzman et al., 2005). The leanness of 
the Sirt7-/- animals cannot be attributed to a restricted energy intake since the food 
consumption of Sirt7 -/- mice was even slightly increased. These data suggest that the 
Sirt7 deficient mice suffer from severe metabolic dysfunction. This dissertation 
predominately focuses on the role of Sirt7 in maintenance of metabolic homeostasis in 
the liver and the adipocytes differentiation in white adipose tissue.   
 
4.1 The role of Sirt7 in the fasting/refeeding adaptation of liver 
     In response to nutrient deprivation stress, the metabolic genes in the liver have to 
be precisely regulated to maintain glucose and lipid metabolic homeostasis. This 
regulation is accomplished by a network of transcription factors and coactivators, which 
functions are heavily dependent on the response to hormonal and nutrient signals. 
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PGC-1α is a key coactivator of this network that has been shown to play several 
important roles in the metabolic adaptation in response to nutrient stresses, through 
regulation of gluconeogenic and fatty acid β-oxidation gene expression (Lin et al., 2005; 
Puigserver and Spiegelman, 2003). Interestingly, PGC-1α knockout animals exhibited 
some phenotypic changes similar to those seen in Sirt7 knockouts such as cold 
sensitivity and leanness (Lin et al., 2004). In fact, a significant reduction of the 
expression of PGC-1α was detected in the liver of Sirt7 -/- mice (Fig 3.1A). PGC-1α 
deficient mice developed mild hypoglycemia after 24hr of fasting due to the inefficient 
hormone-stimulated gluconeogenesis (Lin et al., 2004). In contrast to the defect in 
hormone-stimulated gluconeogenesis after short-term fasting, PGC-1α deficient mice 
had constitutively activated gluconeogenic gene expression in the liver independent of 
feeding conditions (Lin et al., 2004). The increased C/EBPβ expression in the liver, 
which activates gluconeogenic genes in a PGC-1α independent manner, might 
compensate for the lack of PGC-1α (Lin et al., 2004). Despite the decreased PGC-1α 
expression, Sirt7 -/- mice showed even exaggerated response to fasting: transcripts 
levels of genes regulating gluconeogenesis and lipogenesis were more strongly induced 
or repressed, respectively, as compared to WT controls (Fig 3.2A). It is possible that, 
similar to the compensatory increase of C/EBPβ in PGC-1α KO mice, changes in other 
metabolic regulators may play compensative roles to maintain or even exaggerate the 
hepatic metabolic adaptations in Sirt7 deficient mice. Other phenotypes observed in 
Sirt7 KO mice, such as the impaired cold resistance may still be caused by the lower 
expression of PGC-1α, the critical regulator of adaptive thermogenesis. Further 
investigation should focus on the role of Sirt7 in the regulation of PGC-1α transcription 
in brown adipose tissue, the main regulatory tissue of thermogenesis.   
One of factors possibly responsible for the stronger changes of gluconeogenic 
and lipogenic genes detected in the fasting liver of Sirt7 KO mice might be the higher 
Sirt1 expression. Sirt1 is induced in the fasted liver and deacetylates PGC-1α to activate 
gluconeogenic and fatty acid oxidation genes and thus regulates hepatic glucose and 
lipid metabolism response to fasting (Rodgers et al., 2005; Rodgers and Puigserver, 
2007). In the Sirt7 deficient mice, despite the fact that PGC-1α mRNA level is lower, 
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the high expression of Sirt1 upon fasting and its potentially higher activity (see below) 
may lead to the higher activation of PGC-1α and, consequently, result in the stronger 
fasting response in the Sirt7 -/- liver than WT mice. The status of acetylation of PGC-1α 
should be checked in the future investigation. The Sirt7/liver specific Sirt1 double 
knockout mouse will be a valuable model to investigate the potential cross-regulatory 
interrelationships between the two sirtuins.    
Another difference observed in metabolic adaptation in Sirt7 deficient mice 
was the inability to revert the fasting-induced inactivation of fatty acid synthesis and 
activation of gluconeogenesis under the refeeding state (Fig 3.2A). This effect might 
depend on the endogenous insulin resistance. In fact, the inactivation of PEPCK and 
activation of FAS by insulin were severely impaired in primary Sirt7 -/- hepatocytes 
(Christian Smolka, unpublished data). Moreover, without Sirt7, insulin was unable to 
activate its primary signaling targets in hepatocytes as indicated by low levels of Akt- 
and SAPK/JNK phosphorylation (Christian Smolka, unpublished data). Many insulin 
resistance mouse models including ob/ob mice (Lindstrom, 2007), db/db mice 
(Friedman et al., 1997; Kobayashi et al., 2000) and high-fat-diet mice (Winzell and 
Ahren, 2004) exhibit significant fasting hyperglycemia and hyperinsulinemia. These 
studies further demonstrated that the unbridled activity in promoting gluconeogenesis 
correlating with the pathogenesis of fasting hyperglycemia might be caused by the 
deregulated transcription factors such as forkhead transcription factor FoxO1 
(Altomonte et al., 2003), FoxO6 (Kim et al., 2011a), hepatocyte nuclear factor 4α 
(HNF4α) (Hirota et al., 2003), PGC-1α (Koo et al., 2004), CREB coactivator TROC2 
(Koo et al., 2005) and others. The disturbed hepatic adaptation in response to 
fasting/refeeding might be at least partly explained by the certain degree of insulin 
resistance in Sirt7 deficient liver. What is the role of Sirt7 in regulating insulin signaling 
pathway and the status of post-translational modification of the other transcription 
factors/coactivators in Sirt7 deficient hepatocytes should be further investigated. 
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4.2 Sirt7 is necessary for induction of hepatic ribosomal RNA transcription 
by insulin  
      Ribosome biogenesis is a process that consumes a considerable amount of 
energy, so it is important for the cells to regulate ribosome production in response to the 
intracellular availability of nutrients and energy (Rudra and Warner, 2004). This is very 
well illustrated in the liver, where fasting leads not only to a decrease in ribosome 
production, but also to the degradation of ribosomes through autophagy in order to save 
the amino acids and nucleotides during the nutrient shortage. Conversely, refeeding 
quickly stimulates ribosome biogenesis and suppresses degradation resulting in 
increasing the rate of protein synthesis and reestablishing an adequate content of 
ribosomes for the cells to perform their metabolic functions (Conde and 
Franze-Fernandez, 1980; Hutson and Mortimore, 1982). Furthermore, the synthesis of 
rRNA, the rate-limiting step in ribosome production, is regulated by nutritional 
conditions and energy status. Unexpectedly, the hepatic pre-rRNA transcription levels 
were increased upon fasting in WT mice. The increase of hepatic pre-rRNA levels in 
Sirt7 KO mice in response to fasting was significantly higher than in WT controls. 
Moreover, and interestingly, the pre-rRNA levels could not be restored to normal after 
refeeding in Sirt7 KO mice as observed in WT mice (Fig 3.2B). This pattern resembles 
other adaption changes in response to fasting/refeeding in the Sirt7 deficient liver as 
discussed above. The increased pre-rRNA levels after fasting in the liver seemed to be 
contradictory to the decrease in ribosome production caused by fasting as demonstrated 
in some previous reports (Conde and Franze-Fernandez, 1980; Enwonwu et al., 1971; 
Hutson and Mortimore, 1982; Sidransky and Verney, 1971). However, in the previous 
studies, fasting was mainly achieved by deprivation of protein (Sidransky and Verney 
1971; Conde and Franze-Fernandez 1980; Hutson and Mortimore 1982). Moreover, the 
fasting time was extended to 48hrs and even longer (Enwonwu, Stambaugh et al. 1971; 
Anand and Gruppuso, 2005). No data indicated that pre-rRNA levels were decreased 
under fasting for 24hrs, although it was found that the yield of polyribosomal RNA 
decreased dramatically after 42- to 66-hours starvation (Princen et al., 1983). Yet the 
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level of mRNA assembled with polyribosomes may not necessarily match that of rRNA. 
In fact, one investigation indicated that serum albumin, H-ferritin, and ribosomal RNA 
nuclear transcripts were not decreased by fasting for 72hrs (Hayden et al., 1994). 
Despite the observed increase in liver rRNA levels during fasting, the ribosome 
synthesis may still be impaired. Since the cell needs precisely equimolar amounts of 
rRNA and each of the 79 ribosomal proteins (RPs), insufficiency of any one of the 79 
RPs will lead to aberrant processing and insufficient ribosomal production despite of the 
excess of the rRNA (Rudra and Warner, 2004). Finally, the primers for pre-rRNA 
detection used in my experiments were located at the 5’-external transcribed spacer 
(5’-EST) sequence, which would be cleaved and degraded during the process of making 
the mature ribosomal RNAs (Eichler and Craig, 1994). The pre-rRNA level measured 
by QRT-PCR represented the relative dynamic level, reflecting the balance between the 
rate of transcription by RNA Pol I and the efficiency of cleavage to mature rRNAs. 
Thus the increased level of pre-rRNA detected in my experiments might correspond to 
the lower level of the cleavage process than that of the transcription. These results 
suggest that the inhibition of cleaving the pre-rRNA to mature rRNA might play a more 
important role than the suppression of Pol I mediated transcription in the early phase of 
fasting, because the former mechanism would be more efficient and quicker than the 
latter. Further experiments will be necessary to explore changes in RNA Pol I activity 
and the efficiency of cleavage of pre-rRNA during the response to fasting in Sirt7 KO 
and WT mice.            
      Recently, a new mechanism connecting the rDNA transcription to the energy 
status in vitro has been proposed. A regulatory complex, eNoSC, comprising Sirt1, 
histone methyl-transferase SUV39H1, and a novel nucleolar regulatory protein 
nucleomethylin NML, present at the rDNA promoter, can sense the energy starvation 
and induce transcriptional repression through histone deacetylation and H3K9 
methylation, thus protecting cells from energy deprivation (Grummt and Ladurner, 2008; 
Murayama et al., 2008). However, no significant changes of the pre-rRNA levels had 
been found in the primary hepatocytes isolated from either WT or Sirt7 KO mice and 
cultured in different glucose concentrations, while glucose reduction significantly 
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decreased the pre-rRNA levels in HeLa cells (Fig 3.3). These results indicate that 
eNoSC may play its critical role only in some specific cells/tissues. Many cells need this 
mechanism to decrease the intercellular energy expenditure by rDNA silencing in 
response to the energy starvation since they cannot maintain the energy homeostasis by 
themselves. But, unlike these cells, hepatocytes can automatically regulate the 
homeostasis in the glucose, lipid and energy metabolism in vitro when the necessary 
hormone and cellular factors are present in the medium. When the glucose 
concentration is reduced, the hepatocytes stimulate gluconeogenesis to maintain the 
intracellular energy balance.  
Insulin is one of the key factors controlling the hepatic regulation in metabolic 
homeostasis. Most studies demonstrated that insulin elevates the rRNA content of 
primary rat hepatocytes by stimulating rDNA transcription rather than by altering rates 
of processing or stability of the rRNA (Antonetti et al., 1993). As expected, the 
increased pre-rRNA levels were observed in the primary hepatocytes from WT mice 
cultured in high insulin medium (Fig 3.4A). However, in hepatocytes from aged mice 
(more than 18 months) no significant increase in pre-rRNA was observed (Fig 3.4B). 
This result suggests that insulin resistance develops in the aged hepatocytes. In contrast 
to wild-type hepatocytes, insulin failed to stimulate the rRNA transcription in young and 
old Sirt7 deficient hepatocytes even when the insulin concentration had been increased 
to 20nM. In the aged Sirt7 KO hepatocytes, insulin indeed down regulated the 
transcription of pre-rRNA (Fig 3.4A and B). Previous studies have examined the 
molecular mechanisms of insulin stimulated rRNA transcription (Hannan et al., 1998). 
By using 3T6 mouse fibroblasts and H4-II-E-C3 rat hepatoma cells, they found that 
insulin was capable of stimulating rDNA transcription by increasing the nuclear content 
of components, UBF and PAF53, required for assembly of RNA polymerase I at rDNA 
promoter. Such response was not associated with a change of the cellular content of 
RNA Pol I. Although Western blot for determining the content of RNA Pol I and UBF 
was not performed in my experiments, the recruitment of Pol I and UBF to the rDNA 
promoter had been detected using Chromatin Immunoprecipitation (ChIP) assay. Sirt7 
has been described to interact with Pol I and UBF and to be a positive regulator of 
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rDNA transcription (Ford et al., 2006; Grob et al., 2009). It was not surprising that the 
binding of Pol I and UBF was significantly lower in Sirt7 deficient hepatocytes no 
matter with or without insulin. After insulin stimulation, increase in the nuclear UBF 
and PAF53 would favor their association at the rDNA promoter (Hannan et al., 1998), 
thus promoting the recruitment of RNA Pol I to rDNA promoter and increasing 
transcription. It was demonstrated that acetylation of UBF played a positive role in the 
regulation of pre-rRNA transcription (Hirschler-Laszkiewicz et al., 2001; Meraner et al., 
2006; Pelletier et al., 2000). Furthermore, UBF1 acetylation at Lys (K) 352 by CREB 
binding protein (CBP) increases its occupancy at the rDNA promoter and stimulates the 
transcription of pre-rRNA (Lee et al., 2011). Moreover, the HAT activity of CBP can be 
stimulated by phosphorylation (Ait-Si-Ali et al., 1999). CBP phosphorylation by 
insulin-dependent pathway promotes its nuclear localization (Zhou et al., 2004). The 
posttranslational modifications of UBF or PAF53 may be another mechanism for insulin 
stimulated rDNA transcription. Impairment in these mechanisms in Sirt7 deficient mice 
may cause the defects of the rDNA transcription in response to insulin. It is not clear 
whether Sirt7 plays a direct role in regulation of UBF/PAF53 in response to insulin 
stimulation. Further studies will be required to investigate the roles of Sirt7 in 
regulating insulin signaling pathway(s) and the acetylation/phosphorylation status of 
UBF or PAF53 in WT and Sirt7 KO hepatocytes after insulin treatment.                              
 
4.3 Sirt7 is required for the PPARγ-mediated adipogenesis through 
repression of Sirt1 
       In this thesis, I have described the important roles of Sirt7 in maintaining the 
hepatic metabolic homeostasis during adaptation to the fasting/refeeding and its 
requirement for the insulin stimulated rDNA transcription in vitro. In addition to the 
impaired function in the liver, the Sirt7 deficient mice exhibited also a compromised 
adipose tissue phenotype. The finding that Sirt7 deficient mice displayed reduced 
adipocyte size, stunted adipogenic gene expression (Fig 3.6), resistance to high-fat-diet 
(HFD) induced liver steatosis and insulin resistance (Yoshizawa et al., unpublished data) 
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is reminiscent of the phenotype observed in PPARγ +/- mice (Kubota et al., 1999). This 
observation is consistent with the hypothesis that the phenotype observed in Sirt7 KO 
mice is due to the reduced PPARγ expression and/or activity. Quantitative RT-PCR 
demonstrated the significantly reduced expression level of PPARγ in the white adipose 
tissue (Fig 3.6) as well as in the liver (Smolka et al., unpublished data).      
PPARγ is considered the most important regulator in adipogenesis (Rosen and 
MacDougald, 2006; Tontonoz and Spiegelman, 2008). The further investigation in this 
work attempted to elucidate how Sirt7 regulates adipocytes differentiation. The results 
presented in these studies showed that Sirt7 was required for PPARγ expression and an 
efficient adipogenesis. Firstly, the adipogenesis assay in vitro showed that Sirt7 was 
required for the adipocytes differentiation in all in vitro cell models which I have tested 
in this thesis: Deletion of Sirt7 in MEFs (primary or immortalized) or downregulation of 
Sirt7 by retrovirus-mediated RNA interference in 3T3L1 both impaired the adipocytes 
differentiation in vitro (Fig 3.7 and 3.8). Moreover, Sirt7 deficient primary white 
preadipocytes also displayed severe adipocytes differentiation defects (Fig 3.14A). 
However, ectopic overexpression of Sirt7 in MEFs or 3T3L1 preadipocytes did not 
rescue the adipocytes differentiation (data not shown). These results suggest that Sirt7 is 
required but not sufficient to perform a full program of adipogenesis. Concomitant with 
the impaired adipogenesis, significantly reduced expression of adipogenic marker genes 
including PPARγ, C/EBP and aP2 at both mRNA and protein levels were detected by 
QRT-PCR and Western blot or immunofluorescence (Fig 3.7, 3.8 and 3.9). In the early 
phase of adipogenesis in vitro, medium supplements such as fetal bovine serum (FBS), 
dexamethasone, isobutylmethylxanthine, and insulin induce low-level expression of 
PPARγ and C/EBP, which then stimulate each other’s expression in a positive 
feedback loop. Then the high levels of PPARγ and C/EBP activate adipocyte gene 
expression and lipid accumulation and ultimately lead to phenotypic conversion from 
fibroblasts to adipocytes (Rosen et al., 2002). A variety of signaling factors have been 
identified that act upstream of PPARγ as positive or negative regulators (Lowe et al., 
2011). Sirt1 was reported to inhibit adipogenesis through its binding to PPARγ 
promoter and repressing PPARγ transcription (Picard et al., 2004). Our previous studies 
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found that Sirt7 can interact with Sirt1 and inhibit Sirt1 enzymatic deacetylase activity 
on histone H4K16 as a substrate in vitro (Smolka et al., unpublished data). The present 
results showed that the Sirt1 protein expression was indeed elevated in Sirt7 KO MEFs 
especially in the early stages of differentiation (Fig 3.7E, and Fig 3.11C). We speculate 
that the high accumulation and/or high activity of Sirt1 might directly contribute to the 
lower expression of PPARγ in Sirt7 deficient MEFs. In line with the inhibitory role of 
Sirt1, a significant increase of Sirt1 occupancy at the PPARγ promoter in differentiating 
Sirt7 KO MEFs and Sirt7 knockdown 3T3L1 cells was observed (Fig 3.12). As a 
deacetylase, Sirt1 was shown to deacetylate lysine (K) residue 9 of histone 3 (H3K9) 
and facilitate the formation of heterochromatin and transcription repression (Imai et al., 
2000; Vaquero et al., 2004). Sirt1 also regulates SUV39H1 to increase the levels of the 
H3K9me3 modification during heterochromatin formation (Vaquero et al., 2007). 
During the process of muscle development, Sirt1 deacetylates H3K9 and H3K14 in the 
myogenin and MHC promoter to inhibit muscle gene expression resulting in the 
retardation of muscle differentiation (Fulco et al., 2003). Sirt1 was found to interact 
with BCL11A (B cell leukemia 11A protein) and to be recruited to the BCL11A target 
genes promoters in a BCL11A-dependent manner leading to transcriptional repression 
in hematopoietic cell development and malignancies (Senawong et al., 2005). 
Considerable evidence suggests that epigenetic mechanisms, including histone 
methylation, acetylation, phosphorylation, and ubiquitination are critical for gene 
expression in the cellular physiological process (Jenuwein and Allis, 2001). In particular, 
acetylation of histones H3 (K9 and K14) and H4 (K5 and K12), mediated by histone 
acetyltransferases (HATs) such as p300, CBP, and P/CAF, is associated with 
transcriptional activation (Ogryzko et al., 1996; Schiltz et al., 1999). Methylation of 
H3K4, H4R3 and phosphorylation of H3S10 also results in gene activation (Chen et al., 
1999; Cheung et al., 2000; Wang et al., 2001). In contrast, methylation of histone H3K9 
and H3K27 generally correlates with gene repression (Nakayama et al., 2001; Rea et al., 
2000; Vakoc et al., 2006). Recent studies have demonstrated that the chromatin 
remodeling factors were involved in the differentiation of specific cell types including 
muscle, neurons, and T cells (Avni et al., 2002; de la Serna et al., 2001; Machida et al., 
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2001). Furthermore, ChIP assays revealed that histones are dynamically modified at the 
promoter regions of adipocyte marker genes during adipogenesis. The degree of histone 
H3K9 acetylation at the promoters of C/EBP, PPARγ, aP2, ADD1/SREBP1c, and 
adiponectin was increased upon differentiation whereas level of histone H3K9 
methylation displayed opposite patterns (Yoo et al., 2006). The histone methylation 
regulator PTIP (pax transactivation domain-interaction proteins) directly regulates 
H3K4 methyltransferase and H3K27 demethylase to activate PPARγ expression during 
adipogenesis (Cho et al., 2009). My results of ChIP assays to detect the epigenetic 
changes at PPARγ promoter in the differentiating cells showed that the active epigenetic 
marker AcH3K9 was significantly lower and inactivating epigenetic marker H3K9me3 
was at a high level at the PPARγ promoter in Sirt7 deficient MEFs or in Sirt7 
knockdown 3T3L1 cells differentiated for 5 days (Fig 3.9F and G). In agreement with 
the increase of epigenetic marks characteristic for heterochromatin, the increased 
occupancy of Sirt1 at the PPARγ promoter was also observed in Sirt7 deficient cells 
(Fig 3.12). It was demonstrated previously, that Sirt1 knockdown enhances the 
adipogenesis in 3T3L1 preadipocytes (Picard et al., 2004). Thus, it is reasonable to ask 
whether Sirt1 knockdown could improve the differentiation in Sirt7 KO MEFs. Indeed, 
as shown in Fig 3.13, decreased Sirt1 expression through shRNA as well as inhibition 
of Sirt1 activity by nicotinamide partly restored the adipogenic potential of Sirt7 KO 
cells, without, however reaching the level of differentiation in WT cells. Together, these 
data strongly suggest that increased cellular accumulation of Sirt1 and its increased 
binding to PPARγ promoter might result in higher deacetylation and increased 
trimethylation of histone H3K9 at the PPARγ promoter and thus be, at least in part, 
responsible for the reduced expression of PPARγ and impaired adipogenesis in Sirt7 
knockout.               
        Subcellular localization of Sirt1 was found to vary in different tissues of the 
adult mouse and to shuttle between the nucleus and cytoplasm during development and 
in response to physiological and pathological stimuli (Tanno et al., 2007). For example, 
Sirt1 was mainly expressed in the nucleus of C2C12 myoblast cells, and was excluded 
from the nucleus upon differentiation. Moreover, only overexpressed nuclear but not 
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cytoplasmic Sirt1 enhanced the deacetylation of histone H3 (Tanno et al., 2007). These 
data prompted me to investigate the Sirt1 cellular localization during the adipogenesis 
in WT and Sirt7 KO MEFs. As shown in Fig 3.11D, the Sirt1 protein showed higher 
accumulation in cytoplasm and nucleus at the early stages of differentiation in Sirt7 
deficient MEFs. In addition to the higher protein level, the time course of Sirt1 
subcellular distribution was also affected in Sirt7 KO cells. In the wildtype cells the 
initially cytoplasmic Sirt1 gradually accumulated in the nucleus during differentiation. 
In Sirt7 deficient cells, Sirt1 was not only present in higher amounts in the cytoplasm 
but was already detected in the nucleus of undifferentiatied Sirt7 KO cells. In contrast to 
the high level of Sirt1 in the nucleus of Sirt7 KO cells at the early stage of 
differentiation, ChIP assays failed to detect higher Sirt1 occupancy at the PPARγ2 
promoter at this stage (day0 or day2) in Sirt7 KO MEFs or Sirt7 KD cells (data not 
shown). However, the increased Sirt1 binding to the PPARγ2 promoter in Sirt7 KO 
MEFs was detected at day5 of differentiation. Although the nuclear Sirt1 level was 
slightly lower in the late stage of differentiation (day5 or day8) in Sirt7 KO MEFs, the 
recruitment to the PPARγ promoter was still higher as compared to WT MEFs. In 
addition to the binding to PPARγ promoter, previous studies also found that Sirt1 could 
interact with PPARγ protein as a repressor to inhibit its activity (Picard et al., 2004). So 
the higher nuclear Sirt1 may directly inhibit PPARγ activity at the early stage in Sirt7 
KO cells. Of course, technical difficulties in the ChIP experiments cannot be ruled out. 
Further ChIP experiments under varying conditions such as increase the amounts of 
chromatin or antibody for immunoprecipitation should be performed to optimize the 
assay, especially for the cells on day2 of differentiation. 
A recent report indicated that C/EBPα regulated Sirt1 expression in 3T3L1 cell 
line during adipogenesis: Sirt1 protein levels were dramatically upregulated in 
differentiated 3T3-L1 cells along with increased C/EBPα during adipocyte 
differentiation (Jin et al., 2010). Likewise, Picard et al. observed that Sirt1 protein levels 
increased and peaked at day 5 after hormonal stimulation (Picard et al., 2004). 
Consistent with these reports, Sirt1 protein level was slightly elevated during 
differentiation in WT MEFs (Fig 3.7E) and 3T3L1 cells (data not shown). Moreover, 
Discussion 
97 
 
cellular fractionation displayed that Sirt1 was translocated from cytoplasm to nucleus in 
WT cells during differentiation while it was excluded from the nucleus following the 
prolonged differentiation in Sirt7 KO MEFs (Fig 3.11D). In agreement with the 
inhibitory influence of Sirt1 on the PPARγ transcription, PPARγ mRNA level increases 
at the early stage and then decreases from middle stage on during adipogenesis. It is 
likely that in WT cells, C/EBPα might stimulate PPARγ expression to promote 
adipogenesis induction, meanwhile the gradually increased Sirt1 expression (possibly 
induced by C/EBPα) and its accumulation in the nucleus leads to PPARγ repression and 
suppresses further adipogenesis. Thus, Sirt1 and C/EBPα control adipocyte 
differentiation at an appropriate degree to maintain the adipose tissue homeostasis in 
vivo. The elevated protein levels and/or higher activity of Sirt1 together with its 
increased nuclear accumulation before the beginning of differentiation in Sirt7 KO 
MEFs may result in a significantly lower PPARγ expression at the critical time point 
important for induction of adipogenesis and thus result in the severe adipogenesis defect. 
As mentioned above, silencing of Sirt1 expression or inhibition of Sirt1 activity in Sirt7 
deficient MEFs partially rescued the impaired adipocytes differentiation concomitantly 
with the increased expression of PPARγ and aP2, which, however did not reach the 
normal adipogenesis level. These effects were observed by inhibition of Sirt1 
expression by shRNA mediated knock down and by treatment with a sirtuin specific 
inhibitor nicotinamide (NAM). NAM is a noncompetitive inhibitor and may inhibit all 
the members of the sirtuin family (Bitterman et al., 2002). Interestingly, NAM treatment 
can promote adipocytes differentiation in mouse mesenchymal cell line C3H10T1/2 and 
in pig preadipocytes (Backesjo et al., 2006; Bai et al., 2008). The improvement of 
adipogenesis in Sirt7 KO MEFs was stronger after NAM treatment than in Sirt1 
knockdown. It is possible that NAM inhibits another sirtuin suppressing adipogenesis, 
such as Sirt2. In fact, Sirt2 was demonstrated to inhibit adipocytes differentiation 
through regulation of FoxO1 (Jing et al., 2007; Wang and Tong, 2009).  
        In addition to the preadipogenic cell lines such as 3T3L1 and embryonic 
fibroblasts, primary cultures of adipose-derived stromal vascular precursor cells 
(primary preadipocytes) are also commonly used to study molecular and cellular events 
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and regulatory influences on adipocyte differentiation. This culture system has several 
distinct advantages over preadipose cell lines: Such primary cells more closely reflect 
the in vivo characteristics of the tissue from which they are derived (Armani et al., 2010; 
Gregoire et al., 1998). Cells can also be obtained from rodent genetic models of obesity, 
transgenic mice or from rats and/or mice subjected to nutritional or hormonal 
manipulation (Hausman et al., 2008). My results showed that deletion of Sirt7 leads to 
severe defects in adipogenesis of primary white preadipocytes compared to their 
heterozygous littermates (Sirt7+/-). Most interestingly, primary preadipocytes isolated 
from Sirt7 knockouts lacking one Sirt1 allele (Sirt7-/-//Sirt1+/-) exhibited significantly 
improved adipogenesis with a differentiation degree similar to the wildtype or Sirt7+/- 
controls (Fig 3.14A). Moreover, a significantly lower amount of preadipocytes could be 
isolated from Sirt7-/- mice, while no significant difference in amount of preadipocytes 
was observed in Sirt7+/- and Sirt7-/-//Sirt1+/- mice (Fig 3.14A and data not shown). 
Why Sirt1 knock down could not completely restore the adipogenesis in Sirt7 KO 
MEFs in contrast to the obviously successful rescue of adipogenesis in Sirt7-/-//Sirt1+/- 
mice? Decreased Sirt1 expression through Sirt1 knock down in Sirt7 KO MEFs 
augmented the expression of PPARγ, however, the level of PPARγ expression could not 
reach the normal level in WT MEFs (Fig 3.13A, C and data not shown). Thus, it was 
not surprising that knockdown of Sirt1 only partly rescued the adipogenesis defect in 
Sirt7 deficient cells. In contrast to an acute decrease of Sirt1 expression using Sirt1 
knock down in cultured cells, a constitutively decreased Sirt1 expression is present 
throughout the entire development of the Sirt7-/-//Sirt1+/- mice. Therefore, in these 
mice, the PPARγ expression can recover gradually during the development, allowing 
the adipogenesis of preadipocytes to reach the normal level (Fig 3.14).  
       Preadipocytes (or adipocyte precursor cells) reside within the heterogeneous 
adipose stromal vascular fraction (SVF), which also contains fibroblasts, erythrocytes, 
macrophages, endothelial cells and other cell types (Ailhaud et al., 1992). Using the 
PPARγ-reporter (PPARγ-R26R) bearing mice, it has been found that most adipocytes 
descend from a pool of the proliferating progenitors (PPARγ positive) which are already, 
either prenatally or early in postnatal life, committed to adipogenesis (Tang et al., 2008). 
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Later, using fluorescence-activated cell sorting (FACS) in combination with an in vivo 
transplantation scheme, a resident subpopulation of early adipocyte progenitor cells 
(Lin
-
:CD29
+
:CD34
+
:Sca-1
+
:CD24
+
) was identified in adult WAT (Rodeheffer et al., 
2008). These cells could be induced to differentiate into mature adipocytes, they were 
also able to reconstitute a normal WAT depot when injected into the residual fat pads of 
A-Zip lipodystrophic mice (Rodeheffer et al., 2008). Thus, it is reasonable to ask 
whether Sirt7 is required for regulation of the adipocyte progenitor cells and whether 
such regulation requires inhibition of Sirt1. In fact, Sirt1 has been demonstrated to 
regulate many progenitor cells during development and differentiation into the target 
cells. For example, activation of Sirt1 suppressed proliferation of neural progenitor cells 
(NPCs) and redirected their differentiation towards the astroglial lineage, whereas Sirt1 
inhibition had the opposite effect. (Prozorovski et al., 2008). Inhibition of Sirt1 
increased Mash1 and Ngn2 levels, which promotes neural progenitors toward 
motoneuron differentiation (Zhang et al., 2011). Sirt1 has been shown to increase 
muscle precursor cell (MPC) proliferation (Rathbone et al., 2009) but inhibit muscle 
differentiation (Fulco et al., 2003). Sirt1 also promotes osteogenesis of human 
mesenchymal stem cells by upregulating RUNX2 gene expression via an enhanced 
FOXO3A protein expression (Tseng et al., 2011). The discovery that Sirt1-/- and 
Sirt1+/- adult bone marrow had decreased numbers of hematopoietic progenitors 
indicated the critical role of Sirt1 in mouse hematopoiesis (Ou et al., 2011). Further 
experiments should concentrate on the analysis of the adipocyte progenitors in WT and 
Sirt7 deficient SVF cells together with the role of Sirt1.   
       My present results showed that ectopic Sirt7 overexpression could not rescue 
the defect of adipogenesis in Sirt7 KO MEFs or Sirt7 KD 3T3L1 cells (Fig 3.10A and 
data not shown), although the mRNA levels of PPARγ were slightly increased after 
Sirt7 overexpression, but still significantly lower than the normal levels in WT MEFs or 
control 3T3L1 cells (Fig 3.10C and data not shown). However, the impaired 
adipogenesis in Sirt7 deficient MEFs could be fully rescued by overexpression of 
ectopic PPARγ2. The inability of Sirt7 overexpression to rescue the impaired 
adipogenesis of Sirt7 KO MEFs could imply that this phenotype is caused by long-term 
Discussion 
100 
 
changes occurring in the context of the whole organism of Sirt7 knockout mouse. It is 
also possible, as mentioned above, that Sirt7 knockout results in an inhibition of 
adipocyte progenitor cells likely via the suppression of PPARγ or prevention of 
mesenchymal stem cells to commitment to preadipocytes. Indeed, ectopic PPARγ2 
overexpression has been found to rescue several adipogenic defects in certain geneticaly 
deficient cells. For example, adding PPARγ2 to C/EBP −/− fibroblasts via a retroviral 
vector restores their capacity to accumulate lipids and to activate markers of 
adipogenesis (Wu et al., 1999). Furthermore, the adipogenic defect in Med23-deficient 
cells was rescued by ectopic expression of PPARγ2 (Wang et al., 2009). 
 
4.4 Sirt7 regulates Sirt1 activity by interfering with its auto-deacetylation 
The results discussed above have demonstrated that Sirt7 normally ensures 
cellular functions responsible for the efficient adipocytes differentiation by inhibition of 
Sirt1 activity during the cellular physiological process. The influence of Sirt7 on Sirt1 
transcription has been excluded since the transcript levels of Sirt1 were not changed in 
Sirt7 KO cells. Significantly, a direct interaction between Sirt1 and Sirt7 was identified 
in our laboratory. This interaction was dependent on the intact Sirt7 core deacetylation 
domain (Fig 3.15A). We initially speculated that Sirt7 regulates Sirt1 via 
post-translational modification (PTM) most probably through the deacetylation of Sirt1 
by Sirt7. Post-translational modifications of proteins determine their tertiary and 
quaternary structures and regulate their activities and functions (Seo and Lee, 2004). 
Various recent studies indicated the effects of PTMs on Sirt1 in many biological 
processes. One study identified a novel PTM of Sirt1 by sumoylation at Lys734, and 
such sumoylation increased Sirt1 deacetylase activity in response to genotoxic stress 
(Yang et al., 2007). Subsequently, using mass spectrometry, 13 residues in Sirt1 were 
identified to be phosphorylated in vivo, these residues were phosphorylated by cell 
cycle-dependent kinase cyclinB/Cdk1 to control Sirt1 level and function during the cell 
cycle (Sasaki et al., 2008). Another protein kinase, casein kinase 2 (CK2), was found to 
phosphorylate conserved residues Ser154, 649, 651 and 683 in the N- and C-terminal 
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domains of mouse Sirt1 after ionizing radiation (IR) and such phosphorylation increased 
Sirt1 substrate-binding affinity and deacetylation rate of p53 to protect cells from 
apoptosis after DNA damage (Kang et al., 2009). cJUN N-terminal kinase (JNK1) 
phosphorylated Ser27, Ser47, and Thr530 of human Sirt1 and this phosphorylation 
increased its nuclear localization and enzymatic activity (Nasrin et al., 2009). In contrast 
to the findings of JNK1, the phosphorylation of Ser47 by mTOR inhibited the 
deacetylase activity of Sirt1 (Back et al., 2011). Moreover, it was showed that human 
Sirt1 was stabilized via JNK2-dependent phosphorylation of Ser27, but not of Ser47 by 
JNK1 (Ford et al., 2008). However, mouse Sirt1 could be phosphorylated by JNK1 at 
Ser46 (Ser47 in human Sirt1) to induce mSirt1 degradation (Gao et al., 2011). In 
addition, Sirt1 is also modified by methylation. Four lysine sites (Lys233, Lys235, 
Lys236, and Lys238) at the N-terminus of human Sirt1 have been identified to be 
methylated by methytransferase Set7/9. Methylation of these residues disrupts the 
interaction between Sirt1 and its substrate p53 but does not affect its deacetylase 
activity toward p53 (Liu et al., 2011b). A recent report suggested that oxidants, 
aldehydes, and cigarette smoke induced carbonyl modifications on cysteine residues of 
Sirt1 concomitant with decreasing enzymatic activity and marking the protein for 
proteasomal degradation, which was implicated in chronic inflammatory conditions in 
human lung epithelial cells (Caito et al., 2010). So far no acetylation of lysine residues 
was reported for the mammalian Sirt1. However, the Sirt1’s homologue in fruit fly, 
Drosophila Sir2 (dSir2), has been reported to be acetylated by the histone 
acetyltransferase CREB-binding protein (CBP) in in vitro and in vivo acetylation assays 
(Zhao et al., 2009). Moreover, another mammalian sirtuin, Sirt2, can be acetylated by 
p300 resulting in down-regulation of Sirt2 deacetylation (Han et al., 2008). Thus, I was 
interested in the effects of acetylation on Sirt1 enzyme activity and whether Sirt7 
regulates Sirt1 through deacetylation.    
Unexpectedly, overexpression of Sirt7 together with Sirt1 resulted in an 
increased Sirt1 acetylation, whereas Sirt7H188Y inactive mutant failed to increase the 
Sirt1 acetylation level (Fig 3.15B and C). Obviously, Sirt7 as a deacetylase could not 
directly acetylate Sirt1. The possible explanation may be that Sirt7 deacetylates certain 
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acetyltransferase to increase its activity, thus promoting the acetylation of Sirt1. Another 
possibility is that Sirt7 may prevent the auto-deacetylation of Sirt1 through direct 
interaction and inhibition.  
My results revealed that Sirt1 undergoes reversible auto-deacetylation to 
regulate its catalytic activity. Sirt7 restricts Sirt1 activity by inhibition of the 
auto-catalytic process. Autocatalytic modifications of regulatory factors are common 
and play important role in posttranslational regulation of their activity. Such 
autoregulation has been primarily described for kinases, phosphatases, 
acetyltransferases, and also for ADP-ribosyltransferases. For example, the 
autophosphorylation of the ataxia telangiectasia-mutated and Rad3-related (Patrick) 
kinases (Patrick) stimulates the ATR kinase activation after DNA damage and facilitates 
ATR substrate recognition (Liu et al., 2011a). The catalytic activity of p300 is also 
stimulated by autoacetylation (Thompson et al., 2004). Autoacetylation induces the 
dissociation of p300 from the chromatin to enhance TFIID binding and subsequent 
preinitiation complex formation (Black et al., 2006). Autoacetylation of P/CAF 
increases its histone acetyltransferase activity (Santos-Rosa et al., 2003) and controls its 
nuclear localization (Blanco-Garcia et al., 2009). TIP60 is autoacetylated in response to 
UV damage to elevate its activity (Wang and Chen, 2010). Moreover, automethylation 
of the histone methyltransferase G9a creates a binding site for the heterochromatin 
protein 1 (HP1) (Chin et al., 2007), and PARP-1 can be auto-ADP-ribosylated, resulting 
in the release of PARP1 from chromatin (Kim et al., 2004). Among the members of 
mammalian sirtuins, Sirt6 possesses an auto-ADP-ribosylation activity, although the site 
of this automodification and its functions are not clear so far (Liszt et al., 2005). My 
finding that control of Sirt1 auto-deacetylation is instrumental for regulation of its 
activity indicates that the autocatalytic modification does apply for deacetylases as well. 
Thus, my study shows that Sirt1 deacetylates itself and enhances its activity in a 
positive regulatory loop, and Sirt7 negatively regulates Sirt1 possibly to protect from 
cellular damage, which may be caused by the continuous activation of Sirt1.    
Furthermore, my data indicate that the acetyltransferase MOF can acetylate 
Sirt1 and the acetylation of Sirt1 by MOF can inhibit its deacetylase activity on its 
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target substrate H3K9 and p53 (Fig 3.17 and Fig 3.18C). Indeed, deacetylases are also 
subject to post-translational modifications including acetylation, phosphorylation, 
ubiquitylation and sumoylation, which can determine their stability, localization, 
activity and protein–protein interactions (Brandl et al., 2009). Taken together with the 
findings that p300 acetylates HDAC1 and inhibits its enzymatic activity (Qiu et al., 
2006) as well as that acetylation of Sirt2 reduces its activity (Han et al., 2008), it is not 
surprising that the acetylation of Sirt1 down-regulates its deacetylase activity. It has 
been reported that the drosophila homologue of Sirt1, dSir2, is acetylated by CBP and 
the in vitro synthesized murine Sir2 (mSirt1), is acetylated by recombinant p300 and 
p300/CBP (HAT) proteins in the in vitro acetylation assay (Zhao et al., 2009). However, 
I was not able to detect the acetylation of mSirt1 by CBP in IP experiments after 
co-transfection of Sirt1-CFP and CBP-HA plasmids. The difference between 
mammalian and fly proteins and the difference between in vivo and in vitro assay can 
be the explanation of these contradictory results. A novel report showed that Sirt1 
deacetylated the autoacetylated hMOF to improve its robust binding to nucleosomes, 
accompanied with increase of AcH4K16 and activation of gene transcription (Lu et al., 
2011). My results showed that MOF acetylated Sirt1 and repressed its deacetylase 
activity. This provides another possibility for the modulatory mechanism of Sirt1 
auto-deacetylation activity: The auto-deacetylated Sirt1 has high activity, while the 
autoacetylated MOF have reduced activity. Sirt1 can deacetylate MOF and increase its 
acetylation activity. Then MOF acetylates Sirt1 and attenuates its activity to form a 
negative feed-back loop. More interestingly, the acetylation sites seemed not to be the 
lysines for the auto-deacetylation by Sirt1 (such as K230), since the acetylation level of 
inactive Sirt1H355Y mutant was even lower as compared to the WT Sirt1 in presence 
of MOF (Fig 3.17D) and the acetylation of Sirt1 by MOF was also increased in the Sirt1 
K230R mutation (data not shown). Whether Sirt7 deacetylates MOF and increases its 
catalytic activity to repress Sirt1 by post-translational acetylation should be further 
explored.  
The mutation analyses showed that the K230R mutation increased Sirt1 
deacetylase activity. Indeed, Sirt1 efficiently deacetylated lysine 230 in in vitro 
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deacetylase assay using an acetylated Sirt1 derived peptide and recombinant Sirt1 
protein. These data suggest that the auto-deacetylation of Sirt1 mainly occurs on the 
lysine 230 residue. Furthermore, the multiple sequence alignment of Sirt1 homologs 
from various species clearly showed that K230 is shared among species, which indicates 
that auto-decetylation of Sirt1 may be conserved in different species. Interestingly, 
K230 is not localized in the conserved catalytic domain but in the N-terminal part of 
Sirt1. The available data suggest that the N- and C-terminal regions of sirtuins beyond 
the catalytic domain play a role in regulation of sirtuin functions. Moreover, multiple 
PTMs including phosphorylation, methylation and sumoylation, have been identified to 
target these domains (Flick and Luscher, 2012). In addition, initial studies suggest that 
PTMs identified within the N- and C-terminal domains of sirtuins may control the 
properties of their catalytic activity, polymerization, substrate specificity, and 
subcellular localization (Flick and Luscher, 2012). Using a serial multiple KR mutation 
strategy, I could demonstrate that beside the increased activity of Sirt1K230R mutant, 
the 3KR2 (without K369) mutation greatly enhanced the Sirt1 deacetylation activity on 
the p53 target as well, while, the other 3KR mutants and 4KR mutant failed to activate 
Sirt1. These findings indicate that a combination of acetylation and deacetylation at 
specific lysine residues is responsible for Sirt1 activiation. Besides that 
autodeacetylation of K230 increases Sirt1 activity, K369 has to be acetylated to preserve 
Sirt1 activity. Interestingly, the lysine 369 resides in the catalytic domain of Sirt1. As 
the acetylation of Drosophila Sir2 in the catalytic domain by dCBP was required for 
dSir2 activity (Zhao et al., 2009), the acetylation of lysines in the catalytic domain 
might indeed be necessary for the Sirt1 deacetylase activity. However, which 
acetyltransferase is responsible for this acetylation still remains elusive.        
My results highlight the importance of cross-regulatory circuits between two 
individual members of the nuclear sirtuins in organismal homeostasis and emphasize the 
role of posttranslational acetyaltion in the modulation of Sirt1 activity. Furthermore, my 
data demonstrate that Sirt7 can interact with Sirt1 and inhibit the activity of Sirt1, 
although the precise mechanisms of this effect are still unknown and need to be 
elucidated in future. The importance of the Sirt1/Sirt7 cross-regulation was revealed to 
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be pivotal to establish a well-balanced signaling network required for maintenance of 
metabolic homeostasis in vivo including the fasting/refeeding adaptation in liver and the 
adipogenesis in white adipose tissue. Based on the analysis of the Sirt7 deficient model 
in vivo or in vitro, I propose that the lack or decrease of Sirt7 will disturb the balance of 
the regulatory network resulting in an increased activity of Sirt1. Aberrant or 
pathologically sustained activation of Sirt1 distorts principally beneficial effects such as 
fat mobilization and prevention of adipogenesis causing metabolic dysfunctions. In WT 
cells, the adipogenic stimuli induce C/EBP expression followed by PPARγ expression, 
this central regulatory loop promotes adipogenic gene expression. C/EBP also induces 
the Sirt1 expression (Jin et al., 2010), Sirt1 then deacetylates itself and elevates its 
activity; the activated Sirt1 is recruited to the PPARγ promoter and suppresses the 
transcription of PPARγ through the epigenetic modification. Thus, this gradual 
suppression mechanism is able to control adipocytes differentiation at an appropriate 
degree to maintain the adipose homeostasis in vivo. During the adipogenesis, Sirt7 is 
also slightly up-regulated (Fig 3.7E) and negatively restricts auto-deacetylation of Sirt1 
to prevent the occurring of the continuous increase of Sirt1 activity. In the Sirt7 KO 
cells, because of the deficiency of Sirt7 inhibition, Sirt1 is highly activated and the 
auto-deacetylation leads to hyperactivation of Sirt1 and the repression PPARγ 
expression, thus the cells are prevented to enter the adipogenesis program upon the 
adipogenic induction resulting in the defect of differentiation. Further investigations 
will focus on the cross-talk between Sirt1 and Sirt7, and the double knockout mice may 
be the important tools, which will lead to a better understanding of these two sirtuins.
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5. Summary 
Sirtuins are NAD
+
-dependent protein deacetylases or ADP-ribosyltransferases, which 
play decisive roles in chromatin silencing, cell cycle regulation, cellular differentiation, 
metabolism, stress resistance and tumorigenesis. In mammals, sirtuins emerged as key 
metabolic sensors in various tissues and play a prominent role in metabolic adaptation 
to energy/nutrient stress. Sirt1 and Sirt6 are believed to act synergistically to prevent 
liver steatosis, especially under high-fat diet. Sirt1 and Sirt2 inhibit adipogenesis, and 
Sirt1 promotes the brown remodeling of white adipose tissue to control the metabolic 
balance in adipose tissue. Sirt7 was postulated to regulate rDNA transcription by 
associating with RNA polymerase I (Pol I) and maintain oncogenic transformation 
through deacetylation of histone H3K18, but the role of Sirt7 in metabolic regulation 
has remained enigmatic. Here, using the Sirt7 knockout mice and Sirt7 knock down 
approaches, my results describe the role of Sirt7 in maintenance of metabolic 
homeostasis in liver and the adipocytes differentiation in white adipose tissue. In liver, 
Sirt7 is required for the stimulation of hepatic rDNA transcription in response to insulin 
and is necessary for the fasting/refeeding adaptation. The second part of the study 
demonstrates the essential role of Sirt7 in adipocytes differentiation and white adipose 
tissue homeostasis. Absence of Sirt7 resulted in increased protein accumulation and 
activity of Sirt1 and restricted formation of white adipose tissue. In addition, my thesis 
shows that Sirt7 interacts with Sirt1 and restricts Sirt1 activity by inhibition of Sirt1 
auto-deacetylation. These data uncover a new level of complexity in regulation of 
sirtuin activity and identify autocatalytic posttranscriptional modification as a new 
principle for regulation of Sirt1 activity. The antagonistic interactions between the two 
nuclear sirtuins are crucial to establish a well-balanced signalling network required for 
the maintenance of metabolic homeostasis. In the last part of this thesis, two Sirt1 
targeting mouse strains were generated, which allow conditional, tissue specific 
inactivation of the Sirt1 gene and double knock out Sirt1 and Sirt7 in mice. These 
mouse models will help to further evaluate the sirtuin functions and the cross-regulatory 
network between Sirt1 and Sirt7 in the whole body or in the individual tissues.  
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6. Zusammenfassung 
Sirtuine sind NAD
+
-abhängige Protein Deacetylasen und/oder ADP-Ribosyltransferasen, 
die entscheidende Rollen in einer Vielzahl von Prozessen spielen. Dazu gehören: 
Zellzyklusregulation, Differenzierung, metabolische Regulation, Stressresistenz sowie 
Tumorentstehung und Chromatin-Remodellierung. In Säugetieren nehmen Sirtuine eine 
Schlüsselrolle als metabolische Sensoren ein und regulieren die Adaptation auf Energie- 
und Nährstoffveränderungen. Synergistische Funktionen wurden für Sirt1 und Sirt6 in 
der Leber beschrieben. Beide Sirtuine wirken der Entwicklung von Lebersteatose, 
insbesondere bei fettreicher Ernährung, entgegen. Bei der Differenzierung von weißem 
Fettgewebe (Adipogenese) wurde eine hemmende Wirkung von Sirt1 und Sirt2 
beobachtet. Des Weiteren, fördert Sirt1 die Entstehung von braunem Fettgewebe aus 
weißem Fett und kontrolliert somit die metabolische Balance im Fettgewebe. Für Sirt7 
wurde bislang eine Funktion in der Regulation der rDNA Transkription durch die 
Interaktion mit der RNA-Polymerase I postuliert, eine Rolle in der Regulation 
metabolischer Prozesse konnte bis jetzt aber noch nicht nachgewiesen werden. In 
meiner Arbeit konnte ich mittels der Sirt7 Knock Out Maus bzw. verschiedener Sirt7 
Knock Down Versuche belegen, dass Sirt7 eine Rolle in der Aufrechterhaltung der 
metabolischen Homöostase in der Leber und in der Differenzierung von Adipozyten in 
weißem Fettgewebe spielt. In der Leber ist Sirt7 für die Anregung der rDNA 
Transkription als Antwort auf eine Stimulation durch Insulin notwendig. Zudem konnte 
belegt werden, dass Sirt7 für eine Anpassung an Hungerphasen und anschließender 
Nahrungsaufnahme erforderlich ist. Im zweiten Teil meiner Arbeit konnte ich zeigen, 
dass die Funktion von Sirt7 in der Differenzierung von Adipozyten und in der 
Homöostase des weißen Fettgewebes essentiell ist. Hier resultiert der Verlust von Sirt7 
in einer vermehrten Proteinakkumulation und einer erhöhten Aktivität von Sirt1, die der 
Fettgewebsentstehung entgegen wirkt. Hier konnte durch meine Arbeit eine Interaktion 
zwischen Sirt7 und Sirt1 belegt werden, welche mit einem Aktivitätsverlust von Sirt1 
durch Inhibierung dessen Auto-Deacetylasefunktion einhergeht. Diese Ergebnisse 
decken eine neue Stufe der Komplexität der Aktivitätsanpassung der Sirtuine auf und 
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identifizieren eine posttranskriptionelle Modifizierung als einen neuen Weg der Sirt1 
Regulation durch dessen autokatalytische Aktivität. Die antagonistische Interaktion 
zwischen diesen zwei nukleären Sirtuinen ist entscheidend um eine ausgewogene 
Verknüpfung einzelner Signalwege herzustellen, die für die Aufrechterhaltung der 
metabolischen Homöostase notwendig sind. Im letzten Teil meiner Arbeit wurden zwei 
konditionelle Sirt1 Knock Out Mausstämme generiert, welche einerseits eine 
gewebsspezifische Inaktivierung von Sirt1 und zum anderen die gleichzeitige 
Ausschaltung von Sirt1 und Sirt7 in Mäusen erlauben. Die entstandenen Mausmodelle 
können helfen, die Funktionen von Sirt1 und Sirt7 und deren gegenseitige 
Beeinflussung im gesamten Organismus oder speziell in einzelnen  Organen genauer 
zu untersuchen. 
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7. List of abbreviations: 
A                  
ACC 
ACLY 
Adenine 
Acetyl-CoA carboxylase 
ATP citrate lyase 
AceCS1 Acetyl-coenzyme A (acetyl-CoA) synthetase 1 
ADP Adenosine diphosphate 
albCre Albumin Cre 
Akt/PKB  
ATP 
Protein Kinase B  
Adenosine triphosphate 
aP2 adipocyte protein 2 
BAC 
BGH 
BMP 
bp 
BSA 
C                
CBP  
cDNA  
C/EBP 
CFP  
ChREBP   
ChIP  
Cm 
CMV     
Co-IP  
CREB 
DAPI 
DMEM 
DMSO 
Bacterial artificial chromosom 
Bovine growth hormone 
Bone morphogenetic protein 
Base pairs 
Bovine serum albumin 
Cytosine 
CREB-binding protein 
complementary DNA 
CCAAT-enhancer-binding protein 
Cyan fluorescent protein 
Carbohydrate-responsive element-binding protein 
Chromatin immunoprecipitation 
centimeter 
Cytomegalovirus 
Co-immunopräzipitation 
cAMP response element-binding protein 
4',6-diamidino-2-phenylindole 
Dulbecco's Modified Eagle Medium 
Dimethyl sulfoxide 
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DNA 
DSB 
DTA 
DTT 
E. coli  
EDTA 
eNoSC 
ES 
FAS 
FCS 
FGF 
FOXO 
g 
g       
G   
GAPDH 
GFP 
GLUT 
h 
HA 
HBS 
HDAC 
HDL 
HE  
HEPES  
HIF        
HNF-4α  
IF       
IP 
Deoxyribonucleic acid 
Double-strand break 
Diphtheria toxin A 
Dithiothreitol 
Escherichia coli 
Ethylenediaminetetraacetic acid 
Energy-dependent nucleolar silencing complex 
Embryonic stem cell 
Fatty acid synthase 
Fetal calf serum 
Fibroblast growth factor 
Forkhead box protein O 
Gram 
Gravitational acceleration 
Guanine 
Glyceraldehyde 3-phosphate dehydrogenase 
Green fluorescent protein 
Glucose transporter 
Hour 
Hemagglutinin 
HEPES Buffered Saline 
Histondeacetylase 
High-density lipoprotein 
Hematoxylin and eosin 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Hypoxia-inducible factor 
Hepatocyte nuclear factor 4 alpha 
Immunofluorescence 
Immunoprecipitation  
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JNK 
kb 
kDa 
kg 
KO 
M 
MES 
MEF 
min 
ml 
mm 
mM 
MOPS 
MPI 
mRNA 
MS 
mTOR 
NAD
+ 
NAM 
NB 
Neo 
Ng 
NFκB 
nM 
NoRC 
OD600 
ORF 
P300 
PAF53     
c-Jun N-terminal kinases 
kilo-base pairs 
kilodalton 
kilogram 
Knock Out 
molar 
2-(N-morpholino)ethanesulfonic acid 
Mouse embryonic fibroblast 
Minute 
milliliter 
millimeter 
millimolar 
3-(N-morpholino)propanesulfonic acid 
Max-Planck Institute 
messenger RNA  
Mass spectrometry 
Mammalian target of rapamycin 
Nicotinamide Adenine Dinucleotide 
Nicotinamide 
Northern blot 
Neomycin 
Nanogram 
Nuclear factor kappa-light-chain-enhancer of activated B cells 
Nanomolar 
Nucleolar remodeling complex 
Optical density measured at a wavelength of 600 nm 
Open reading frame 
E1A binding protein p300  
Polymerase-associated factor 53 
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PBS    
PCAF  
PCR 
PEPCK 
PFA 
PGC-1 
PGK 
PI3 
pM 
PMSF 
Pol I 
PPARγ 
Pre-rRNA   
Q-PCR    
rDNA    
RNA 
RPM 
rRNA 
RT 
RT-PCR    
s  
SB       
SDS 
SDS-PAGE  
ShRNA    
SILAC    
SREBP 
SSC 
STAT 
Phosphate Buffered Saline 
P300/CBP-associated factor 
Polymerase chain reaction 
Phosphoenolpyruvate carboxykinase 
Paraformaldehyde 
Peroxisome proliferator-activated receptor gamma coactivator 1 
Phosphoglycerate kinase 
Phosphorus triiodide 
Picomolar 
Phenyl methyl sulfonyl fluoride 
RNA Polymerase I 
Peroxisome proliferator-activated receptor gamma  
Preribosomal RNA 
quantitative PCR 
Ribosomal DNA 
Ribonucleic acid 
Rotations per minute 
Ribosomal RNA 
Room temperature 
Reverse transcription PCR 
Second 
Southern blot 
Sodium dodecyl sulfate 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Small hairpin RNA 
Stable isotope labeling with amino acids in cell culture 
Sterol Regulatory Element-Binding Protein 
Saline-sodium citrate buffer 
Signal transducer and activator of transcription 
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T 
T3 
TBS 
TIP60 
TNF-α 
TORC 
TSA 
UBF 
UCP1 
UV 
V 
WT 
WAT 
YFP 
μg 
μl 
μM 
μm 
 
   
Thymine 
Triiodothyronine 
Tris-Buffered Saline 
HIV-1 Tat-inactive protein 60 
Tumor necrosis factor alpha 
Targets of rapamycin complex 
Trichostatin A 
Upstream binding factor 
Uncoupling protein 1 
Ultraviolet 
Volt 
Wild type 
White adipose tissue 
Yellow fluorescent protein 
micro gram 
micro liter 
micro molar 
micro meter 
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